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Theileria anmilata is a protozoan parasite of cattle of the genus Apicoinplexa, which
causes the life threatening disease Tropical Theileriosis. In susceptible animals
progression of this disease can be rapid with death occurring within 14 to 20 days
post infection. T.annulata infection is characterised by the proliferation of
macrophages (M0s) infected with the macroschizont stage of the parasite's life cycle.
This stage is closely associated with pathology but may also be the main stage against
which animals mount a protective response.
The aims of this thesis are to (1) examine the levels of MHC class II on infected
cells, (2) attempt to relate MHC class II expression to their T cell stimulatory ability,
(3) investigate the cytokine mRNA expression of infected cells and ascertain
correlations between this and the T cell reactions they induced, (4) study the
relationships between the cytokine mRNAs produced by infected cells and their
potential effects on pathogenesis. In vitro, T.annulata infected cells possess augmented
antigen presenting function and also the ability to activate resting naive/memory
autologous T cells in a contact dependent manner. In vivo infected cells have been
shown to congregate initially in the medulla of the draining lymphnode, where they
associate with and activate T cells.
This thesis investigates T cell stimulatory ability of T.annulata infected cells. Clonal
populations of T.annulata infected cells were generated from CD14' monocytes and
M9s, cultured and used to stimulate autologous naive T cells. T cell proliferation
assays showed the clonal cultures possessed different T cell stimulatory abilities.
Previous work showed that infected cells expressed elevated levels of MHC class II
molecules. These molecules are involved in the stimulation of T cells and the
possibility that the signals involved in nonspecific T cell activation were linked to
MHC class II expression was investigated. Expression levels of MHC class II
molecules by the clonal cultures did not correlate with the T cell stimulatory ability
of the infected cells. After this finding the production of cytokine mRNA by infected
cells was investigated. Cytokines are known to play major roles in the control of
cellular activation/proliferation and immune responses.
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During this study the production of cytokine mRNA specific for: IL-la; IL-1P; IL-2;
IL-4; IL-6; IL-10; TNFa and IFNy by clonal populations of infected cells were
investigated using reverse transcriptase polymerase chain reaction (RT-PCR).
Experiments showed that parasitised cells produce cytokine mRNAs typically
associated with cells of the monocyte/M9 lineage. Limiting cycle RT-PCR was then
employed to study differences in the levels of cytokine mRNAs produced by the
different infected cell populations. This showed that variation in the T cell
proliferation induced by the various populations of infected cells positively correlated
with the levels of T cell stimulatory cytokine mRNAs produced by the infected cells.
T cell proliferation assays showed the in vitro nonspecific T cell response peaks at
day 5 post stimulation. The cytokine profiles of the responding T cells were then
investigated from days 1 to 7. It was found that the T cell response following
stimulation with infected cells always skewed to a Th, like response and that the
differences in induced proliferation did not correlate with the levels of IL-2 and IL-4
produced by the responding populations. This suggested that infected cells possess
the ability to manipulate T cell activity and that this would appear to occur via
infected cell/T cell contact and T cell stimulatory cytokine production by the infected
cells. Study also showed that infected cells initiate a none protective Thj like
response, before leaving the node to enter the periphery.
The main method of control of T.annulata in many areas of the developing world is
the immunisation of animals with attenuated T.annulata infected cell line vaccines.
Long term in vitro culture of infected lines has been employed to produced successful
vaccines. The mechanisms of attenuation are poorly understood. Following the
findings that cytokine production by infected cells may have important consequences
with respect to the induction of pathology and the control of immune responses during
T.annulata infection, a clinical trial was performed to assess the efficiency of two of
the clonal cultures as cell line vaccines. The two clones chosen (clones I and L)
differed greatly in the levels of T cell stimulatory cytokine mRNA they produced and
the levels of T cell proliferation they induced. Clone I induced low levels of T cell
proliferation and produced low levels of cytokine mRNA, whilst clone L induced high
levels of T cell proliferation and produced higher levels of cytokine mRNA. After
inoculation of three animals with each of these cell lines and analysis of the data
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obtained (temperature, red/white blood cell counts, packed cell volume) it was found
that the severity of the infection induced by clone L was greater than that induced by
clone I. However, challenge of these animals some 60 days later showed all six to
be equally resistant to infection with a lethal dose of T.annulata sporozoites.
In summary, this thesis shows that the levels of T cell stimulatory cytokines produced
by T.annulata infected cells correlate with the proliferative response of autologous T
cells cultured with infected cells but that the levels of T cell proliferation do not
correlate with the levels of autocrine cytokines produced by the proliferating T cells.
The findings of this study also suggest that assessment of T cell stimulatory ability
and cytokine mRNA production can aid in the selection of putative cell line vaccines.
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Chapter I.
Theileria annulata, Tropical Theileriosis and The Immune System.
Introduction.
In the developing world many farmers continue to operate on a subsistence basis (eg,
80% of African farmers (Innes et al, 1992)). Cattle are of high importance to many
of these farmers and especially european breeds very much so due to the low
productivity of local breeds of cattle (Pino, 1981). The practice of importing exotic
european breeds is attractive to many governments as a method of improving
productivity (Gill et al, 1980).
A serious drawback to these attempts to improve stock has proved to be tick borne
diseases such as theileriosis and babesiosis (Uilenberg et al, 1993). This thesis
concerns tropical theileriosis, the disease caused by the protozoan parasite Theileria
annulata. A study in 1982 estimated that in excess of 250 million cattle were at risk
from tropical theileriosis world wide (Robinson, 1982). Investigations have also
shown the disease to be a significant burden upon the economies of developing
countries, e.g. losses of at least S15 million per annum in Morocco (R.L.Spooner, pers.
comm).
T.annulata is transmitted by ticks of the genus Hyalomma, whose distribution ranges
from southern Europe, the USSR and the mediterranean littoral to China and The Far
East (Purnell, 1978; Robinson, 1982). Entry of the infective stage of the parasite (the
sporozoite) into the host is via a tick bite, with the parasite then localising in the
draining lymph node. Within the node the parasite develops into the macroschizont
stage which resides within host leucocytes. Infected cells proliferate rapidly, with
infected cells then moving to the peripheral circulation and infiltrating many host
tissues (Neitz, 1957; Barnett, 1977). The parasite is able to pass back into feeding
ticks after macroschizont infected cells produce microschizonts, which give rise to
merozoites. After release merozoites invade erythrocytes forming the piroplasm stage
of the life cycle, infecting ticks after ingestion and forming new sporozoites within the
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tick salivary glands.
Infected susceptible cattle suffer a range of symptoms following infection. These
include: fever; anaemia; respiratory distress and cachexia (Barnett, 1977). There is
some mortality and morbidity in endemic cattle but by far the worst problems occur
when susceptible exotic cattle are introduced into areas where T.annulata is present
(Hashemi-Fesharki, 1988; Uilenberg et al, 1993). The mortality rates recorded in
exotic cattle vary between 40-70% (Uilenberg et al, 1993; Brown, 1990) but can be
as high as 90%, severely reducing the productivity of affected areas (Robinson, 1982;
Hashemi-Fesharki, 1988).
It is possible to control infection by the use of accaracides (controlling tick numbers)
and to protect susceptible animals by immunisation with attenuated infected cell line
vaccines (Pipano, 1981; Hashemi-Fesharki, 1988) and chemotherapy (McHardy et al,
1985; Dhar et al, 1990) but these approaches are expensive, time consuming and prove
an extra burden upon developing areas.
Vaccine production and dosage have not been standardised, with methods of
production and immunisation protocols varying from country to country, with groups
sometimes using large cell doses to produce protection (Adalar et al, 1994). There are
a number of drawbacks to cell line immunisation which include: production and
distribution of vaccines; the waning of immunity if animals are not challenged
(Pipano, 1977; Baylis et al, 1993); revaccination with the same cell line results in a
reduction in protection (Ouhelli et al, 1994; Nichani et al, 1997). These problems
show that further work into vaccine development and production remains to be carried
out.
There has been much research into the behaviour of the parasite in vitro and has led
to the discovery of a number of interesting characteristics of infected cells. It was
shown in vivo that only macroschizont infected cells need to be present to induce all
the symptoms of tropical theileriosis (Hooshmand-Rad, 1976) and in vitro studies have
demonstrated that these rapidly proliferating cells can have dramatic effects upon
autologous T cells when cultured together (Glass et al, 1990; Campbell et al, 1996).
It was found that infected cells generally expressed high levels of Major
histocompatibility complex (MHC) class II molecules and that when T cells from
2
naive animals were cultured with macroschizont infected cells they were induced to
proliferate (Glass et al, 1990; Rintelen et al, 1990; Spooner and Glass, 1990a). This
T cell activation is contact specific and can be blocked by the presence of anti MHC
class II or anti CD4 mAbs (Campbell, pers. comm.).
The infected cells also caused responding T cells to always produce a T helper type
1 cytokine response, producing high levels of Interleukin 2 (IL-2) and Interferon
gamma (IFNy) but low levels of Interleukin 4 (IL-4) (Nichani, 1994; Campbell, 1995).
The mechanism by which responding T cells become activated is unknown but work
by Campbell et al (1995) showed that T cell activation and proliferation was contact
dependent and Preston et al (1992) found high levels of macrophage (M0) associated
cytokines (such as Tumour necrosis factor a (TNFa) and Interleukin 1 (IL-1)) present
when peripheral blood mononuclear cells (PBM) were incubated with infected cells.
These cytokines appeared to have no deleterious effect upon infected cells and it was
speculated that they may exacerbate theilerial infections and possibly enhance the
growth of infected ceils (Preston, Brown and Richardson, 1992). High levels of
cytokines such as these are observed in cases of septic shock (Waage et al, 1989;
Creasy et al, 1991). This may relate to a number of the symptoms observed during
tropical theileriosis, such as, cachexia, fever and respiratory distress.
This study investigates the roles of MHC class II and cytokine expression by cells
infected with T.annulata in the immunopathology of tropical theileriosis. The
phenomenon of non-specific T cell activation by infected cells and the possibility that
damage observed in the lymph nodes of animals undergoing infection may be due to
inappropriate stimulatory abilities of infected cells is investigated.
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The aims of this study are:
(1) To quantify the levels of MHC class II expression by infected cells.
(2) To attempt to relate the MHC class II expression to the T cell stimulatory
ability of the infected cells.
(3) To investigate cytokine mRNA expression of infected cells and ascertain
correlations between this, T cell stimulatory ability and the T cell reactions
induced.
(4) To study the relationships between cytokine mRNA production by infected




Theileria aruudala, the parasite, infection and immunity.
This thesis investigates the host response to the protozoan parasite Theileria annulata.
The parasite infects cattle, causing the disease Tropical theileriosis and induces high
levels of mortality and morbidity within endemic areas. This study relates to the
infection of exotic animals (nonindigenous species of cattle) by this parasite and to in
vivo reactions post infection.
Section 1.1.
The taxonomy of Theileria spp.
The protozoan parasite T.annulata was first discovered in 1904, in Russia by
Dschunkowsky and Luhs (Melhorn & Schein, 1984). Despite the fact that both
piroplasm and schizont forms of T.parva were probably observed by Koch, T.annulata
and T.parva were originally named Piroplasma (reviewed by Norval et al, 1992). Work
by Bettencourt et al, resulted in renaming them as Theileria in 1907.
Taxonomic studies have revealed 39 species of Theileria (Levine et al, 1988),
however, the actual number is almost certainly lower, with a number of the species
names being synonyms (Uilenberg, 1981). Because T.annulata and T.parva induce the




















Table 1.0 Taxanomic classification of Theileria spp.
The table above is adapted from Irvin (1987) and Norval et al, (1992)
and shows the taxanomic classification of Theileria Spp from kingdom
to genus.
T.annulata and T.parva share a common lineage with malarial parasites but diverge
from these related protozoans to form the Piroplasmida. This divergence in
classification is due to the lack of crystalloid and pigment in the Piroplasmida, as
opposed to their presence in the Eucoccidian malarial parasites. There are only two
types of organisms in this order, which are Theileria and Babesia (Barnett, 1977).
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Section 1.2.
Geographical distribution of the T.annulata and T.parva.
Areas affected by T.annulata range from across the mediterranean littoral, Southern
Europe, North Africa, southern former USSR, to the Middle East, India, China and
The Far East (Purnell, 1978; Robinson, 1982), as shown in the Diagram 1.
T.parva has a much more restricted distribution, being present only in Africa. Within
this continent affected areas are concentrated around the Eastern coast but the parasite
has also been detected in central and southern regions (Norval, 1992; Uilenberg et al,
1993). The territories affected by these two parasites only overlap in the Sudan
(Norval 1992).
Diagram 1. The geographical distributions of T.annulata and T.parva.
A map showing the distibutions of T.annulata (shown in red) and T.parva
(shown in green).
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The reasons for the differences in the distributions are not fully known, however, they
are probably related to the distributions of their respective invertebrate hosts. These
two Theileria species are transmitted to their bovine hosts by ticks, with the two
parasites favouring different tick species as vectors. T.annulata has been shown to be
transmitted exclusively by ticks of the genus Hyalomma (Purnell, 1978), whilst
T.parva is mainly transmitted by ticks of the genus Rhipicephalus (Norval, 1992) but
can also be transmitted by some Hyalomma ticks. Robinson demonstrated in 1982
that 15 species of Hyalomma ticks were capable of transmitting T.annulata but the
most widely recognised vector species are H. anatolicum anatolicum and H. detritum.
These ticks both have wide distributions, with H. a. anatolicum being present from
North West Africa through to India, with the distribution of H. detritum ranging from
the Far East, India to the former USSR (Norval, 1992). The main cause of the
differences in distribution of these protozoan parasites is therefore probably the
differences in vector distribution.
Section 1.3.
Life cycle of T.anrudata.
Development within the tick.
The life cycle of T.annulata is shown in Fig 1.1. Ticks become infected when they
feed upon an infected animal, ingesting a blood meal consisting of piroplasm infected
red blood cells (RBC). Once the RBC pass into the tick's digestive tract, the changes
in environment cause them to lyse. This lysis initiates sexual reproduction of the
parasite. Schein (1975) showed that gametes were detectable 4 to 6 hours following
ingestion and that zygotes became visible within the wall of the gut after 3 days. The
zygote then matures to form the kinete; this stage of the parasite is motile and has
a characteristic club shape. Following the formation of this stage, the kinete leaves the
gut wall and enters the haemolymph, migrating to the salivary glands. The duration
of this migration is variable and has been reported to take from 7 to 20 days, which
may be reliant on the moult stage of the tick (Schein and Friedhoff, 1978; Reid and
Bell, 1984).
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Fig. 1.1 The life cycle of the protozoan parasite T.aiuudata.
A diagram depicting the life cycle of T.annulata, showing
the vector stages (within the tick) on the left and the stages
within the bovine host on the right. Sporozoites enter the
bovine host via a tick bite, infecting and replicating within
leucocytes. Later stages of the life cycle (merozoites) infect

















T. annulata life cycle.
(Taken form Nichani, 1994).
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Penetration of the kinete into the salivary glands only takes place following moulting
of the tick (Melhorn and Schein, 1984). Once in the salivary glands the kinetes invade
acinii and replicate (Schein and Friedhoff, 1978), forming large masses of parasite
material which can be seen to contain nuclear and mitochondrial material (Reid and
Bell, 1984). Replication within the salivary gland is only possible after the tick has
commenced feeding (Melhorn and Schein, 1984).
Sporozoite maturation and transmission occurs when an infected tick feeds on a
susceptible host (Robinson, 1982). If an infected tick feeds on a non susceptible host
the sporozoites are induced to mature but are not passed to the host. This phenomenon
has been used to obtain mature sporozoites for use in in vitro infections. Infected ticks
of the species H.a.anatolicum fed on rabbits, undergo an increase in sporozoite burden
which peaks after three days of feeding (Walker and McKellar, 1983). Maturation has
also been linked to high temperatures (Samish et al, 1977), which has led to
speculation that ticks which become infected in areas with high temperatures may be
infective much sooner than those carrying T.annulata in cooler climates.
Transmission of T.annulata is transtadial, with the parasite being passed from tick to
host following moulting to form the next instar (Robinson, 1982). Robinson suggests
that transovarial transmission of T.annulata is of little importance. The ticks implicated
in this phenomenon (namely H. scupense and H. rufipes) are one host ticks and
therefore not major vectors of T.annulata. It would thus seem logical to assume that
transovarial transmission is of little relevance to infection in the field.
The act of engorgement by a tick on a susceptible animal stimulates maturation of the
sporozoites within the tick and causes disruption of the parasite material within the
acinii. The parasite material begins to contain aggregates or particles (Reid and Bell,
1984), with these particles forming the rhoptries characteristic of parasites of the
phylum Apicomplexa. As noted previously this does not occur if the infected ticks
feed on nonsusceptible hosts, with sporozoite development halting at replication and
not forming discreet particles or rhoptries.
The passage of infective sporozoites from vector to host occurs after sporozoite
maturation, whilst the tick is feeding. Developed sporozoites pass from salivary acinii
during feeding and enter the peripheral circulation of the host. The parasite burden of
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ticks has been estimated at an average of 50000 sporozoites per acinus. One tick can
have a number of infected acinii, meaning that ticks provide an extremely large
reservoir of parasite material (Melhorn and Schein, 1984).
Development within cells of the vertebrate host.
After subcutaneous inoculation by infected ticks and passage into the lymphatic
system, sporozoites come into contact with host cells. In vitro study of the entry of
sporozoites into bovine cells has shown that this stage of the parasite first attaches
to the host cell. The sporozoite is then able to penetrate the membrane and reside
within the host cell cytoplasm as little as 5 to 10 minutes after initial contact (Jura
et al, 1983; Fawcett et al, 1982). When the parasite and the cell come into contact the
membrane boundaries appear to merge and the parasite sinks into a depression formed
in the host cell. As this depression deepens the host cell membrane begins to cover
the parasite. This results in the reformation of the host cell membrane and the
presence of the parasite within a vacuole bounded with residual host cell membrane
(Melhorn and Schein, 1984).
Sporozoites have been observed to attach to the host cell in various orientations, which
do not show the apical complex binding to the host cell membrane. This suggests a
mode of entry into cells different from those used by other protozoan parasites such
as: Toxoplasma; Sarcocystis or Eimeria spp (Melhorn and Schein, 1984). Once within
the cytoplasm of the host cell, the outer layer of residual host cell cytoplasmic
membrane disintegrates and the parasite begins to enlarge. This differs from Eimeria
and Plasmodium Spp, which retain their outer membrane to form a parasitophorous
membrane (Melhorn and Schein, 1984).
The invasion and in vitro "transformation" of cells after infection with T.annulata has
been shown to be a temperature dependent process (Hulliger et al, 1964; Jura et al,
1983) (infected cells are referred to as "transformed", as continuously growing cell
lines are formed from infected cells). This involves the invading sporozoites maturing
to a single trophozoite, within the cytoplasm of the infected cells, which is followed
by division of the parasite material and the formation of a macroschizont.
Parasite replication within the host cell occurs by binary fission, forming large
11
schizonts containing numerous smaller nuclei (Melhorn and Schein, 1984). Soon after
this process begins the host cells are induced to divide. Parasite replication
synchronises with that of the host cell and has been shown to occur during the G2,
phase of the cell cycle (Jura et al, 1985). During cell division spindle formation occurs
within the host cell, with parasite material aligning along these spindles soon after the
trophozoite stage (Hulliger et al, 1964). During host cell division parasite material
moves with the spindles to infect both daughter cells. The division of infected cells
has been shown to displace uninfected host lymph node tissue (Melhorn and Schein,
1984) and to cause enlargement of lymphoid tissue (Neitz, 1957; Barnett, 1977).
The replication of Theileria spp was studied by Hulliger et al (1964) and it was found
that parasite replication (but not replication of the infected cells) was resistant to the
spindle inhibitor colchicine. Infected cells treated with this drug failed to divide,
however, the parasite within these cells continued to divide. This suggests that the
mechanics of division, employed by the parasite are separate from those of the cells.
However, it would appear that if the infected host cell is prevented from dividing,
parasite division is eventually inhibited, as toxic effects (such as foamy changes in
cytoplasm and giant cell formation) in the infected cells are observed. This is seen to
occur as the number of parasite particles increases to around 100 per cell (Hulliger et
al, 1964).
If the infected cells are not chemically treated, they undergo schizogony and continue
to divide, producing many infected daughter cells. Infected cells have been shown to
begin to produce merozoites by 8-10 days after infection. Merozoites are the stage of
the parasite which infect RBCs in vivo and later produce piroplasms. The trigger for
merozoite formation is not totally understood but work by Sheiles et al (1994), shows
that temperature increases induce merozoite formation in vitro. This is possibly linked
with the onset of fever, which is a symptom of infection (Neitz, 1957). Rupture of the
infected cell releases the merozoites and these then contact and invade erythrocytes.
These merazoites now form piroplasms and can either be ovoid/circular in shape,
possessing an area of nuclear material at one pole (giving the appearance of a signet
ring to the piroplasm) or comma shaped. Of these two forms it is only the comma
shaped forms of the parasite which are able to divide, doing so by binary fission. The
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numbers of RBCs which can become infected can be very high, with severe cases
showing 90% infection (Melhorn and Schein, 1984). The presence of piroplasms
within RBCs leads to their ingestion during tick feeding and the infection of fresh
ticks to continue parasite dissemination.
Section 1.4.
The vertebrate host and susceptibility.
Although various different Theileria spp are known to infect sheep and goats, the main
hosts of T.annulata have been shown to be: buffalo, yak, cattle and crosses of these
animals (Barnett, 1977; Wenshun, 1994). Cells from other animals such as sheep and
goats can be infected by T.annulata sporozoites in vitro but genuine field cases have
not been observed (Steuber et al, 1986). Infection of indigenous breeds of cattle or
buffalo usually result in mild infections (Hashemi-Fesharki, 1988). It has also been
shown that the majority of animals within enzootic areas ofMorocco carry antibodies
specific for T.annulata (Oudich et al, 1993) and local breeds were much less likely to
exhibit clinical disease than Friesians imported to boost milk yields.
The main economic problems occur when exotic breeds of cattle are introduced into
endemic areas to increase the productivity of local stock. The mortality rates shown
in the literature vary from account to account, with a review by Robinson (1982)
stating up to 90% mortality in exotic breeds and only 5% in local breeds, whereas
figures given by Hashemi-Fesharki (1988) show mortality rates of 40-80% in exotic
breeds and 10% in indigenous breeds in Iran. There are several factors which may
cause these variations, including differences in parasite virulence from area to area,
differences in vector life cycles, levels of parasite burden (numbers of infected ticks)
and also differences in the resistance of indigenous cattle to T.annulata infection.
These factors make direct comparisons of infections within different areas difficult.
However, it can be seen from the literature that the mortality induced by this
protozoan in indigenous breeds of cattle is much lower than those of imported breeds,
although infection rates are similar (Oudich et al, 1993).
However, losses due to mortality are not the sole problem because animals which do
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not die or exhibit severe clinical disease will generally show a decrease in productivity
due to T.cmnulata infection. The levels of morbidity induced by infection are more
difficult to calculate than the mortality rates, resulting in less reliable data concerning
these losses. However, field observations by veterinarians in Morocco suggest
significant losses in the productivity of indigenous breeds as well as imported cattle
(Flach, unpublished observations).
The mechanism or mechanisms of resistance to T.annulata infection exhibited by
indigenous breeds is as yet unknown. This is because of difficulties in the study of the
genetics of resistance in cattle (due to a lack of suitable markers). However, one study
has shown that Bos taurus x Bos indicus cattle are slightly more resistant to infection
than pure Bos taurus cattle (Preston et al, 1992a). This study does not however, agree
with data from India, where the majority of cattle are cross breeds and yet tropical
theileriosis is still a major problem (Grewal et al, 1991). Another problem which
complicates studies into resistance is that the vast majority of indigenous cattle
surveyed have generally already been exposed to the parasite (Flach and Ouhelli,
1992), thus making comparisons of resistance difficult.
Section 1.5.
Clinical disease and Pathology.
The pathology in susceptible cattle observed in T.annulata infection includes
pronounced anaemia (with "thin" blood and pale muscles), lymphoid hyperplasia,
haemorrhage of the draining lymph node, enlargement of the liver and spleen, oedema
and dyspnoea, necrotic lesions in intestinal tract and anorexia (Neitz, 1957; Barnett,
1977; Samantery et al, 1980; Preston et al, 1992a).
Most of the pathology and clinical disease caused by T.annulata infection is probably
due to the schizont stage of the parasite life cycle, during which infected cells
undergo rapid proliferation (Barnett, 1977; Melhorn and Schein, 1984; Pipano et al,
1971; Hooshmand-Rad, 1976). Also, severe clinical cases can be observed in calves
which did not exhibit a piroplasm stage to their parasitaemia (Pipano et al, 1971).
The onset of clinical symptoms is variable, typically between 9-24 days after
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infection (Barnett, 1977) and depends on a number of factors such as tick burden and
virulence of the protozoan parasite. However, following even the heaviest of infected
tick infestations the onset of clinical disease is not observed before 5 days (Barnett,
1977).
One to two days prior to the onset of fever, swelling of the lymph node draining the
site of tick infestation can be seen and lymph node biopsies show small numbers of
cells containing a small number of schizonts. Within 2-5 days of the enlargement of
the draining lymph node piroplasms can be seen in circulating RBCs. This is also
observed when the disease is induced by the experimental inoculation of sporozoites
(Nichani, 1994; Campbell, 1995). After the onset of fever, schizonts can be found in
the majority of tissues (which show hypertrophy) and also in the spleen and liver
(Barnett, 1977). In severe cases the fever (in cattle a temperature of 39.5°C or above)
becomes persistent and usually remains until either death or recovery. In some cases
there is a remission in fever around the fifth day post infection, with fever rising once
again after this.
During the early stages of the febrile period the animal eats normally but appetite is
seen to decrease as fever continues. The animal then begins to lose weight rapidly and
also loses coat condition. Around this time the faeces increases in water content and
diarrhoea follows, often containing blood and mucus. Animals also often develop a
sporadic cough, accompanied with nasal and ocular discharges. During the onset of
severe disease, petechial haemorrhages of serous and mucous membranes occur and
oedema in the lungs causes respiratory distress (Neitz, 1957).
The presence of the parasite has profound effects on the peripheral blood cell pool.
Progressive leucocytosis is a characteristic of T.annulata infection, with white blood
cell (WBC) counts rising from around the normal 10000 cells/mm3 to numbers as
great as 36000 cells/mm3 (Barnet, 1977). The RBC counts are also affected as the
disease progresses, with counts generally falling severely in the later stages of
infection and producing a profound anaemia. These symptoms of increased white cell
counts and decreased RBC counts are typical of T.annulata infection and are probably
the most pronounced differences between this infection and that caused by T.parva
(which causes WBC numbers to fall and only slight changes in RBC counts, as
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reviewed by Losos, Infectious Tropical Diseases of Domestic Animals, Chapter II).
It has been suggested that the loss of RBCs during T.annulata infection could be due
to the destruction of cells when the erythrocytic stage of the life cycle (the piroplasms)
cause RBC lysis. However, this phenomenon is now known to be associated with the
removal from the circulation of infected RBCs by the spleen and liver, although the
mechanism for removal is not entirely understood (Uilenberg, 1981). Changes in RBC
numbers may be linked to the presence of inflammatory cytokines, especially Tumour
Necrosis Factor a (Bielefeldt-Ohmann et al, 1989; Sileghem et al, 1994; Morrison et
al, 1981), during illness and this possibility will be discussed in detail later
The multiple lesions seen in severe cases of tropical theileriosis and the presence of
infected cells within many organs may be linked to the ability of infected cells to
metastasise. Work by Baylis et al (1994) has showed that infected cells are capable
of digesting basement membrane material and to metastasise and penetrate through
basement membranes. This characteristic may be linked with the expression of
metalloprotease enzymes by the infected cells and may account for their ability to
infiltrate other tissues (Baylis et al, 1994; Forsyth et al, 1994).
Section 1.6.
Prevention and treatment of infection.
The control of T.annulata infection has involved numerous strategies, such as: use of
acaracides to decrease tick numbers, cross breeding of cattle to reduce susceptibility,
infection of animals with sporozoites followed by chemotherapeutic treatments,
administration of attenuated macroschizont infected cell line vaccines (McHardy et
al, 1985; Hashemi-Fesharki, 1988; Brown, 1990) Of these approaches the most
commonly used is that of the administration of attenuated schizont infected cell line
vaccines.
However, all of the methods of control listed have drawbacks associated with their
use. Acaracides and prophylactic treatments are expensive to use, with these agents
usually being supplied by the developed to the developing world. Cross breeding of
animals has failed to produce cattle with the required resistance to T.annulata
infection, possibly due to the inherent difficulties associated with the study of
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resistance in outbred populations). Infection and treatment regimes run the risk of
inducing pathology prior to treatment, plus, as mentioned, chemotherapeutic agents are
generally expensive.
Attenuation of infected cells is associated with the in vitro passage of this protozoan
parasite (Hulliger et al, 1964; Gill, 1976; Pipano, 1977). Propagation of infected cells
in vitro, appears to alter the reactions induced between infected cells and the bovid
host. If vaccines are passaged through bovid hosts, they retain a higher level of
virulence than if simply kept in tissue culture, as shown by the S3 challenge strain
used in Iran (Hashemi-Fesharki, 1988). The main problem with the use of attenuated
cell line vaccines is the high cost of tissue culture maintenance of infected cell lines.
However, these cell line vaccines produce strong immunity, which if boosted by
natural infection can protect animals for long periods (Baylis et al, 1993). Also once
a vaccine is available many cattle can be quickly vaccinated, thus reducing the cost.
The mechanism by which the parasite decreases or loses virulence is still unknown
and production of a vaccine line of reproducibly low virulence often takes up to two
to three years. Attenuation of cell lines may be due to negative selection of virulent
cells during in vitro culture, as suggested by Hooshmand-Rad and Hashemi-Fersharki
(1968). This work demonstrated that virulent lines showed the lowest ability to adapt
to in vitro culture.
Further investigations into the mechanisms which may be involved in the loss of
virulence of T.annulata infected cells include, (1) studies of the metalloprotease
activity of macroschizont infected cells (Baylis et al, 1994), (2) alterations in the
frequency of certain parasite associated alleles, suggesting selection of different
populations of cells in long term culture (Littlebury et al, 1994) and (3) studies of
differences in glucose-phosphate-isomerase types and restriction fragments revealed
by two parasite specific cDNA probes, between virulent and attenuated lines, plus also
the expression of a possible parasite and virulence marker bound by the mAb EU106
(Preston et al, 1994, 1996). These and other possible mechanisms of attenuation will
be discussed further in later chapters.
Other problems associated with this method of tropical theileriosis control are those
of cryostorage and transportation in hot climates. In addition there are the difficulties
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ofmaintaining sterile culture conditions, preserving the purity of the vaccine line and
preventing contamination with other pathogens.
However, attenuated cell line vaccine administration remains the favoured procedure
for the protection of naive animals from field challenge. Various studies have been
carried out to assess the most reliable method of vaccine administration (Gill et al,
1980; Ouhelli et al, 1989). These studies show that administration of infected cells to
naive animals produces solid immunity to challenge with various strains of T.annulata.
This means that a cell line vaccine can be used to immunise animals over a wide
area, even if this area contains a range of parasite strains (Gill et al, 1980).
The numbers of infected cells necessary to produce immunity to T.annulata can vary
greatly (Ouhelli et al, 1989) and that vaccination is most efficient when administered
as a heterologous cell line (Innes et al, 1989). During the study by Ouhelli et al
(1989), it was found that reactions to vaccine lines, (which in this case were
unattenuated), such as induction of fever, did not correlate with the dose of vaccine
given. Also some animals which were given only 102 infected cells showed more
severe symptoms than those given higher doses (Ouhelli et al, 1989). However, the
generally accepted dose range of vaccine administered today is between l-5xl06
heterologous infected cells, administered subcutaneously, usually in the shoulder
(Ouhelli et al, 1989). Innes (1989) showed that the use of a non Major
Histocompatibility Complex (MHC) matched cell line to vaccinate animals, led to less
severe reactions than when a homologous cell line was used as a vaccine. This may
relate to the way in which the host detects and responds to the presence of infected
cells expressing autologous MHC molecules.
Possible reasons for these phenomena are: administration of a low dose may not
trigger a strong enough anti-parasite immune response quickly enough to prevent
parasite cross over and development of parasite within cells of the recipient. Once the
parasite crosses over into the cells of it's new host, it may be able to replicate
unhindered (due to the lack of an anti-MHC response), producing large numbers of
parasitised cells before the immune system begins to react to the presence of parasite
infected cells. Similarly, use of an MHC matched line may allow the infected cells to
undergo many more rounds of replication with no anti MHC response to remove them
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from circulation. Innes et al (1989) showed that when an allogeneic cell line infected
with T.annulata was used to immunise animals, an initial cytotoxic T lymphocyte
(CTL) response was directed towards the MHC class I molecules, also that parasite
cross over into cells of the recipient was essential for the production of a protective
response. But later in infection the CTL response was directed towards the infected
recipients cells. It was concluded that the initial anti MHC response aids in the delay
of the onset of parasitaemia and allows the host to mount a more effective response
once the parasite transfers to the recipient host's own cells. This obviously cannot
occur when an autologous vaccine line is used.
Another problem with attenuated cell line vaccines, is that of post vaccinal reactions.
These reactions occur in animals around days 15 to 20 post vaccination and are
characterised as subacute episodes of tropical theileriosis (slight fever, loss of appetite
and lethargy) (Dr R. L. Spooner, pers. comm.). The reason for established vaccine
lines causing mild disease are unknown but may result if vaccine lines are not fully
attenuated. Despite all these drawbacks, use of attenuated vaccines provides the most
reliable, widely available protection against T.annulata infection.
Chemotherapeutic treatment, though expensive, does provide a final line of defence
against infection with this parasite. A number of drugs have been used to treat tropical
theileriosis, with most being quinoid derivatives which act on the respiratory chain
of the parasite but not the mammalian respiratory chain. The most successful of the
chemotherapeutic agents used are derivatives of the hydroxynapthoquinone compound
parvaquone. The two most widely employed agents are Parvaquone (Clexon;
Wellcome) and Buparvaquone (marketed as Butalex, Mallinckrodt Veterinary Ltd). In
a study of the effectiveness of these two drugs McHardy et al (1985) showed
buparvaquone to be 20 times more effective at clearing T.parva and T.annulata
infections than was parvaquone. The increase in efficiency of Butalex being due to
alkylation of the hydroxynapthoquinone. This process removes the cyclohexyl moiety,
which the host can metabolise (through hydroxylation), to remove the drug from
circulation. This increases the length of time that the drug stays in the host circulation
and therefore increases the exposure of the parasite to this drug.
Treatment with Butalex during a T.annulata infection results in strong immunity to the
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parasite (Dhar et al, 1990), with treated animals resistant to 30 times the LD50 dose
of sporozoites (Kumar et al, 1990; Samantery et al, 1980; Preston et al, 1992a). A
dose of sporozoites is measured in tick equivalents (TEs), 1TE being equal to the
sporozoites contained in the acinii of one engorged tick and producing an approximate
LD50 (Samantery et al, 1990; Preston et al, 1992a). The production of solid immunity
post treatment shows that removal of living parasite from an infected host, allows the
production a protective anti-parasite immune reaction. The reactions induced are
capable ofprotecting the host from either field infection or experimental infection with
either sporozoites or a schizont infected cell line (Samantery et al, 1990; Preston et
al, 1992a). Elowever, Butalex treatment is very expensive when compared to the
income of the average third world farmer and infection and treatment may cause
significant falls in milk yields (Dr R. L. Spooner, pers. comm.)
Attempts were made to use killed schizont infected cells to immunise animals.
However, this method resulted in a lack of protection against challenge with
T.annulata (Pipano et al, 1976; Hashemi-Fesharki, 1988). These findings suggest that
the presence of live parasite is necessary to allow the production of immunity. It
should also be noted that since a single T.annulata stock can immunise against stocks
from different areas, the parasite does not appear to utilise high levels of antigenic
variation to evade the immune system (as do certain organisms, such as Trypanosomes
(Borst, 1982; Donelson and Turner, 1985)). It would seem that T.annulata employs an
alternative strategy to evade the immune system.
Section 1.7.
Immunity to T.amudata infection.
Although susceptible animals usually succumb to T.annulata infections it is possible
for animals to form a protective immune response against this parasite (Nichani, 1994;
Campbell et al 1995). It has been known for some time that animals which have
recovered from the infection show solid immunity not only to the stock of T.annulata
they became infected with but also cross immunity with other parasite stocks (Gill et
al, 1980). This suggests that the molecules which the immune system reacts against
during a protective response are expressed by T.annulata infected cells regardless of
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the origin of the parasite stock.
The mechanisms which act against T.annulata infections in an immune animal vary
depending upon the stage of the parasite life cycle in question. Immunity against the
infective stage of the parasite (the sporozoite) is thought to be reliant upon neutralising
antibodies, which prevent attachment of sporozoites to bovine cells and probably lead
to opsonisation and clearance from the system (Preston and Brown, 1985). Ahmed et
al (1988) showed that immune serum could prevent sporozoite entry into leucocytes
and induce killing of free merozoites but was unable to show any activity against
macroschizont infected cells. Therefore, Ab may play a important role in preventing
parasite from re-establishing an infection within an immune animal.
However, further work has shown that immune mechanisms are induced which can
act against infected cells. Soon after sporozoite invasion a trophozoite forms within
the infected cell and Preston, Brown and Richardson (1992) showed that trophozoite
destruction can be mediated by cytokines. This study showed that the presence of a
number of cytokines including: TNFa, IFNy, IFNa, IL-1 and IL-2 to inhibited the in
vitro development of trophozoite infected cells. However, the presence of TNFa was
shown to consistently enhance the proliferation of macroschizont infected cells,
suggesting that this cytokine may actually exacerbate established infections. Studies
by Nichani in naive animals showed that the presence of high levels IFNy within
infected animals did not clear infection (Nichani, 1994). The presence of these two
cytokine is normally associated with the initiation of immune reactions capable of
removing intracellular parasites (Howard, 1986; Ghalib et al, 1995). One may
therefore suggest that the roles of cytokines may differ depending upon the particular
stage of the parasite life cycle in question and whether infected animals have already
been exposed to T.annulata.
The destruction ofmacroschizont infected cells relies upon cytotoxic T lymphocytes
(CTLs) specific for infected cells and the presence of cytostatic M0s (Preston, Brown
and Spooner, 1983; Innes et al, 1989a,b). CTL responses against infected cells have
been demonstrated in T.annulata immune animals (Preston, Brown and Spooner, 1983;
Innes et al, 1989a,b) and work in vitro by Conze et al, (1994) showed that purified
peptide fractions from T.annulata infected cells are recognised by T.annulata specific
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CTL in association with MHC class I molecules. These data show specific CTLs can
be generated against macroschizont infected cells and that such CTLs may provide a
mechanism of parasite removal, agreeing with the work by Preston, Brown and
Spooner (1983) and with suggestions by Ahmed et al, (1988).
T.annulata infection in susceptible animals.
The production of immunity in susceptible animals is reliant upon either the
inoculation of animals with attenuated infected cell line vaccines, to provide protection
against subsequent infection or by drug treatment of infected animals to clear the
infection and allow an anti parasite immune response to be mounted (Ouhelli et al,
1989; Dhar et al, 1990). However, if a susceptible animal becomes infected with
T.annulata and is not treated then generally the animal will fail to produce a suitable
immune response and will die.
The exact mechanisms which prevent a susceptible animal from producing an effective
immune response are unknown. Some reasons which could be responsible for this lack
of anti parasite activity are: (1) the uncontrolled, rapid proliferation of infected cells;
(2) the properties of infected cells, such as the production of cytokines and (3) the
effect which T.annulata infected cells have upon autologous naive and memory T cells
(as shown in vitro by Campbell (1995). In this section development of infected cells
and their interaction with the susceptible host's immune system will be discussed.
Infected cell development.
In vitro T.annulata sporozoites have been shown to infect principally cells of the
monocyte and macrophage (M9) lineage (Glass et al, 1989; Campbell et al, 1994).
Once these cells are transformed by the parasite they begin to proliferate, generating
continuously growing cell lines in vivo and in vitro and causing the leucocytosis
characteristic of a T.annulata infection (Barnett, 1977; Melhorn and Schein, 1984).
Prior to in vitro infection bovine monocytes and M9s exhibited a typically myeloid
phenotype (ie, lobed nucleus, extensive areas of cytoplasm and expressing cell surface
markers specific for myeloid cells such as Fc and lipopolysaccheride receptors
(Campbell et al, 1994). However, following infection with the parasite the phenotype
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of the proliferating cells alters.
Infected cells increase in size and show increased but variable expression of MHC
class II (Spooner et al, 1988; Glass et al, 1990). There are changes in the expression
of various surface markers, particularly CD14. This molecule is the lipopolysaccheride
(LPS) receptor, which is expressed on monocytes, M9s and a small number of B cells
in humans (reviewed by Ziegler-Heitbrock and Ulevitch, 1993) and appears to show
a similar expression in cattle (Campbell et al, 1994; Yang et al, 1995). After infection,
cells lose surface expression of CD 14 but attain a phenotype similar in other aspects
to mature MGs, as designated by expression of epitopes bound by the mAbs IL-A24
and IL-A109 (Ellis et al, 1987; MacHugh, et al, 1990; Campbell et al, 1994).
Expression of the antigen bound by IL-A24 increases after infection, whilst expression
of the epitope bound by IL-A109 decreases post infection. IL-A24 binds an epitope
expressed by mature MGs and associated with antigen presentation, whilst the epitope
bound by IL-A109 is thought to be analogous to CD64 (FcyRl), the low affinity Fc
receptor, found on small monocytes. The fall in IL-A109 binding and the rise in the
binding of IL-A24 suggests maturation of the infected cells (Campbell et al, 1994).
The identification of the cells infected in vivo has proved difficult, mainly due to the
fact that once infected, cells rapidly change the surface expression of numerous
markers, masking their original identity. However, comparison of flow cytometric data
obtained from analysis of in vivo and in vitro derived infected lines has shown the
majority of T.annulata infected cells have a similar phenotype (Campbell, 1995),
suggesting that the cells infected in vivo and in vitro are similar. Also new data
produced by Forsyth et al (1997) shows in vivo infected cells express the CD1 lb, the
C3bi complement receptor and CD2. Providing further evidence that T.annulata does
infected cells of the myeloid lineage in vivo.
Studies by other groups have suggested that T cell lineages can also be infected by
T.annulata sporozoites. One such group Herrmann et al, (1989) discussed the
expression IL-2 receptor molecules by T.annulata infected cell line. However, reports
of these cell lineages becoming infected have been limited and certainly in our hands
T cells are not infectable (Spooner et al, 1989; Campbell et al, 1994).
Herrmans work suggesting that infected cell lines contained infected T cells, was
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based upon data concerning the uptake of 125I-IL-2 by infected cells. Thismethodology
relied upon the idea that cells expressing the IL-2 receptor will bind free IL-2 and
internalise the receptor/ligand complex, thus identifying T.annulata infected cells
bearing the IL-2 receptor.
However, there are drawbacks to this hypothesis. T.annulata has been shown to infect
and "transform" cells of the myeloid lineage with much greater efficiency than those
of the T cell lineage. Myeloid cells are known to possess the ability to ingest proteins
present outside the cell via pino/endocytosis, one must therefore allow for the
possibility that the uptake of I25I-IL-2 was due to non-specific internalisation by
infected M9s. It must also be noted that in vivo, no evidence has been found that T
cells become infected and although infected cells expressing CD25 (the IL-2R a
chain) have been identified, no infected cells have been found to express T cell
receptors or CD3 as detected by flow cytometry (Campbell, 1995).
In vivo development.
The effects of the presence of parasite within susceptible hosts can be seen soon after
an animal is infected by a tick vector or experimental infection. Inoculation of
sporozoites into a susceptible host by either route leads to the enlargement of the
draining lymph node within 5-8 days (Barnett, 1977). Although the draining lymph
node is known to be the main site of development, until recently the site at which
cells become infected was unknown. However, recent afferent and efferent cannulation
experiments now suggest that the initial site of infection is the draining lymph node.
As infected cells are only found in the efferent and not the afferent lymph of the
infected node (Nichani, 1994; Goel, 1996).
Immunohistological staining of infected lymph node sections has shown that the
numbers of monocytes and M9s in the draining lymph node begin to increase after
infection (Campbell, 1995). Investigation of the expression of the monocyte/M9
lineage markers bound by the mAbs IL-A109 (MacHugh et al, 1990) and IL-A15
(binding CD1 lb/CD 18) (Splitter and Morrison, 1991) in infected lymph node sections
and co-staining with the anti proliferation marker mAb Ki-67, showed cells expressing
these monocyte/M9 markers proliferate and colonise the majority of the lymph node
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(Campbell, 1995). Also later in the infection there is an increase in the numbers of IL-
A24+ cells (Ellis et al, 1987) leaving the lymph node (Nichani, 1994). IL-A109
expression has been associated with immature monocytes, whereas IL-A24 (Ellis et
al, 1987) has been associated with antigen presenting function (which relates to mature
monocytes and M0s). These data suggest that cells of the myeloid lineage within the
lymph node become infected, proliferate and express a more mature phenotype, then
begin to migrate from the node (Campbell, 1995). This agrees with data collected
from many in vitro T.cmnulata infected cultures, showing established cultures of
infected cells are mainly IL-A24 positive (Glass et al, 1989; Nichani, 1994; Campbell
et al, 1994).
In susceptible animals the numbers of infected cells can become very large and the
immune system is unable to reduce these numbers. The reasons for this are still not
known but recent work by Nichani (1994) and Campbell (1995) has shown infected
cells alter the behaviour of both naive and memory T cells in vivo and in vitro.
Research into T cell responses during T.annulata infection in vivo (Nichani, 1994;
Campbell, 1995) and post stimulation with infected cells in vitro (Campbell et al,
1995; Campbell et al, 1997) indicates that naive autologous T cells become activated
and consistently show a Tht type phenotype. Infected cells therefore possess the ability
to "non specifically" activate autologous T cells and once non specifically activated,
T cells are unreactive against infected cells (Nichani, 1994; Campbell, 1995). In vitro
work has also shown the T cell stimulatory ability of infected cells to be contact
dependent (Campbell et al, 1995). When T cells are incubated in the presence of
infected cells but separated by a semipermeable membrane the T cells do not activate.
This suggests that there is a molecule or molecules present on the surface of infected
cells which induces T cell activation and "non-specific" proliferation.
The molecules involved in reactions inducing T cell proliferation are as yet unknown.
It has however, been speculated that changes in the levels of expression of MHC class
II molecules on the infected cell surface may be involved in the induction of T cell
proliferation (Glass and Spooner, 1990). It was found that infected cells possessed
enhanced antigen presenting capabilities (when compared to uninfected cells),
stimulated increased T cell proliferation, plus also expressed higher than normal levels
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of MHC class II molecules. Glass and Spooner hypothesised that it was the altered
expression of these molecules that were in some way involved in the abnormal
stimulation of T cell activation/proliferation. It is these abilities of T cell stimulation
and variations in the levels of MHC class II expression by infected cells, along with
cytokine production, which are investigated in this thesis.
The architecture of infected lvmph nodes of susceptible hosts post infection.
After infection with T.annulata changes begin to take place within the draining lymph
node (Campbell et al, 1995). In susceptible animals these changes become marked
within 4-7 days of infection, with infected cells visible within the node becoming foci
for responding T cells, which are seen to activate within 2-3 days post infection. The
rate at which these T cells become activated suggests that this process is in some way
different to the normal activation process. Campbell's work showed that in vitro
proliferating T cells are CD4+ and of both the memory and naive phenotype
(Campbell, 1995). The activated cells are only present surrounding proliferating
infected cells in the medulla, an area where T cell activation does not normally occur
(Bogen et al, 1991; Bogen et al, 1993; Campbell et al, 1995). These activated T cells
are then seen in the efferent lymph from day 7 onwards. Nichani (1994) also showed
that in vivo derived, activated T cells from susceptible infected animals were
unresponsive to IL-2 and cytotoxic T lymphocytes were not active against infected
cells.
Soon after T cell proliferation begins, the structure of the cortico-medullary region
starts to break down and the organisation of germinal centres within the node begins
to deteriorate. As these reactions proceed the organisation of the lymph node continues
to break down and the node can become necrotic within 9 days of infection
(depending upon the severity of infection). The rate of apoptosis in the infected node
increases between days 2 to 8, then begins to decrease (Campbell, 1995). It has been
suggested that this is due to the death of infected cells. As the population of newly
infected cells undergoes rapid proliferation, many of the cells initially infected by
sporozoites may not survive and undergo apoptosis (Campbell, 1995; Campbell et al,
1995).
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The premature activation of T cells within the draining node (Campbell et al, 1995)
may prevent reactions necessary for the formation of reliable T cell help required to
mount specific anti theilerial immune reactions. This may also explain why no one has
succeeded in making theileria specific T cell lines from immune animals, when using
T.annulata infected cells as APCs (Campbell, unpub obs). It has been suggested that
the aberrant activation of lymph node T cells is the major cause of the lack of a
protective immune response against infected cells and one of the causes of severe
clinical disease (Nichani et al, 1995; Campbell, 1995). Nichani (1994) found large
numbers of CD2" CTLs present in efferent lymph, suggesting that CTLs produced
during a non protective immune responses are incapable of normal immune function.
If cytotoxic T cells do form the main mechanism for the removal of macroschizont
infected cells, then the alteration of T cell responses may well interfere with the
production of parasite infected cell specific CTLs. However, this raises a question, if
the presence of the parasite induces a Th, type response (which would usually be
associated with the production of a cell mediated cytotoxic response), why are CTLs
isolated from naive susceptible animals not specific for macroschizont infected cells?
The answer may lie in the way in which infected cells trigger T cell activation,
activation is rapid, antigen non-specific and occurs in areas of lymphoid tissue not
usually associated with T cell activation (Glass and Spooner 1990; Campbell, 1995).
I have studied possible mechanisms by which T.annulata infected cells may activate
autologous T cells. The findings of my work are detailed and discussed within this
thesis.
Section 1.8.
The Major Histocompatibility Complex (MHC).
Major Histocompatibility Complex (MHC) class II molecule expression of cells alters
post infection with T.annulata (Glass & Spooner, 1990). Alterations of the expression
of these molecules is thought to be related to non specific T cell activation (Glass &
Spooner, 1990). For this reason the MHC will be discussed below. The genetics,
proteins and function of the MHC have been an area of intense scientific investigation.
The initial work in this field concentrated on the human and mouse MHC and
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therefore these are the two systems about which most is known. There is less data
relating to the bovine MHC but during the last 5 to 6 years advances have been made
in understanding the similarities and differences between this and other species.
The MHC Complex is a cluster of highly polymorphic genes on the short arm of
chromosome 23 in cattle (chromosome 6 in humans), which are responsible for many
essential immunological functions and code for amongst other products, the MHC
class I and II cell surface glycoproteins. In humans these molecules are designated
HLA molecules (human leucocyte antigens) and in the bovine system were named
BoLA or bovine leucocyte antigens (Spooner et al, 1979).
MHC class I and class II products are encoded by different genes and serve different
purposes within the immune system. The class I products generally present
endogenously derived peptides to cytotoxic T cells and also allow the recognition of
self. The class II products mainly present exogenously derived peptides to helper T
cells.
The bovine MHC is divided into four areas; class I, class Ha, class lib and class III
(Andersson and Davies, 1993). A map of the bovine map is shown in Fig 1.2 (taken
from Sawnhey (1996)). This map is based on data from studies of the bovine MHC,
with knowledge of the human, mouse and rat MHCs gene arrangement used to assign
likely positions of the bovine genes (virtually no mapping studies of the BoLA system
have been performed).
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Fig. 1.2 A map of the bovine Major histocompatibility complex.
A diagram of the bovine MHC constructed using current
knowledge of the bovine MHC genes and also utilising
information relating to the organisation of the human MHC.
Shown are the class I, class II and class III areas. The class
I and II areas contain genes coding for the cell surface
MHC class I and class II molecules necessary for the
immunological presentation of peptides, whilst the class III
region contains genes coding for proteins of the
complement system.
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The BoLA class I loci and products.
There are a large number of BoLA genes (possibly up to twenty) in the class I region
(Lindberg and Andersson, 1988). Bovine class I antigens were first described by
Spooner et al (1978) and Amorena and Stone (1979). These molecules have been
identified using alloantisera obtained after immunisation with leucocytes or
subcutaneous skin grafting (Spooner et al, 1978; Amorena and Stone, 1979). The
polyspecific alloantisera produced were tested against a panel of cells and the cross
reactivity reduced by absorbtion. This produced (mainly monospecific) alloantisera
which could be used in microcytotoxicity assays, for the determination of the MHC
class I specificities of particular animals.
The BoLA class II loci and products.
The BoLA class II genes are located in two regions (class Ila and class lib) and
possess a high recombination frequency. The class Ila region is tightly linked to the
class I region and contains DQ and DR loci (Andersson and Rask, 1988; Bissumbher
et al, 1994; Dutia et al, 1995). Both genomic and cDNA clones of DR and DQ genes
have been isolated and homology with the human genes has been clearly established
(Andersson and Rask, 1988). DR and DQ molecules have been identified in the bovine
system but no product equivalent to the human DP product has been found (Monaco,
1993; Sigurdardottir et al, 1991). Also no evidence for the bovine DP equivalent loci
has been reported.
The class lib region is separated from the rest of the bovine MHC by a recombination
frequency of 17% and contains the DOB, DNA, DYA, DYB, DIB and DZ genes
(Andersson et al, 1988; Stone and Muggli-Cockett, 1990; Andersson and Davies,
1993). The bovine DOB and DNA genes have not been cloned but are assumed to be
homologous to their human counterparts and as in the human show only limited
polymorphism and do not appear to be expressed (Andersson and Davies, 1993).
DYA/DYB are novel bovine genes which also show low polymorphism and do not
appear to be expressed (Van der Poel et al, 1990). The DIB genes are also thought to
be silent.
Studies of the functional bovine MHC class II genes have shown them to be highly
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polymorphic (Davies et al, 1992), as are their human equivalents, with the potential
to present a very wide range of peptides. Comparison of the human DRa and DRP
genes with those expressed by cattle has shown large sequence homologies.
Investigation of the DRP3 genes of cattle showed high levels of polymorphism in
exon 2 and this has been identified as the peptide binding region of the class II
molecule (van Eijk et al, 1992; Russell et al, 1994; Fraser et al, 1994). The
functionally expressed bovine MHC class II molecules identified so far are products
of the DQ and DR loci, which present Ag to T cells (Glass et al, 1991; Fraser et al,
1996).
Antigen (Ag) processing.
Bovine MHC class II molecules consist of a heterodimer of an a and P chain (35 kDa
and 28 kDa respectively) (Andersson and Davies, 1993). These protein molecules are
synthesised in the rough endoplasmic reticulum (R.E.R.) from messenger RNA
(mRNA) encoding the class II genes. In humans the heterodimer associates with
another molecule at the E.R, this is the Invariant chain (Ii (CD74)), which can exist
in four forms (p33, p35, p41 and p45) (Henne et al, 1995). The predominant form of
this molecule is p33, with the addition of extra residues on the cytoplasmic tail
forming the larger molecules. It is not known if bovids express a functional Ii but
since a targeting signal is necessary to allow the class II molecules to reach the
endosomes/lysosomes in humans one would assume that this would also be the case
for cattle. The exact conformational changes induced by the binding of these
molecules are not known (Lamb et al, 1992). However, assembly and loading of the
class II molecule appears to be less efficient without the presence of the Ii (Sadegh-
Nasseri et al, 1991; Stern et al, 1992).
The presence of the Ii chain does not appear to be essential for class II expression and
Ag presentation, as shown by Fraser et al (1996). Mouse LTK cells transfected with
bovine class II DRa and p genes expressed bovine DR molecules at the cell surface
(Fraser et al, 1996). Presentation assays showed these cells are capable of presenting
Ag to Ag specific bovine T cells. No bovine Ii molecule was transfected with the
expressed DR gene suggesting that expression is either possible without such a
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molecule or that the mouse cells provide a suitable molecule to aid expression.
The Ii may also be involved in the restriction of class II molecules to the presentation
of exogenous peptides (Roche et al, 1992. Teyton et al, 1990). In humans it appears
that antigenic peptides can be bound only when the Ii is removed from the
heterodimer. This ensures that binding of Ag is prevented when the class II molecule
passes through the Golgi and Trans-Golgi Reticulum (TGR) (which is the area of the
cell containing the endogenous Ag pool). Antigen can only bind when the Ii chain is
lost, possibly due to a lowering of pH in the MHC containing vesicles (upon fusion
with the late endosomes containing the degraded/processed exogenous Ag) (Roche et
al, 1990). More recent data has suggested that an area of the Ii in humans (termed the
CLIP molecule) is able to bind to the peptide binding groove of a large percentage of
class II molecules (Ghosh et al, 1995). This molecule effectively blocks the peptide
binding site until it is removed. Removal of the CLIP molecule is mediated by the
human class II molecule DM, which then enables the class II molecule to bind peptide
(Sloan et al, 1995; Ghosh et al, 1995). The presence of bovine DM genes has not been
proven but a bovine LMP7 gene has been found. It has been suggested that since the
human LMP, TAP and DM genes are adjacent in the HLA system the organisation of
these genes will be the same in bovids (Andersson and Davies, 1993)
It is thought that the Ii is also responsible for a sorting signal, which directs the MHC
class II heterodimer past the Golgi and TGR. The chains are now directed to the
endocytic route and come into contact with internalised and degraded proteins. This
sorting signal is thought to be sited in the cytoplasmic tail of the Ii chain, as
truncation directs the trimers to the cell surface (Bakke et al, 1990, Lamb et al, 1991).
Further work has suggested that the Ii chains bind with MHC class II heterodimers to
form a protein nonamer, consisting of three Ii chains and three MHC class II a/p
heterodimers (Cresswell, 1992). The Ii chains contain a retention signal, which is
presumed to be situated in the cytoplasmic extension of the p35 form of Ii chain.
However, binding of MHC class II heterodimers overrides this signal and initiates
transport to the endosomes. This is thought to be due to an endosomal transport signal
expressed by the p33 form of Ii. When heterodimers are bound the p35 molecules of
the Ii causing retention are covered, whereas the p33 areas are not. This is thought to
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bring about transport to the endosomes, where the Ii chains dissociate from the
heterodimers which then bind processed peptides (Cresswell, 1992).
The site of intracellular binding of peptide bv MHC class II.
The determination of the site of peptide association with class II molecules came
closer in 1994 when Tulp et al discovered a distinct MHC class II+ organelle.
Fractionation and electrophoretic/immunohistochemical analysis of this compartment
showed it to be distinct from lysosomes and early/late endosomes. Within this
compartment class II molecules were found to lose the Ii chain (with the NH2-terminal
area of the Ii containing the endosomal targeting signal, being lost last), associate with
peptide and become resistant to degradation by SDS (Tulp et al, 1994). This data
suggests that there are specific compartments for class II loading, which are distinct
from compartments used to transport other molecules to the cell surface.
The expression of MHC class II molecules.
MHC class II molecules can be expressed constitutively or have their expression
induced. Cells constitutively expressing class II molecules are termed professional
APCs and include: dendritic cells; Langerhans' cells; B cells; monocytes and M0s.
Other cell lineages can have class II expression induced by various stimuli, these
lineages include: T cells and epithelial/endothelial cells. The stimuli able to induce
class II expression include: cell/cell interactions (such as MHC/TCR binding) (Unanue
and Allen, 1987); adhesion molecule contact between cells (Larsen et al, 1994;
Makgoba, Sanders and Shaw, 1989) and cytokines, such as IFNy (Steeg et al, 1982).
These factors vary in their action depending on the cell type and conditions involved.
For example, IFNy is one of the most potent inducers of class II expression from
monocytes and M0s and it's effects are exerted through promoters situated upstream
of the class II genes (Benoist and Mathis, 1990), e.g. expression of the I-Aa gene of
mice is effected by TNFa via the NF-kB site (Freund et al, 1990), whilst in the HLA-
DRA gene the effect is mapped to the S,X and Y regions (no obvious NF-kB site has
been found) (Panek et al, 1993). One cytokine which is important for the down
regulation ofMHC class II proteins, especially in professional antigen presenting cells
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is Interleukin 10 (IL-10) (de Waal et al, 1991; Howard et al, 1992). This cytokine
appears to play an integral role in the control of inflammatory reactions (Fiorentino
et al, 1991; de Waal et al, 1991). There has been little research into the initiation and
control of class II synthesis in bovids, however, one would assume that it will be
generally similar to that of the other systems studied.
Antigen interaction with MHC class II products and presentation.
Soon after the biochemical and cellular features ofAg presentation were outlined two
different pathways were proposed for the processing and presentation of intra and
extracellular Ags. It was suggested that the peptides presented in class I molecules
were from cytosolic processing, whilst those presented in class II molecules were
derived from endocytic routes (reviewed by Townsend et al, 1989 and Chicz et al,
1993). MHC class I molecules bind peptides derived from: viruses; intracytosolic
bacteria and proteins targeted to the cytosol and endogenously synthesised proteins.
In contrast class II molecules bind and present peptides derived from exogenous Ag
or Ags within endosomes. These Ags may be derived from soluble proteins or
fragments of endocytosed bacteria (Unanue, 1992) and also self peptides (Chicz,
1992). One possible mechanism of dictating whether a peptide is presented by class
I or class II molecules is the Ii chain, which prevents the binding of peptides by class
II molecules before arrival at the correct compartments (Cresswell, 1992).
For proteins to be presented as peptide fragments by class II molecules, two processes
are probably necessary. These are reduction of disulphide bonds to allow unfolding
of the protein molecule and enzymic degradation of the unfolded molecule (Allen and
Unanue 1984; Collins, Unanue and Harding, 1991). Reduction of disulphide bonds
opens up the protein's tertiary structure, revealing concealed epitopes, allowing
enzymatic degradation to produce peptides which can then associate with class II
molecules.
The point at which molecules enter the endocytic route is still under investigation, but
MHC class II molecules have been seen in both early/late endosomes and lysosomes
(Harding et al, 1991. Peters et al, 1991). Studies have indicated that the site of
generation of peptides is the lysosome (known for some time to be able to degrade
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endocytosed material) (Harding et al, 1991). It has been found that targeting of Hen
Egg Lysozyme (HEL) to lysosomes results in significantly higher immunogenicity
than when targeted to the endosomes (Harding, et al 1991). When this is viewed in
relation to more recent data, it seems possible that processing may occur within the
lysosome but that the processed Ags are moved to the newly discovered cellular
compartment to associate with empty class II molecules (Tulp et al, 1994).
X-ray crystallographic data of three human MHC class I molecules ((HLA-A2, HLA-
A68 and HLA-B27) as reviewed by Germain and Margulies, 1993) allowed the
structure and peptide binding functions of this group of molecules to be investigated.
However, crystallisation of class II products proved much more difficult, with the
crystals formed being too small for analysis. A group eventually crystallised a HLA-
DR1 class II molecule from human B cells and its structure was assessed by X-ray
crystallography (Brown et al, 1993). The structure of this molecule proved remarkably
similar to those predicted by theoretical methods and studies of class II function
following site directed mutagenesis.
The ocp heterodimer was found to possess a peptide binding groove between two areas
of a helices and the floor of the groove formed from a P-pleated sheet structure. The
tertiary structure of the peptide binding groove has also been shown to hold a pocket.
The position of this pocket corresponds to the position of a side chain of the bound
peptide, with hydrogen bonds formed between the peptide and conserved areas of the
peptide binding groove (Brown et al, 1993).
The ends of the peptide binding groove were found to be open (unlike the class I
peptide binding groove), meaning that the ends of longer peptides are able to droop
over the edge of the class II molecule. Brown et al (1993) also found that the class
II aP heterodimers crystallised as dimers. He suggests that this dimerisation may occur
at the cell surface and increase the stability of interactions between MHC class II
molecules and T cell receptor molecules (TCR). The formation of dimers of class II
molecules may also increase their affinity for the CD4 coreceptor molecules expressed
on the surface of helper T cells and aggregates of class II/TCRs and CD4 molecules
may initiate T cell activation more easily than if single molecules were involved
(Brown et al, 1993).
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The ends of peptides bound by class II molecules are termed as "ragged", since the
overall length can vary between 15 and 25 amino acids (Chicz et al, 1992). However,
the differences in length seem to matter little (with respect to T cell recognition), as
long as a certain core motif to the peptide is maintained. Polymorphic variations in
the peptide binding groove structure, dictate the peptide motifs which individual class
II molecules are able to bind, giving rise to the phenomenon of allele specific peptide
binding (Sette et al, 1987). The variation in the peptides which a class II molecule can
bind is due to the structure and organisation of the MHC binding groove and the
motifs of the peptides. The floor of the MHC binding groove contains pockets or
depressions, into which fit amino acid (aa) residues (termed anchor residues) of the
bound peptide.
However, the binding of ligands by class II molecules does appear to be somewhat
promiscuous, with peptides able to bind a number of class II molecules produced from
different alleles. The allelic variation of class II molecules means that within a species
most animals will express class II molecules able to present the majority of peptides
it encounters. Also by the use of tandem mass spectrometry, one species of class II
molecule was found to bind 2000 different peptide ligands (Hunt et al, 1992). Since
as few as 200 MHC molecules with bound peptide are required to trigger a Th cell
(Harding and Unanue 1990), a single APC would be able to present a large number
of different peptide epitopes efficiently. These two characteristics allow the MHC class
II molecules of a species to present a very large range of peptides, which is very
important when one considers the amount of naturally occurring antigenic variation.
It would be incorrect to think that the class II molecules only present Ags taken into
a cell from the extracellular matrix (exogenous Ags). Class II molecules will present
any peptides constructed of a suitable amino acid sequence, present in the novel
endosomal compartment at the point of peptide binding. One may think that this
would allow the presentation of self peptides and so prompt autoreactivity. However,
T cells which would react against these Ags whilst presented by self MHC should
have been deleted from the T cell repertoire during T cell ontogeny (Nikolic-Zugic,
1991), thus removing the dangers of mounting an autoimmune reaction.
Also it should be noted that a peptide showing a high affinity for an MHC molecule
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may not necessarily prove to be immunogenic. Processing of peptides may produce
peptides which bind well to the class II molecule but may not be suitable for
mounting an immune response, either because MHC/peptide/T cell reactions fail to
form a response or the immune response illicited is not directed at a susceptible area
of the pathogen in question.
Section 1.9.
Macrophages, phenotype, functions and intramacrophage parasites.
Macrophages have been known to play an important role in immunological functions
for a long time. Possibly the most famous early work on this lineage of cells was that
of Metchnikoff . This work consisted of watching cells of the myeloid lineage
phagocytose foreign particles and lead to the hypothesis that macrophages played the
role of scavengers within the body, mopping up invading organisms and detritus. This
is of course true, however, it is now known that monocytes and macrophages play key
roles in the activities ofmany areas of the immune system, including: innate responses
(such as inflammation and microbicidal activities); Ag presentation; cytokine
production and T and B cell stimulation.
Macrophage phenotvpes.
In 1972, cells classified as mononuclear phagocytes were grouped together on the
basis of: a common origin; similar morphologies; cytochemistry and function (Van
Furth et al, 1972). However, following further research it became clear that
macrophages found in different tissues possessed a range of varying phenotypes,
secretory products and antigen presentation functions (van Furth, 1982; Gordon et al,
1995).
Since the initial grouping ofmononuclear phagocytes into one group, work in different
laboratories has shown that the functions of isolated macrophages vary depending
upon the site from which they are isolated but also that macrophages obtained from
a single site can also show heterogeneity (Dijkstra et al, 1985; Robinson et al, 1986;
Miller et al, 1992). Miller et al (1992) showed differential antigen expression between
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rat alveolar, pleural and peritoneal macrophages and work by Wewers and Herzyk
(1989) demonstrated that freshly isolated human alveolar macrophages activated in
vitro with LPS release low levels of IL-ip but high levels of TNFa, whilst blood
monocytes release higher levels of IL-ip but low levels of TNFa. These data
demonstrate the variation in monocyte/M0 activities and suggest that within the body
as a whole these cells play different roles in different cellular and innate immune
reactions.
Macrophage Immunobiology.
The immunological activity of M0s can be split into two areas, that of innate
protection and that of acquired immunity. Innate protective mechanisms will be dealt
with here first.
Among the innate immunological properties ofM0s are the ability to phagocytose and
destroy foreign material (such as extracellular bacteria or protozoa). The degradation
of internalised material is achieved by a number of mechanisms, including: protease
activity; reactive oxygen intermediate (ROI) synthesis (Nathan et al, 1979; Murray and
Cohn, 1980) and nitric oxide (NO) activity (Moncada, Palmer and Higgs, 1991). ROIs
(especially superoxide) have been known to possess activities against microbial and
protozoan pathogens for some time, however in the last few years another anti
microbial molecule has come to light. This molecule is nitric oxide, which is produced
from L-arginine by nitric oxide synthase (producing L-citrulline as a by-product)
(Hibbs et al, 1987; Moncada, Palmer and Higgs, 1991). When rats were treated with
E.coli LPS there was an increase in the urinary output of N03", which correlated with
the levels of fever observed (Wagner et al, 1983). Also LPS treatment of LPS
sensitive but not LPS resistant mice increased the urinary excretion of N03" and the
activation of peritoneal M0s (Stuehr and Marietta, 1985). These and other data led to
the conclusion that it was M0s which were mainly responsible for the production of
NO, which quickly breaks down to form N03", prior to excretion.
In recent years much research has been carried out into the synthesis and activity of
NO, as discussed in a recent review by Liew (1995). Synthesis and release of NO
provides an efficient way of dealing with pathogens such as bacteria and protozoa. NO
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can act both intra and extracellularly but the range over which the molecule can
function extracellularly is limited (probably due to its short half life). The action of
NO is thought to be via its effect upon iron-sulphur-centred enzymes within target
cells (Pellat et al, 1990; Moncada, Palmer and Higgs, 1991) and whether the molecule
acts in a cytotoxic or cytostatic way appears to be due to the sensitivity of these
enzymes in the various cell types.
There is now evidence for the action of this molecule against numerous organisms
including: Cryptococcus neoformans (Granger et al 1986a, b); Toxoplasma gondii
(Adams et al, 1990); Leishmania major (Green et al, 1990; Liew et al, 1990,
Schistosoma mcmsoni (James and Claven, 1989) and T.cmnulata trophozoites (Visser
et al, 1995). These data show that NO provides a protective and probably very
important line of defence against a number of pathogens.
The induction ofNO synthesis by macrophages appears to be via two main routes, (1)
LPS stimulation and (2) cytokine stimulation (especially IFNy (reviewed by Green et
al, 1994)). LPS binds to the LPS receptor (CD 14) of monocytes and MGs in
association with LPS binding protein (LBP) (Wright et al, 1990), inducing cellular
activation and triggering the production ofNO. Monocyte and M9 activating cytokines
such as IFNy bind via their specific receptors to initiate the production of this reactive
nitrogen intermediate.
Other innate functions are also mediated through M0s, the majority of those known
appear to be induced and controlled by cytokine molecules released from the activated
M0s. An example of this is the proinflammatory activity of IL-1 (Waage et al, 1989).
Due to the lack of specific knowledge which exists with respect to the production,
structure and activities of bovine cytokines the majority of the following data relates
to human or murine cytokines, with the functions of cattle cytokines being
extrapolated from this.
Cytokines associated with M9 function.
Cytokines are pleiotropic molecules which have numerous functions, acting in both
innate and acquired immune mechanisms. These molecules are produced by many
cells including: monocytes/M9s; T cells; B cells; NK cells; granulocytes; neutrophils;
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basophils; mast cells and epithelial cells. The effects of these molecules are highly
specific acting through specific receptors (Stylianou et al, 1992). At present there have
been 17 interleukin cytokines characterised, with between 2 or 3 identified every year.
The M0 derived cytokines which will be discussed here include: IL-la; IL-1(3; IL-6;
IL-10; IL-12 and TNFa (reviewed by Dower et al, 1992; Van Snick, 1990; Moore et
al, 1993; D'Andrea et al, 1992; Bacon et al, 1995; Beutler and Cerami, 1988). Of these
cytokines, IL-la, IL-1P, IL-6 and TNFa are proinflammatory and have all been shown
to play a role in the mediation of endotoxic shock (Waage et al, 1989; Creasey et al,
1991), producing similar symptoms to those seen during cases of tropical theileriosis.
Interleukin la and (3.
IL-la and IL-1 P are products of distinct genes, the products of which recognise the
same receptors. These two cytokines are structurally related polypeptides showing
approximately 25% homology at the aa level (Oppenheim et al, 1986). The peptides
are produced as 31 kDa precursors and are later cleaved into proteins with molecular
weights of approximately 17 kDa (Giri et al, 1985; Hazudu et al, 1988). There are two
receptors for these cytokine molecules but the activities shown to be transduced
through each are still under investigation. The type 1 receptor has a cytoplasmic
domain of 213 aa residues, whilst the type 2 has only 23 aa cytoplasmic residues
(Dower et al, 1992). IL-la has been shown to bind preferentially to the type 1
receptor and IL-1 p preferentially to the type 2 receptor (Dinarello, 1991; Dower et al,
1992). These data have led to the idea that the type 2 receptor is involved in the
regulation of IL-1 by acting as an antagonist or soluble receptor (Sims et al, 1993).
Glucocorticoids have been shown to up regulate the type 2 receptor, possibly
explaining some of the anti-inflammatory effects of these compounds (Colotta et al,
1993). The results of IL-1 production upon cells have been shown to be: induction of
prostaglandin (PGE2) synthesis by endothelial cells and smooth muscle; stimulation
of the acute phase response by liver and an increase in glucogenesis; collagen
production by fibroblasts; the induction of slow wave sleep via action of the central
nervous system and stimulation of monocytes/M0s to produce IL-l/IL-6 and TNFa.
IL-1 also has effects in acquired immunity ie, stimulation of B cells to increase Ig
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production and also the activation of T cells leading to production of IL-2/IL-2R/IL-4
and granulocyte/macrophage colony stimulating factor (GM-CSF) (Unanue et al,
1984).
Interleukin 6,
IL-6 has been shown to be produced by numerous cell types including; T cells; B
cells; monocytes/MGs; fibroblasts; hepatocytes and vascular endothelial cells. Its
expression has been shown to be upregulated by IL-1, IL-2, TNFa and IFNy
(reviewed by Van Snick, 1990). Human and murine IL-6 are 212 and 211 aa in length
respectively, containing hydrophobic signal peptides of 28 and 24 aa respectively (Van
Snick, 1990; Akira et al, 1993). This cytokine exerts its effects through an 80 kDa
binding protein and a 130 kDa signal transducing protein (Hibi et al, 1990). As with
IL-1 the functions of IL-6 are numerous and are induced in many cell types. IL-6
shows effects on: B cell differentiation and Ab production; induction of the IL-2Ra
chain and T cell differentiation/activation; haemopoietic progenitors in synergy with
IL-3 to decrease G0 time; the liver inducing acute phase responses (Ogawa, 1992).
Tumour necrosis factor alpha (TNFa).
TNFa (also known as cachectin) is another of the proinflammatory cytokines produced
by monocyte/MGs (Beutler et al, 1985). This cytokine has a relative molecular mass
of 17.35kDa (Jones, Stuart and Walker, 1989) and possesses a trimeric tertiary
structure in its active form. It also shares 30% aa homology with another molecule
called TNF(3 (also known as lymphotoxin). However, the activities of these two
molecules are markedly different. TNFa will be dealt with here, as it is this cytokine
which possesses proinflammatory activity and is produced by MGs. Mature human
TNFa is a polypeptide of 157 aa (with mouse, rabbit and rat being one aa shorter),
with an apparent molecular weight of 17 kDa (Vilcek and Lee, 1991).
There are two main TNF receptors, termed TNFR-I (55 kDa) and TNFR-II (75 kDa)
as well as a number of smaller soluble receptors. The binding of the TNF molecules
to their receptors is an interesting area of investigation, with signalling probably
occurring when two or three identical subunits are brought together, through binding
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a TNF molecule. The binding and signalling is thought to be similar for both TNFa/p
but has only been demonstrated for TNFP (Jones et al, 1989; Eck et al, 1992). There
has also been a ligand passing model put forward for TNF binding (Tartaglia, Pennica
and Goeddel, 1993). This model suggests that TNFa binds to and localises around the
TNF-R2 receptor and this regulates the association to the TNF-R1 receptor (which
transduces a signal into the cell) by rapid association/dissociation at the cell surface.
There is now evidence that the 55 kDa receptor is associated with the lytic activity of
TNF binding, whilst the 75 kDa receptormodulates proliferative and regulatory signals
in lymphocytes. However, more work is necessary in this area (Tartaglia et al, 1993a,
1993b). TNFa is also involved with acquired immune reactions and possesses the
ability to activate T cells (Reem et al, 1989; Tartaglia et al, 1993b). This work showed
that TNFa could activate and stimulate the proliferation of T cells and that this occurs
via binding to the TNF-R2 receptor.
TNFa is a potent activator of inflammatory responses, mainly due to its activating
effect on monocytes and M0s (Epstein, 1986; Bachwich et al, 1986). The activation
of these myeloid cells induces the synthesis and release of both IL-1 and IL-6. This
leads to an increase in inflammatory reactions and the recruitment of cells such NK
cells and neutrophils to the site of inflammation (Tracey, Lowry and Cerami, 1987;
Beutler and Cerami, 1987). The ability to induce these reactions means that TNFa
plays a large and important role in immune responses to remove pathogens. However,
this cytokine has also been implicated as a cause of pathology when present at high
levels or for prolonged periods (Tracey et al, 1988; Bielefeldt-Ohmann et al, 1989).
Septic shock is a condition induced by the presence of lippopolysaccheride (LPS) from
gram negative bacteria. This molecule is able to bind to the LPS receptor present on
monocytes/M0s and some B cells (Raetz et al, 1991; Ziegler-Heitbrock and Ulevitch,
1993). The binding of this receptor by LPS stimulates these cells to produce IL-1, IL-
6 and TNFa. These cytokines (especially TNFa) then produce cytokine and
inflammatory cascades, resulting in the systemic upregulation of prostaglandins and
the induction of fever (Dayer et al, 1985). Research in a number of systems has shown
that the presence of high levels of TNFa alone are able to induce many of the
symptoms observed in septic shock (Tracey et al, 1987; Gaskill, 1988; Bielefeldt-
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Ohmann et al, 1989).
Bielefeldt-Ohmann et al (1989) showed the chronic symptoms induced by recombinant
TNFa in cattle to include; fever; weight loss (cachexia); depression; anorexia;
diarrhoea and tissue damage to the kidneys/liver and lymphoid organs. This work
demonstrates the necessity of tight control over the production/secretion of cytokines
and is possibly of relevance to research into tropical theileriosis, as these are similar
symptoms observed following infection with T.annulata (Neitz, 1957; Barnett, 1977).
Macrophages and acquired immune reactions.
Macrophages also play a role in acquired immunity as well as innate protection.
Probably the most important role of M0s (apart from the innate immune functions
they perform) is that of providing stimuli for T and B cells during cell mediated
immune reactions. M0s constitutively express MHC class II antigens and are
professional Ag presenting cells. This means that M0s are able (once they have
phagocytosed the material in question) to degrade and process molecules and present
them in the context ofMHC class II molecules to CD4+ T helper cells, allowing the
formation of Ag specific immune reactions.
The induction of immune responses by MHC class II/peptide/TCR interactions.
A ntizen specific activation of T cells.
The reactions mediated by the bovine MHC class I and class II molecules have been
shown to be restricted to appropriate T cells, as in the human and murine systems.
Bovine class I molecules act as restriction elements for CD8" T cells (Eugui and
Emery, 1981; Goddeeris et al, 1986; Goddeeris, Morrison and Teale, 1992; Innes et
al, 1989a,b), whilst the class II molecules act as restriction elements for CD4~ T cells
(Rothel, Dufty and Wood, 1990; Glass et al, 1991)
For correct signalling via the MHC/TCR complex it is also necessary for MHC
molecules to contact the CD3 and CD4 molecules expressed by the T cell (as
reviewed by Finkel, Kubo and Cambier, 1991). These cognate interactions, together
with several non-antigen specific interactions including accessory molecule interactions
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(such as; B7/CD28 (Larsen et al, 1994; Stein et al, 1994) and ICAM-l/LFA-1 (Van
Seventer et al, 1990)) and cytokine interactions (such as the effect of IL-1 on T cells
(Kaye and Janeway, 1984), lead to T cell activation via intracellular second messenger
signals. The networks of intracellular second messenger molecules are highly complex
and remain an-area of intense research.
Following activation via normal MHC/peptide/TCR reactions numerous changes occur
within the naive T cell which include the upregulation of certain surface molecules (eg
class II) and the secretion of cytokines such as IL-2 and IFN-y (reviewed by Pichler
and Wyss-Coray, 1994). T cell stimulatory cytokines (eg, IL-2) secreted by the
responding CD4+ T cells stimulate clonal proliferation of memory/primed T cells,
producing large numbers of antigen specific T cells (also Ag-specific memory T cells).
The activated T cells are then able to activate effector cells. These effector cells
include a wide range of cell types (ie, monocytes/MGs, granulocytes, natural killer
(NK) cells, neutrophils, cytotoxic T cells, B cells and vascular epithelium). Once
activated these cells act against the organisms or material eliciting the reaction.
Therefore, the main response mechanism of helper T cells is to secrete cytokines
which act on potential effector cells, these cells producing reactions directed against
the invading organism (King et al, 1990; Miller, 1990; Grau et al, 1991).
Non classical T cell activation.
As noted a characteristic of T.annulata infected cells is the ability to non-specifically
activate autologous T cells. This can also occur when T cells are exposed to mitogens
(such as concanavalin A and phytohaemagglutinin) or superantigens (such as toxins
produced by Staphylococcal bacteria ie, Staphylococcal enterotoxin B (SEB))
(reviewed by Webb & Gascoigne, 1994). These molecules activate T cells by
stimulating the cells through non polymorphic regions of the TCR (Roitt, 1988).
Mitogens are generally lectin molecules which bind glycoproteins and interfere with
the normal signalling between the MHC and TCR molecules. These reactions induce
second messenger cascades within T cells and initiate non antigenically restricted
reactions.
Superantigens bind to the lateral faces of the MHC and TCR molecules, bypassing the
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normal site of Ag presentation (reviewed by Webb and Gascoigne, 1994; Acharya et
al, 1994). The binding of a particular superantigen to the lateral side of the TCR relies
on the VP expression of the T cell. The expression of VP genes being an essential
part of TCR expression, with the products of these genes forming the less polymorphic
P strands of theJCR. Activation of the T cells therefore occurs in a very VP specific
manner, with the stimulation and expansion of only those cells with the correct Vp
structure to bind the superantigen.
The reactions induced by this non-antigen specific activation can be catastrophic,
inducing shock and sometimes death eg, toxic shock syndrome, caused by SEB (also
known as toxic shock syndrome toxin 1 or TSST-1) (Swaminathan et al, 1992). The
effect of stimulation by superantigens upon second messenger systems is still under
investigation. However, following stimulation by a superantigen T cell clones have
been shown to proliferate but not to show the expected rises in intracellular second
messengers (such as inositol phosphates or Ca"+ fluxes (O'Rourke et al, 1990; Liu et
al, 1991; Gaugler et al, 1991).
Many of the deleterious results of these stimulations are mediated through cytokine
release, after the activation of T cells (Kappler et al, 1992). The activation of T cells
by autologous APCs infected with T.annulata shows aspects akin to those of T cell
activation by bacterial superantigens. These similarities will be discussed in the
following chapters.
T cell responses and T helper subsets.
Research into T cell responses has shown that in certain systems, murine helper T
cells can be placed into phenotypic groups based on their cytokine profiles (Mosmann
et al, 1986). The work in humans showed that CD4+ helper T cells could be placed
in three subtypes, T helper 1, 2 or 0 (Th,, Th2 and Th0) (Elson, et al, 1995). The
functions of these differing subtypes is to mediate different aspects of the immune
system's responses. Th, cells have been associated with the initiation and control of
cell mediated responses via the production of cytokines IL-2, IL-12 and IFNy, with
these cells involved in the stimulation of delayed type hypersensitivity reactions
(DTH) and cytotoxic T cells production/stimulation. Th2 cells show a cytokine profile
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which is primarily involved in the control of humoral responses. Two important
cytokines involved in the mediation of these reactions are IL-4 and IL-10 (Mosmann
et al, 1986; Cher and Mosmann, 1987; Scott et al, 1987; Paul and Ohara, 1987; Hsieh
etal, 1992).
The third set of helper T cells has been termed Th0, which were first thought to be
simply a precursor phenotype for the Th, 2 cells. However, data from humans and mice
suggests that Th, 2>0 are produced from the same progenitor pool and the development
of the subsets depends upon the stimuli which the T cells experience (such as Ag type
and cytokines in their microenvironment) (Rocken et al, 1992; Del Prete, Maggi and
Romagnani, 1994; Sad and Mosmann, 1994). Work in cattle agrees with these findings
and showed that some Th0 cells are able to produce not only IL-2 and IFNy but also
IL-4 (Brown et al, 1993; 1994). These cells were also shown to be specific for Ags
of Babesia bovis, suggesting that what were thought to be intermediates in T cell
development are actually functional T cells.
The exact mechanisms by which T cells diverge into subsets are not known, however,
Figures 1.3 & 1.4 (taken from Del Prete, Maggi and Romagnani, 1994) show possible
mechanisms for the production of polarised T cell subgroups. These diagrams are
based on the human system (however, due to the similarities between the bovine and
human T cell subdivisions these models are probably also relevant to the bovine
system). Fig 1.3 represents a possible mechanism for the production of a Th, response.
This mechanism relies on the APC producing IL-12 and stimulating the production of
IFNy by activated NK cells. The presence of high levels of IL-12 and IFNy suppress
the production of a Th2 reaction, causing the Th precursor (Thp) cells to produce a Th,
response (with the synthesis of IL-2 and IFNy). This sequence of events leads to the
activation of B cells and MGs and the initiation of cell mediated immune responses
(Nathan et al, 1983; Mosmann and Coffman, 1989; Del Prete, Maggi and Romagnani,
1994).
Fig. 1.4 outlines a mechanism by which Th2 cell responses could be initiated. This
process involves the production of more IL-4 than IFNy or IL-12. The source of the
high IL-4 levels is not absolutely certain, Del Prete (1994) suggesting that mast cells
or basophils may supplement the IL-4 produced by the Th02 cells. Following initiation
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of these reactions the high IL-4 and low IFNy maintain Th2 development. These
reactions result in stimulation of B cells (via cell contact and IL-4/IL-6 production
(reviewed by Paul, 1991; Van Snick, 1990; Del Prete, Maggi and Romagnani, 1994)).
Th2 cells also aid antibody (Ab) production (also isotype switching) and the down
regulation of inflammatory responses (Alderson et al, 1987; Hudak et al, 1987; Paul
et al, 1991).
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Fig. 1.3 A schematic representation of a possible mechanism for the
preferential development of a Thl response following
stimuli from intracellular bacteria and viruses.
A diagram outlining a possible mechanism by which an
animal may mount a T helper type 1 response acting
against an infection with intracellular bacteria or viruses.
Endogenous antigens arising from pathogens are processed
and presented in the context of MHC class I molecules to
T helper cells. The cells presenting the antigens also
provide soluble cytokine messengers (i.e. IL-12 and IFNa)
which promote the T helper cells to initiate a type 1
response (also mediated by soluble factors, including IL-2










Fig. 1.4 A schematic representation of a possible mechanism for the
preferential development of a Th2 response following
stimuli from allergens and exogenous materials.
A diagram outlining a possible mechanism by which an
animal may mount a T helper type 2 response acting
against an infection with extracellular pathogens. Exogenous
antigens arising from pathogens are endocytosed and
processed/presented in the context of MHC class II
molecules to T helper cells. The cells presenting the
antigens also provide soluble cytokine messengers (i.e. IL-
4) which promotes T helper cells to initiate a type 2
response (also mediated by soluble factors, including (IL-3,
IL-5 and IL-6), involving B cell activation/differentiation,
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The actions of these two groups of cytokines are also antagonistic with for instance,
Th, cytokines upregulating M0 activity, whilst Th2 cytokines downregulate this action
and suppress inflammatory reactions. The segregation of these responses means that
the stimulation and expansion of a particular T cell subset determines the response
against a particular pathogen. The most suitable T cell response varies depending on
the nature of the pathogen/infection involved. This can be seen in the responses to
infection with intracellular parasites of the genus Leishmania. It has been shown for
both L.donovani and L.major that Th, mediated responses are able to produce anti-
leishmanial activity, with special emphasis placed on the role of IL-12 and IFNy,
which act as powerful stimuli for M0 activation (Wang et al, 1994; Nathan et al,
1993; Ghalib et al, 1995). IFNy has also been shown to induce killing of Toxoplasma
gondii infected cells, by activating M0s (Suzuki et al, 1988). With these facts in mind,
one would think that the presence of IFNy would be beneficial for the host during
T.annulata infection (ie, that IFNy would activate M0s and induce killing of
intramacrophage T.annulata). However, data produced by Nichani (1994) and
Campbell et al (1997), showed very high levels of IFNy during T.annulata infections,
which appeared to have little effect upon parasite burden.
However, the placement of T cells into these rigid subgroups maybe an
oversimplification of the true facts. This is possibly due to the methods by which the
majority of this data has been produced. The majority of studies relying upon the
generation and in vitro study of T cell clones. Many of the systems used to study the
phenomenon of T cell subsets have relied on the cloning and in vitro stimulation of
T cells with mitogens or high levels of cytokines (Firestein et al, 1989; Street et al,
1990). These are artificial systems and one wonders about the validity of using these
systems to describe the activities of normal non clonal T cell cultures.
CD8+ cytotoxic cells.
An important mechanism of adaptive immunity is the production and expansion of
CD8+ cytotoxic T cell populations, which are able to destroy infected cells.
Investigations into the role of these cells during T.parva infections showed that
transfer of T.parva specific CTLs protected recipient cattle from a lethal sporozoite
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challenge (McKeever et al, 94). It has also been suggested that these cells also play
a role in the removal of T.annulata macroschizont infected cells (Preston et al, 1983;
Innes et al, 1989a,b). The activity of cytotoxic CD8+ T cells is in part mediated by
CD4+ T cell subsets and stimulation/activation of cytotoxic T cells can result in the
removal of intracellularly infected cells (ie, infected with viruses, bacteria or
protozoa). Bovine CD8 is an antigen consisting of an alpha chain (34 kDa) and beta
chain (38 kDa) and is found on T lymphocytes which mediate cytotoxicity through
recognition of Ags presented in the context of MHC class I molecules (MacHugh and
Sopp, 1991). The specificity of these cytotoxic cells is controlled via TCRs specific
for peptide epitopes expressed in the context of MHC class I.
Binding of this epitope/class I complex, as well as costimulatory signals such as the
presence of cytokines (ie, IL-2/IFNy) activates the CD8+cell whilst in close proximity
to the infected cell. Once this mechanism has been set in motion the cytotoxic cell
secretes degradative lytic granules, which perforate the target cell's membrane, killing
the cell (Poenie et al, 1987, Takayama et al, 1987). A molecule linked with the
toxicity of these lytic granules is perforin, which has been shown to damage cell
membranes (Kagi et al, 1994). Cytotoxic cells can also induce the expression of the
Fas molecule which transduces an apoptosis signal into the infected cells, which also
causes cell death (Kagi et al, 1994). Once damaged the cells loose integrity and are
phagocytosed by cells such as M0s and other mononuclear phagocytes.
Cytokines affecting T cell responses.
The four main T cell derived cytokines dealt with in this work are: IL-2; IL-4; EL-12
and IFNy. Also addressed is the production and activity of another cytokine produced
by T cells, IL-10. These cytokines are produced by T cells, however, other lineages
can also make some of these molecules. For example, IL-4 can also be produced by
Mast cells, IL-10 by monocytes and M0s and IFNy by NK cells. These four cytokines
play very important roles in the induction and maintenance of acquired immune
reactions and the regulation of M0 activity (as reviewed by Doherty, 1995).
Interleukin 2.
IL-2 is a cytokine produced by activated T cells which stimulates T cell responses
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(Morgan et al, 1976). This cytokine aids the activation of T cells and later in the
clonal expansion of Ag specific T cells. Human IL-2 is a polypeptide of between 15
and 18 kDa. Following synthesis the peptide is 153 aa in length but 20 of these aa
constitute the signal sequence (which is later cleaved leaving the mature 133 aa
factor). In humans the IL-2 receptor consists of three glycoprotein chains. IL-2Ra
shows low affinity for IL-2, IL-2RP contains the cytoplasmic domain used to
transduce the IL-2 signal and the IL-2Ry chain associates with these to allow high
affinity binding of IL-2, ligand internalisation and signalling (Hatakeyama &
Taniguchi, 1990; Smith, 1989; Takeshita et al, 1992). However, in cattle this receptor
only appears to consist of two peptide chains a and (3 but nevertheless shows a high
affinity for IL-2 (Siess and Reeves, 1989).
Interleukin 4,
IL-4 is also produced by activated T lymphocytes but the production of this cytokine
depends upon the particular subset ofT helper activated. This phenomenon of T helper
cell subsets producing differing cytokine profiles has undergone intense investigation
and will be discussed in depth in a later section. IL-4 has been shown to be an
extremely pleiotropic cytokine, which has effects upon amongst others: T cells;
monocytes; M0s; mast cells; fibroblasts; endothelial cells; and hepatocytes. This
cytokine is produced by CD4+ T cells as well as mast cells, basophils and CD8" T
cells. Human and mouse IL-4 are 129 aa and 120 aa long respectively. Bovine IL-4
has recently been cloned and sequenced, the sequence codes for an initial product of
15.1 kDa, 135 aa peptide with a putative 24 aa leader sequence and a 121 aa product
(Heussler, Eichhorn and Dobbelaere, 1992).
IL-4 activity is mediated by receptor complexes, of which there appear to be at least
two forms. Most information is known about the IL-4 receptor which consists of an
IL-4 binding subunit (IL-4R) and a y chain (this y has been shown to be the same
chain which acts to bind IL-2 at high affinity in this receptor complex) (Russell et al,
1993; Kawahara et al, 1994). This extra chain appears (as for IL-2 to the IL-2R
complex) complex to facilitate high affinity binding of IL-4 (Russell et al, 1993).
However, there also appears to be an alternative IL-4 receptor complex, as
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demonstrated by Lin (1995), who showed that some cells which did not express the
common y chain were still able to transduce IL-4 signals (Lin et al, 1995).
IL-4 has been shown to play an important role in the differentiation of T helper cells
to a Th, or Th2 like phenotype (Del Prete, Maggi and Romagnani, 1994) and to down
regulate the activities of Th, like cells, such as IFNy production (Paul et al, 1991).
Principle upregulatory activities of IL-4 are exerted upon B cells: causing increases
in cell viability and size; upregulation of surface molecules (ie, CD23 (low affinity Fc
receptor), MHC class II, IgM and B7) and influencing Ab switching (Paul et al, 1991;
Gollob and Coffman, 1994). Another very important activity of IL-4 is the
downregulation of inflammatory responses, with this cytokine inhibiting
proinflammatory cytokine (IL-1, IL-6 and TNFoc) release from M0s and causing the
down regulation of CD 14 expression by these cells (Lauener et al, 1990). Work on
bovine recombinant IL-4 by Estes et al (1995), has confirmed that this cytokine plays
an important role in T and B cell reactions (as in other systems) and also that the
presence of IL-4 increased B cell proliferation in mixed PBM cultures and upregulated
the surface expression of CD23, MHC class II and IgM (as is observed in the human
and murine systems). However, this work did show that the effect of bovine IL-4 upon
Th, and Th2 clones differed from that seen in the murine system, with this cytokine
inhibiting the proliferation of both subsets in a dose dependant manner (Estes et al,
1995).
Interferon gamma.
Interferon gamma (IFNy) is the product of a single gene (Gray et al, 1982) and is a
143 aa glycoprotein in humans, the relative molecular mass of which depends upon
the glycosylation state of the peptide (Rinderknecht, O'Connor and Rodriguez, 1984).
The 25 kDa peptide has two glycosylated sites, whilst the 20 kDa peptide is only
glycosylated at one site. However, glycosylation at neither site is essential for
biological activity. The receptor for IFNy is highly species specific and is also the
product of a single gene (Auget et al, 1988).
This cytokine is produced by: Th, CD4+ T cells; CD8* T cells and NK cells and
possesses antiviral and antiprotozoal activities (Fleischmann et al, 1979; Suzuki et al,
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1988). However, bovine y5 T cells do not produce IFNy (Collins et al, 1993). IFNy
is a potent activator of monocytes and M0s, with the presence of this molecule
upregulating MHC class I and II expression, IL-1 and superoxide production and in
the presence of LPS induces large scale NO synthesis (Bielefeldt-Ohmann et al, 1986;
Nathan et al, 1983; Gordon et al, 1995). Ab production is also enhanced by IFNy,
with IgG2a synthesis being upregulated in B cells exposed to LPS and IFNy (Snapper
et al, 1988). IFNy can also induce the upregulation of ICAM-1 of endothelial cells
(Thornhill et al, 1992), which probably aids lymphocyte sticking and migration into
tissues at sites of inflammation. This cytokine can also induce it's own synthesis at
sites distant from infection/inflammation, possibly due to IFNy present in the
circulation or the presence of migratory cells which also produce this cytokine
(Halloran et al, 1992).
Two other cytokines which have important immunoregulatory effects are IL-10 and
IL-12.
Interleukin 10,
IL-10 is a cytokine which stimulates Th2 like responses and is produced by activated
CD4+ Th, 2,0, CD8+ Th2 like T cells, B cells and also activated monocytes and M0s (Le
Gros and Erard, 1994). The IL-10 molecule itself is (in human, mouse and rat) 160
aa long, with at least 73% identity between the three species at the aa level (Feng et
al, 1993). The majority of the variation between these molecules arises from
differences in glycosylation. The IL-10 receptor is approximately 110 kDa and
expressed on monocytes/M0s, B cells, thymocytes, endothelial cells, neutrophils,
granulocytes and mast cells. The most potent immunoregulatory aspect of this cytokine
would appear to be the effect which IL-10 exerts on APCs and in particular M0s.
Work has shown that IL-10 down regulates the expression of MHC class II, adhesion
molecules such as B7/ICAM-1 and suppresses the expression of a number of
proinflammatory cytokines including: IL-1; IL-6 and TNFa (Willems et al, 1994;
Fiorentino et al, 1991a; de Waal et al, 1991). This cytokine also indirectly effects the
production of cytokines from Th[ like cells (Fiorentino et al, 1991b) through the down
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regulatory effects which IL-10 exerts upon the APCs. It would therefore appear that
IL-10 plays a major role in the regulation of immune functions and especially
inflammatory reactions. Indeed it has been shown that mice made deficient in IL-10
by gene targeting show normal lymphocyte development but suffer inflammation of
the bowel due to uncontrolled immune responses resulting from the high enteric Ag
load (Kuhn et al, 1993).
Interleukin 12.
IL-12 also known as NK stimulatory factor is a cytokine comprised of two unrelated
subunits. The smaller subunit (p35) shows homology to IL-6 and the larger subunit
(p40) homology to IL-6R. This has lead investigators to speculate if IL-12 has evolved
from an IL-6 cytokine/receptor complex (Stern et al, 1990; Wolf et al, 1991). The
main cells producing this cytokine are monocytes/M0s and B cells, with the 110 kDa
receptor for IL-12 being expressed upon: NK cells; CD4" T cells; CD8* T cells. IL-12
stimulates both the growth and development of both CD4^ and CD8" T cells and the
production of predominantly a Th, like cytokine profile (Hsieh et al, 1993). The effect
on NK cells is marked with increases being seen in proliferation, differentiation and
activity. The presence and action of IL-12 has also been suggested to aid in
monocyte/M0 activation. The method relies on the induction of expression of IFNy
by IL-12 stimulated T or NK cells and so activates these myeloid cell indirectly (as
shown in Fig 1.3).
M0s and intracellular protozoan pathogens.
T.annulata sporozoites infect monocytes and M0s, as do a number of protozoan
parasites including: Toxoplasma.gondii\ Leishmania. spp\ Trypanosoma cruzi. In this
section I shall highlight some of the recent relevant work in this area and compare it
with the current knowledge of T.annulata.
Campbell et al (1994) showed that once infected with T.annulata the cells acquire an
activated phenotype. However, when monocytes and M0s infected with other
intracellular protozoan parasites are activated it results in the destruction of the
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parasite within the cell. This can be seen in Leishmanial infections (Howard, 1986;
Ghalib et al, 1995). Work has shown that Leishmania major infections in certain
strains of susceptible mice augment a Th2 like reaction and that the immune responses
induced are not capable of eliminating the protozoal infection (Cakkalath and Titus,
1994, Reiner et al, 1994). The study by Cakkalath and Titus (1994) also showed that
the infected M0s produced IL-1 but not IL-6 and that the IL-1 played a role in the
augmentation of the Th2 response. The fact that IL-6 was not produced suggests that
the M0s were not fully activated following infection with this parasite and that the
presence of the parasite appears to force the production of a nonresponsive Th2
reaction. Substantial work has been carried out upon L. donovani infections and again
it has been shown that the leishmanial parasite within the M0s can be removed by the
induction of a Th, response, aided by treatment of cultures with IL-12 (Ghalib et al,
1995).
Toxoplasma gondii also infects M0s and activation of cells infected with this
protozoan also results in the destruction of the parasite (Remington and Krahenbuhl,
1982, Sibley et al, 1991). This is also the case for Trypanosoma cruzi grown in mouse
peritoneal M0s (Nogueira and Cohn, 1978). Thus protozoan parasites ofM0s are often
susceptible to activation of their host cells and this is a major mechanism for the
removal of intracellular organisms. However, at least one of these parasites
(Leishmania) is able to alter the T helper cell response to evade killing. One
interesting aspect of T.annulata infection is that infected cells not only appear to
possess an activated phenotype but that they also induce the very type of T helper cell
response that one would think would aid in the removal of the parasite (eg, a Th, type
response). This is not seen to happen and suggests that this parasite also possesses the
capability to manipulate the immune response to evade destruction.
This thesis details investigations into the MHC class II expression, T cell stimulatory
ability and cytokine expression of T.annulatamacroschizont infected cells and attempts
to relate this to some of the properties of cell line vaccines.
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Chapter II.
General Materials and Methods
Section 2.1
Production of T.cuwulata infected cell lines.
In vitro infection ofbovine peripheral blood mononuclear cells with Theileria annulata
sporozoites of the Ankara (Turkey) strain (Schein, 1975) and production of
continuously growing infected cell lines and clones is outlined below.
Peripheral Blood Mononuclear Cells (PBM).
The PBM used during this study were isolated from an 8 month old Friesian calf
(No. 12929), as described by Glass and Spooner (1989). Whole venous blood was
collected, using 20% ACD as an anticoagulant, layered over Ficoll-Hypaque S.G.
1.077 ("Lymphoprep", Nycomed) and centrifuged at 1500g for 25 minutes. The
mononuclear cell layer was collected and washed in phosphate buffered saline (PBS)
by centrifugation at 300g for 10 minutes. Cells were then washed twice more in PBS
and finally in RPMI 1640 medium (Gibco BRL), centrifuging at lOOg for 10 minutes.
Cells were resuspended in TC medium (500ml RPMI 1640 (Gibco BRL)
supplemented with 25mM Hepes, 10% FCS (Imperial Laboratories), 2mM L-
Glutamine (Gibco BRL), 100 IU ml"1 Penicillin 100pg ml"1 Streptomycin (Gibco BRL))
counted and adjusted to the required concentration.
Magnetic A ntibody Cell Sorting ofCD14+ monocytes-Principles ofMA CS separation.
CD14+ cells were separated from PBM by the Magnetic Antibody Cell Sorting
(MACS) System (Miltenyi, 1990). The principle of the MACS system is as follows:
specific populations of cells are separated from PBM by positive selection following
labelling with mAbs binding specific epitopes (eg, CD14). These primary mAbs are
subsequently labelled with a secondary Ab conjugated to a magnetic tag (MACS
beads).
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Fig. 2.1 Diagrammatical representation of Magnetic Antibody Cell
Sorting (MACS) apparatus.
Diagram of MACS cell separation apparatus, including -
magnet (A), MACS column (B), syringe (C), three way tap
(D)/needle (E) and collection tube (F). Cells tagged with
primary mAbs and secondary mAbs/magnetic MACS beads
are separated from unlabelled cell populations as the former
adhere to the magnetised cell binding matrix of the MACS
column. Unlabelled cells are then flushed away, labelled
cells are subsequently harvested from the column after its





A = MACS magnet
B = MACS column.
C = 10ml syringe.
D = Three way stop tap.
E = Needle (variable gauge).
F = Collection tube.
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The column (Fig 2.1) is placed between the poles of a powerful magnet and the
plastic coated steel wool is conditioned with ice cold PBS/ 1% FCS before the
addition of the cell suspension. This ensures that cell membranes are not damaged
when in contact with the steel wool's surface.
The cell suspension is then run through the column. The speed of passage of the cells
is controlled by a needle attached (via a three way stop tap) to the base of the column.
The flow rate is altered by the use of needles with varying gauges. Magnetically
tagged cells bind to the magnetised steel wool as they pass through the column and
unlabelled cells are washed out of the column. The population of cells attached to the
steel wool are then washed by removing the column from the poles of the magnet and
backflushing the column with lOmls of chilled PBS 1% FCS from the syringe
attached to the three way stop tap. The needle is then changed to a larger gauge to
increase the flow rate through the column. The column is then placed back between
the poles of the magnet and contaminating cells washed from the column, while the
labelled cells adhere, once again to the steel wool. Once washed the cells can then be
eluted from the column. The column is removed from the magnet and lOmls of
chilled PBS/1% FCS used to flush labelled cells from the column. During the
separation of CD 14* cells used during this study, the cells were run through the
MACS column, washed, eluted and passed back through the column to obtain
maximum purity. The three cell populations (initial CD 14" population, second CD 14"
"wash" population and the CD 14* population following the second separation)
obtained were analysed using flow cytometry to assess the purity of each population
(data shown in Chapter III, Figs 3.1 a-d).
Cell labelling.
PBM were washed in chilled PBS/1% FCS. 2x10s PBM were adjusted to
lxl07cells/ml labelled with a 1/200 (final) dilution of the mouse anti ovine CD14
mAb VPM65 (Gupta et al, 1996) for 20 mins on ice. Cells were then washed twice
in chilled PBS/1% FCS and magnetically labelled using a rat anti mouse IgGl, MACS
bead conjugate (sodium azide removed as per manufacturers instructions), for 20 mins
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at 4°C (labelling is inhibited at temperatures below 4°C). The cells were diluted to 107
cells per 80jul PBS/1% FCS and 20jul of MACS beads added per 80|ul. After a 20
minute incubation (4°C) cells were washed (lOOg, 10 mins) twice and resuspended in
chilled PBS/1% FCS at 4xl07 cells ml"1.
Column preparation.
During cell preparation and staining the MACS column was prepared. A B2 MACS
column (Miltenyi Biotec), capable of retaining 1x10s positive cells was prepared. The
column was sterilised by filling with 70% ethanol from the tap/syringe assembly (Fig.
2.1) and allowed to stand for 10 mins. Following this the column was washed three
times with 15mls of chilled PBS/1% FCS, then refilled and allowed to stand until
used. The column was filled with freshly chilled PBS/1% FCS just before use, to cool
the column prior to addition of the cells. Cells were then separated as detailed above
using a 24 gauge needle for the first stage and a 22 gauge needle for the second.
T.annulata sporozoites.
T.annulata sporozoites were provided by the Centre for Tropical Veterinary Medicine,
University of Edinburgh. Parasite was produced as ground up tick supernatant (GUTS)
(Brown et al, 1983) and supplied as cryopreserved GUTS at 1 Tick equivalent (TE)
mF1 in 7.5% glycerol (BDH) and MEM/3.5% BPA.
In vitro infection of CD14+ monocytes with sporozoites.
T.annulata infected cell lines were produced by infecting CD 14" monocytes using
cryopreserved GUTS as described by Brown et al (1983, 1989). Before infection,
GUTS (1ml at ITE/ml) were allowed to thaw rapidly and then equilibrate at room
temperature for 20 minutes. The parasite material was then serially diluted in doubling
quantities of TC medium containing 20% FCS to an approximate volume of 8ml,
allowing 20 minutes between dilutions. The sporozoite containing medium was then
added to l-2xl07 CD14+ monocytes in 2ml of TC. The flask was placed upright in a
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37°C, 5% C02 incubator for 24 hrs, 7ml of medium was carefully removed and
replaced with 7ml fresh TC, and the flask placed horizontally.
Once an infected cell line had been established, fresh medium was added depending
on the rate of growth of the culture (typically every 48-72hrs). Infection could be
visualised using cytocentrifuge preparations (Cytospin II, Shandon). Here l-2xl05 cells
were centrifuged at 350rpm for 6 minutes using slide/filter assemblies (pre-wet with
RPMI 1640 medium). The slides were then air dried, fixed in methanol, and stained
for 30-40 minutes in Giemsa stain (Sigma) diluted 1:10 with "Gurr" buffer pH 7.2
(BDH). In well established cultures, >95% of viable cells could be identified as
containing schizonts, as shown in Fig. 2.2.
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Fig. 2.2 A photograph of leucocytes infected with T.anmdata
macroschizonts.
A typical cell line infected with T.annulata macroschizonts,
visible as clusters of small pinkish dots within the




Cloning of T.anmdata infected, cell lines.
Clonal cell lines were produced by soft agar cloning (Cotton et al, 1973) of infected
cells. 15ml Petri dishes (Nunc, Gibco, Paisley, UK) were covered with 10ml of TC
medium containing 1% tissue culture grade agarose at 37°C. Once this had cooled and
solidified, 2ml T.cmnulata infected cells in TC medium (100 cells ml"1) were mixed
with an equal volume of culture medium/1% agarose suspension at 37°C and layered
over the solid agar. The suspension was left at room temperature for 30 mins to
become semi-solid before incubating at 37°C in 5% C02.
Petri dishes were examined daily, with discrete colonies first appearing at day 4.
These colonies were transferred to separate wells of a 96 well round bottomed plate
(Nunc, Gibco, Paisley, UK) containing 150jal of culture medium. Cells were incubated
until the cell density approached 300-400 cells/well and transferred to a 24 well plate
(Nunc, Gibco, Paisley, UK) and incubated until the cell density was approximately
2xl05cells/well. Cells were then transferred to 10ml Nunc tissue culture flasks and
treated in an identical manner to standard T.annulata cultures (Brown et al, 1983).
Mitomycin C treatment ofPBM and T.annulata infected cells.
T.annulata infected cells were treated with Mitomycin C prior to use as stimulator
cells. This compound prevents the cell growth and thus infected cells from
overgrowing PBM cultures (Fraser et al, 1996). Mitomycin C ((Sigma) produced by
the fungus, Streptomyces caespitosus)) cross links DNA and inhibits it's replication.
PBM or T.annulata infected cells used to stimulate T cells were incubated in culture
medium at lxl07cells ml"' with 25p.g ml"1 and 50jug ml"1 of Mitomycin C respectively




T cell proliferation induced by the infected cell lines was measured as previously
described (Glass & Spooner 1990). The T.unnulata cells used in these experiments
were passaged 24 hours prior to use, 2 mis of the cell culture was added to 8 mis of
fresh medium. Briefly, autologous PBM (4xl0Vwell) were incubated with mitomycin
C treated autologous T.cnmulata infected cells (4xl04/well) or 5pg/ml Con A for 5
days in 96 well flat bottom plates (Nunc, Gibco, Paisley, UK). Following a 6 hour
pulse of tritiated thymidine (IpCi well"1 [3H]dThd, supplied by Amersham Int.) plates
were harvested and counted as previously outlined using a Wallac MicroBeta and Cell
Harvester).
Seel ion 2.4.
Quantitation ofMHC class II expression.
F(ab')2 fragments of the anti ruminant, pan MHC class II mAb SW73.2, which is
specific for nonpolymorphic epitopes on the P-chain of MHC class II molecules
(Hopkins et al, 1986; Knowles et al, 1994), were iodinated with I25Iodine (Amersham
Int, Amersham, U.K.). Iodination was carried out as per the Pierce IODO-beads
iodination protocol (Lee et al, 1984). During the process of radioiodination,
radioactive l25Iodine is introduced into tyrosine residues at positions ortho to the
hydroxyl group of the residue. The mechanism of iodination used during IODO-bead
protocol involves the oxidising agent jV-chloro-benzenesulphonamide (sodium salt)
(Markwell, 1982) covalently linked to nonporous polystyrene beads. This two phase
iodination system allows removal of the bead from the protein suspension, thus
limiting damage caused by extended contact with an oxidising agent.
F(ab') 2 Iodinution.
One Iodobead was placed in a sterile eppendorf tube and washed with 500pl of PBS
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(pH 6.5). The PBS was removed and 250pl of fresh PBS added, 0.6 mCi
(approximately 6jul) of sodium 125iodide was then added to the bead. The bead was
incubated at room temperature for 5mins and 30jul of SW73.2 F(ab')2 (14.5pg/10pl
PBS) added. 164jul of PBS was added making a final volume of 450pl, followed by
a 5 min incubation at room temperature. The F(ab')2 suspension was removed from
the bead to a sterile eppendorf and the bead washed in 50pl of fresh PBS, this was
then added to the rest of the antibody suspension.
The F(ab')2 suspension was passed down a PD-10 sephadex column (Pharmacia)
pretreated with RPMI 1640/1% FCS (0.1% NaN3). Fractions were collected in 0.5ml
volumes and the I25I content (cpm sec"1) of the fractions gauged using a Mini Assay
Type 6-20 y counter (Mini Instruments). The 125I labelled fragments were generally
found to be in the 3rd- 5th fractions and the total volume varied from between 1500-
1800jul. 1/j.l of the fragment suspension was removed and added to 1ml of ice cold
20% trichloroethanoic acid (TCA), following a 5 min incubation on ice. The
F(ab')2/TCA was centrifuged at 14000g for 5 mins and the supernatant removed. The
amount of 125I attached to 1 jul of F(ab')2 was assessed using a Wallac 1261
Multigamma. The specific activity of the labelled fragments were calculated as shown
below.
Calculation of the concentration of Ffab'fr fragments fas supplied).
(1) F(ab')2 supplied at 1.45g/l and has a molecular weight of 70,000Da.
(2) Therefore 1.45/70000 = 2.07xl0"5 moles of F(ab')2 molecules.
(3) 2.07xl0"5 x 6.02295xl023 = 1.25xl0i9 F(ab')2 molecules l"1 (1.25xl013 pi"1).
(4) Therefore 1.25xl013/1.45 = 8.6xl012 F(ab')2 molecules jug"1.
(5) Therefore 30pl (or 43.5pg) of F(ab')2 = 3.74xl014 molecules (total F(ab')2
iodinated).
(N.B. - During radiolabelling experiments the volume of eluent which the 125I-SW73.2
was diluted in and therefore the concentration of iodinated F(ab')2 fragments per
labelling reaction was taken into consideration. Also two assumptions are made here,
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Calculation of the specific activity of radiolabeled SW73.2 F(ab')2 molecules.
(1) (Mean cpm of lpl F(ab')2/3) x 4 = dpm of lpl of F(ab')2 suspension.
(2) dpm of lpl F(ab')2/60 x volume of F(ab')2 suspension/106 = Total MBq of 125I-
labelled F(ab')2.
(3) Specific activity = total MBq/43.5 (pg F(ab')2 iodinated)/37000 = pCi/pg
F(ab')2.
(N.B, cpm = counts min"1, dpm = decays min"1).
The !25I labelled F(ab')2 suspension was stored at 4°C for up to 5 days.
MHC class II Quantitation.
T.annulata infected cell cultures were passaged the day before use, to maintain the
cells in exponential growth phase. The expression levels of MHC class II molecules
were measured by saturation binding using 125I-F(ab')2 fragments as previously
described (Trucco et al 1981, Hopkins et al 1986). SW73.2 F(ab')2 molecules have
only one binding site for MHC class II molecules. One binding arm of SW73.2 binds
a nonpolymorphic epitope on the beta chain of class II molecules, whilst the other
binds an epitope expressed on the Y3 myeloma line used to immortalise the Ab
producing B cell.
To ascertain the concentration of 12:,I-SW73.2 which would bind all the MHC class
II molecules present on infected cells, triplicate samples of 106 cells were incubated
with lOOpl samples of 125I-SW73.2 at dilutions of 25, 50, 75 and 100% (100% being
F(ab')2/RPMI undiluted after collection from the PD-10 column). A 50% solution of
12T-SW73.2 F(ab')2 was found to bind all the MHC class II expressed by the uncloned
infected cell line (Fig. 2.3). This cell line was used to assess saturation binding
conditions as it was found (during preliminary flow cytometric analysis) to express
the highest levels of any of the cell lines used in this study (Chapter III).
Fig. 2.3 shows the percentage of 12:>I-SW73.2 suspension added to infected cells and
also the number of MHC class II specific F(ab')2 fragments contained in lOOpls of
F(ab')2 suspension at each dilution. This takes into account the number of MHC class
II specific fragments added to the column (3.74xl014) and the volume of 123I-SW73.2
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also the number of MHC class II specific F(ab')2 fragments contained in lOOpls of
F(ab')2 suspension at each dilution. This takes into account the number of MHC class
II specific fragments added to the column (3.74xl014) and the volume of I25I-SW73.2
containing liquid collected off the PD-10 column, (in this instance 1500pls) and gives
a concentration of 2.49xl013 class II specific molecules per lOOpls of undiluted eluent.
During binding assays triplicate samples of lxl 06 cells of different T.arinulata infected
cultures were labelled on ice for 30 mins with 50pl of 125I-F(ab')2/RMPI 1640 (0.1%
NaN3), plus 50pl of RPMI 1640. Unbound F(ab')2 was separated from the cells by
washing with 3 x 750pl aliquots of chilled PBS followed by centrifugation at 1000
rpm for 2 mins (Eppendorf centrifuge). Cells were pelleted after the third wash
(centrifugation at 10000 rpm, 2 mins (Eppendorf centrifuge)) and the supernatant
removed. The amount of I25I-SW73.2 bound to the cells was assessed by direct y
counting using a Wallac 1261 Multigamma. The numbers ofMHC class II molecules
per cell were calculated as shown below.
(1) jaCi of labelled cell sample/specific act = jug of class II specific F(ab')2
molecules bound to labelled cells.
(2) pg F(ab')2 bound x 8.60xl012 = No. F(ab')2. (8.60xl012 = No. F(ab')2 pg')•
(3) No. F(ab')2/lxl06 = No. F(ab')2 cell"1 = No. MHC class II molecules cell"1.
(N.B. 8.60xl012 = MHC class II specific F(ab')2 molecules per pg, lxlO5 = total
number of cells labelled.
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Fig. 2.3 Assessment of the concentration of nsI labelled SW73.2
F(ab*)2 fragments necessary to bind the MHC diss II
expressed by 106 T.awudata infected cells under saturating
conditions.
Data from a saturation binding assay where I25I-SW73.2
F(ab')2 fragments were used to assess the amounts of
radiolabelled anti-pan MHC class II antibody fragments
necessary to bind MHC class II expressed by T.annulata
infected cells under saturating conditions. Triplicate samples
of 106 macroschizont infected cells were incubated for 30
min on ice with varying concentrations of 125I radiolabelled
SW73.2 F(ab')2 fragments. Three washes with ice cold PBS
removed unbound fragments and radiolabelling of cell
samples was then assessed by y-counting. A 50% solution
containing 1.25x10° F(ab')2 fragments was found to bind all
MHC class II molecules expressed by 106 infected cells.
Assessment of radiolabeled SW73.2 F(ab') fragment concentration needed to bind
MHC class II molecules under saturation conditions.
6.25x10*12 1.25x10*13 1.88x10*13 2.5x10*13 F(ab') molecules.




Flow cytometric (FC) analysis of T.annulata infected cells was performed to assess
phenotype and the expression of MHC class I and class II molecules (Campbell,
1995). Analysis was performed using the mAbs shown in Table 2.1 and the secondary
conjugates shown in Table 2.2. Primary mAbs and secondary conjugates used in FC
analysis were titrated before use to determine optimal concentrations, primary mAbs
were used at 1:1000 (final concentration of diluted ascites) and secondary conjugates
were used at concentrations of 1:100 (final concentration).
Table 2.1
mAb (isotype). Specificity. Reference.
VPM36 (IgG,). MHC class II (DQ). Dutia et al, 1993; Dutia
et al, 1995.
VPM54 (IgG,)- MHC class II (DR). Dutia et al, 1993; Dutia
et al, 1995.
VPM65 (IgG,). CD14. Gupta et al, 1996.
IL-A21 (IgGjJ. MHC class II. Davis et al, 1994.
IL-A24 (IgG,). Macrophages. Ellis et al, 1988.
IL-A109 (IgM). Monocytes. MacHugh et al, 1990.
Table 2.1 Primaiy monoclonal antibodies used during flow cytometric analysis.





Rabbit anti-mouse (MAR) Ig-FITC 1:100
Table 2.2 Fluorochrome conjugated secondary antibody.
Details of the secondary antibody (supplied by Sigma) used during this
study. The secondary used was a fluorescein isothiocyanate (FITC)
conjugated Ab.
Staining of cells forflow cytometric analysis.
Cells were prepared for FC analysis by washing twice in Cell Wash (PBS/NaN3 (pH
7.2) Becton Dickinson) and resuspended in chilled cell wash (supplemented with 5%
y-globulin free horse serum) at lxl07cells ml"1 (FC assays were performed at 4°C).
Aliquots of 50pl of cell suspension (5x10s cells) were added to separate wells of a 96
well round bottom plate and 50pi of each mAb added to a well. Negative controls
consisted of cells incubated with normal mouse (1:1500, Sigma), followed by
secondary conjugate. Cells were incubated on ice for 30 mins, unbound mAb
molecules were removed from cells by washing 3x with 150jul of chilled cell wash
(plates were centrifuged at lOOg for 2'/2 mins at 4°C). Cells were then resuspended
in 50pl of the appropriate secondary mAb conjugate and incubated (covered from
light) on ice for a further 30 mins. The cell samples were then washed a further 3x
as before, resuspended in 100pl of cell wash and covered from light until use.
FA CScan settings and operation.
A FACScan (Becton Dickinson) was used for all FC analysis. Data acquisition and
analysis was performed using Lysis II software (Becton Dickinson). The FACScan
flow cytometer uses a single argon laser to produce a beam of light (A, = 488nm),
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which is used to assess the fluorescence, size and internal complexity of cells passed
through the FACScan. As cells pass through the path of the light beam, changes in
the beam's pattern/intensity are recorded by photomultiplier tubes and converted into
electronic impulses. These impulses are then processed by the FACScan and are used
to produce the data shown on the monitor. The parameters assayed by this method are
the fluorescence of conjugate labelled cells and their size/complexity.
Calibration of the FACScan prior to data acquisition is achieved using the negative
control samples (cells stained with secondary Ab and mouse serum only). The effect
that the cells have on the path of the laser beam is used to assess the size and
complexity of the cells. The presence of the cell within the light beam causes the
beam to bend, the larger the cell, the higher the degree of bending. The degree of
bending of the light relates to the amplitude of the light scatter. Changes in this
parameter are recorded as forward scatter (FSC) along the axis of laser emission and
give an indication of the size of the cells passing through the beam. The degree of
scattering of the light beam relates to the complexity or degree of organisation within
the cells. Side scatter (SSC) is caused by the cells' ultrastructure and organelles
refracting the light beam as they pass through. The light is refracted at 90° to the
angle of incidence, detectors record these emissions and convert them to electronic
impulses. High SSC values indicate high levels of internal organisation within cells,
eg T.annulata infected cells show higher FSC and SSC readings than uninfected PBM.
Data produced is plotted as a dotplot and live cells are gated on a linear scale to
remove dead cells and red blood cells.
Fluorochrome conjugates passing through the laser beam absorb light at 488nm and
emit light at an altered wavelength. Fluorescein isothiocyanate (FITC) emits light at
530nm and Phycoerythrin (PE) emits light at 580nm. Florescence is measured on log10
scales, with settings typically between 580-620meV (FITC, FL1) and 500-540meV
(PE, FL2). The transmitted light of these differing wavelengths are measured by
detectors on the FACScans optical filters, the amount of emitted light detected is
proportional to the amount of fluorochrome bound to the cell surface.
Data acquisition was carried out in Lysis II acquisition mode, with 10000 cells taken
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for each sample. Control fluorescence levels were obtained from the negative control
samples. Data was analysed using either Lysis II at the FACScan work station or PC
Lysis (Becton Dickinson) operating in Microsoft Windows and was presented as either
histograms of cell frequency against logI0 fluorescence or dotplots of log10
fluorescence against FSC or SSC.
Molecular biological techniques used to assess cytokine expression.
Section 2.6.
RT-PCR analysis of cytokine transcripts from T.annulata infected cell lines.
RNA Extraction.
Total cell RNA was isolated from various T.annulata cell lines, clones and T cells
using RNeasy method (Quiagen) according to the manufacturers instructions. This
method does not require the use of chloroform/guanidinium isothiocyanate extraction
and can be carried out at room temperature in approximately 20 mins. The method
relies on the fact that RNAse enzymes are unable to function at the high salt
concentrations in the lysis buffer.
Homogenisation of the cells in a solution of guanidinium hydrochloride, by repeated
passage through a syringe and fine needle, bursts the cells and shears nuclear DNA.
Addition of 70% ethanol precipitates the RNA, which binds to the RNeasy column's
silica based membrane. Contaminating material is removed during subsequent washes.
The purified RNA is then eluted by addition of double distilled/deionised/autoclaved
water (DDA H20) and brief centrifugation.
RNA preparation Protocol.
107 cells were pelleted at lOOg for 10 mins and the supernatant removed. Cells were
resuspended in 350pl of lysis buffer (plus 10pl tissue culture grade 2-mercaptoethanol
ml"1 lysis buffer (Sigma)) and homogenised by passing the suspension rapidly back
and forth 20-25 times through a 21 gauge needle and 1ml syringe. 350pl of 70%
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ethanol was added to the lysate and mixed using a 1ml pipette (Gilson). The 700pl of
lysate was added to an RNeasy column and centrifuged at 10000 rpm for 15 seconds
in an Eppendorf centrifuge. The supernatant was then removed from the collection
tube and 700pl of wash buffer No.l added, the tube was then centrifuged at 10000
rpm for 15 seconds. The collection tube was then discarded and a fresh 2 ml
collection tube placed on the column, 500pl of wash buffer No.2 was then added and
the column centrifuged as before with the supernatant being discarded. These buffers
are designed to wash unwanted protein off the membrane, away from the RNA.
A further 500pl of wash buffer No.2 was added to the column followed by
centrifugation at 14000rpm for 2 mins. The column was then transferred to a fresh 1.5
ml eppendorf tube and 40pl of DDA H20 added to the column, which was incubated
on ice for 5 mins. The column was then centrifuged at 10000 rpm for 1 min
(Eppendorf centrifuge) and the resulting 40pl of RNA suspension placed on ice.
The total RNA yield was assessed by U.V spectrophotometry at 260nm and 280nm
(Sambrook et al, 1989). lpl of the 40pl RNA suspensions was diluted 1:100 in DDA
H20, U.V absorbtion (Abs) was determined using a Beckman DU-62
spectrophotometer with a 1 OOjul quartz cuvette. The apparatus was calibrated against
DDA EI20 and then the Abs at 260nm and 280nm (Abs260, Abs2g0) were taken for the
diluted RNA samples. The ratio of Abs260 to Abs280 gives an indication of the
condition of the RNA sample. A ratio of approximately 2260:1280 suggests an RNA
sample with little nucleic acid degradation or contaminating protein. An Abs260 value
of 1 corresponds to an RNA concentration of 40pg ml"1, the concentration (pig ml"1)
of RNA was calculated by multiplying the Abs260 value by 40 (and the suitable
dilution factors).
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Reverse transcription ofRNA to cDNA.
Samples of 5pg RNA were used for reverse transcription to cDNA using the
Superscript preamplification system (Life Technologies Ltd.) with oligo dT as a
primer, according to the manufacturer's instructions.
Samples of 5pg of total RNA were placed in 500pl PCR tubes and a volume of DDA
H20 added to make a final volume of 12pl. lpl of oligo dT primer (500pg ml"1) was
added to the RNA suspension. This mixture was incubated at 70°C for 10 mins on an
Omnigene PCR machine (Hybaid) and then chilled on ice. This allowed the RNA to
separate and the oligo dT to bind to the poly A tails of the mRNA molecules, with
the exclusion of the other RNA molecules present. The tubes were then centrifuged
(10000 rpm, 15 sec (Eppendorf centrifuge)) and the following superscript mix added
to each sample.
Superscript mix:- 4pl 5x synthesis buffer.
2|ul 0.1M Dithiothreitol (DTT/reducing agent),
lpl lOmM dNTP mix.
1 jlxI 200u pi"1 superscript reverse transcriptase.
Samples were then centrifuged at 10000 rpm for 15 sec and incubated at room
temperature for 10 mins. The samples were then heated on an Omnigene PCR
machine (Hybaid) at 42°C for 50 mins (allowing synthesis of the cDNA, followed by
90°C for 5 mins. This final step allowed the denaturation of the superscript enzyme.
The samples were then placed on ice for 5 mins and centrifuged at 10000 rpm for 15
sees. cDNA samples were either used immediately after synthesis or stored at -20°C.
Primer design and manufacture.
Oligonucleotide primers were designed using the EMBL data base and the FASTA
and PCRPLAN PC/GENE (version 6.7, Intelligenetics Inc. California. U.S.A.)
computer programmes. The sequences of the mRNA transcripts of the bovine
cytokines were located on the EMBLE data base (Switzerland). The majority of the
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primers shown below were produced specifically for this study. However, the primers
used to detect P-actin, IL-2, IL-2R, IL-4 and IFNy were designed by G. Russell and
J. D. M. Campbell (Roslin Institute) (Van Lerope et al, 1995).
Table 2.3









IL-12 (p40) BT14416, U11815.
TNFa Z14137.
IFNy M29867.
Table 2.3 Cytokine sequence references.
Details of the cytokine primers made for this study and the accession
number of the cytokine sequences used to design these primer
sequences.
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Using the PC gene program these sequences were analysed to locate suitable areas of
cytokine mRNA sequence which could be used as the basis for oligonucliotide
primers. When more than one sequence was found for a particular bovine cytokine,
the sequences were compared and primers were designed to sit in areas which
matched for all known sequences. The parameters used to select these primer pairs
were as follows: primer lengths of no more than 20 bases; annealing temperatures of
between 55-60°C; GC contents of approximately 50%; exclusion of self binding sites.
Once primer pairs were selected their sequences were checked for homology to the
known cytokine sequences and other known sequences using the FASTA computer
programm. Oligonucliotide primers which also showed homology to other known
sequences were discarded and only primers which primed from specific cytokine
templates were selected for use. Primer pairs were manufactured by Oswel DNA
Service (Dept of Chemistry, Edinburgh University). Oligos were supplied at
approximately O.lnM pi"1, diluted to a working concentration of 25pM pi"1 and stored
at -20°C, stock solutions were aliquoted and stored at -80°C.
76
Polymerase chain reaction analysis of cDNA.
Polymerase chain reaction (PCR) reactions were performed using 2pl of the resulting
cDNA. Primers specific for bovine cytokine sequences (Tables 2.4a and b) were used
to amplify cytokine cDNA, during a 30 cycle PCR program (Taq polymerase and
buffers from Gibco BRL). The PCR mix used in each 30p.l reaction contained; 19pl
DDA H20, 3pi lOx PCR buffer (Gibco BRL), 1.2pl MgCl (50mM, Gibco BRL), 2.4pl
dNTP mix (dATP, dCTP, dGTP, dTTP, each at lOmM, Pharmacia), lpl +ve primer
(25pM), ljul -ve primer (25pM), 2pl cDNA suspension, 0.4pl (2 units) Thermus
aquaticus Taq polymerase (Gibco BRL). Sample tubes (500/ul PCR tubes, Robbins
Scientific Corporation) were centrifuged at 10000 rpm for 15 sec and then a thin layer
of liquid paraffin added to prevent evaporation during the PCR program.
The PCR programm was carried out on an Omnigene PCR machine (Hybaid), the






Hold temp = 20°C.
Following the PCR reaction samples either underwent electrophoresis or were stored
at -20°C until required.
x 3 mins. (denaturation step).
x 1 min. (denaturation step),
x 1 min. (primer attachment step),
x 1 min. (elongation step).
(Stage 2 cycles 30 times).
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Table 2.4a Cytokine primer sequences.
Details of PCR primers specific for P-actin, IL-la, IL-ip, IL-2 and
IL-2R, including, direction, size of product in base pairs, melting
temperatures and nucleic acid sequence.
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Table 2.4b




























Table 2.4b Cytokine primer sequences.
Details of PCR primers specific for IL-4, IL-6, IL-10, IL-12, TNFa,
IFNy and G3PD, including, direction, size of product in base pairs,
melting temperatures and nucleic acid sequence.
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The products of the RT-PCR reactions were visualised (under ultraviolet light) on a 2%
agarose (Sigma, type l-A)/lx TBE (Tns/Bonc acid/EDTA) gel, containing O.lpg/ml Ethidium
Bromide. Before loading of the samples 15pl of sample was added to 5pi of loading buffer
(80% glycerol, 0.02% bromophenol blue, 19.98% Tris:EDTA). Gels were electrophoresed at lOOv
for 1.5-2 hours in lxTBE running buffer. Polaroid photographs were taken to record the
resulting gels. j3-actin or Glucose-3-phosphate dehydrogenase (G3PD) primers were used as
positive controls during these reactions. G3PD primer sequences were supplied by I.L.R.I.
(Kenya), these primers proved a more reliable control than the original P-actin control.
Restriction digest analysis ofPCR products.
Restriction maps of the PCR products were calculated from the known bovine
cytokine sequences when cut with specific restriction enzymes, chosen using the PC
Gene computer program. 15pd of the PCR products were digested with selected
restriction enzymes, the fragments were visualised as previously outlined. Production
of fragments the size of which matched those predicted allowed the authenticity of the
PCR reactions to be assessed. Five enzymes were used: Taq 1 (Pharmacia), Pvu II
(Boehringer-Mannheim), Bgl II (Boehringer-Mannheim), Hae III (Biolabs), Pst 1
(Pharmacia).
Semi-Quantitation ofmRNA.
Limiting cycle PCR was performed to ascertain the relative expression levels of the
various cytokine mRNAs between different clones, cell lines and stimulated T cells.
In all experiments 5pg of RNA was used to synthesise cDNA and 2pi of cDNA
suspension was used as templates for the primer pairs in each PCR reaction. This
means that the amount ofmRNA present before reverse transcription correlates to the
amount of PCR product synthesised during the PCR reactions. The presence of high
levels of cytokine mRNA in a cell at the point of RNA extraction, means the PCR
product produced from the resulting cDNA templates will be visible at a lower
number of PCR cycles than for cells with lower levels ofmRNA present at the point
of RNA extraction.
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The PCR protocol remained the same apart from the number of cycles used to amplify
each 2pl of cytokine cDNA. Cycle numbers ranged from 20 to 30, in increments of
2 cycles. Comparison of the cycle at which the PCR products became visible under
U.V light were used to assess the relative expression of the cytokine mRNA species.
Gels were cast, electrophoresed and visualised as previously described.
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In vivo assessment of clones I and L.
Section 2.7.
Immunisation trial of clones I and L.
Based on the in vitro data (contained in chapters III and IV) produced from studies
of the parent line and the clones, clone I and L were selected for the immunisation
of six three year old cows. The aim of this experiment was to compare the effects of
these different clonal cell lines upon the subject animals. Three animals were
immunised with clone I and three immunised with clone L and progression of
infection and the health of the animals followed for 30 days post infection. Data
gathered included; daily temperatures, packed cell volume (PCV), total erythrocyte
count (TEC), total leukocyte count (TLC), the time of appearance of macroschizont
infected cells and piroplasms were also noted. Attempts were also made to isolate and
grow macroschizont infected cells from each animal and to compare the phenotypes
of any lines produced to the original clone.
Immunisation with macroschizont infected cells.
Clones I and L were passaged the day prior to immunisation. Immediately before
immunisation, rectal temperatures and 2 ml EDTA venous blood tubes (Vacutainer,
Becton Dickinson) were taken from each animal and notes taken of, PCV, TEC and
TLC. Each animal was immunised (subcutaneously in the shoulder) with lxlO6
macroschizont infected cells of either clone I or clone L diluted in TC culture
medium. Post immunisation rectal temperatures and 2 ml EDTA venous blood tubes
were taken daily. Cattle suffering fever (temperatures over 39.5°C) or severe clinical
symptoms (such as drastically reduced PCVs) for two or more days were treated with
the quininoid drug Butalex (2.5mg kg"1; Mallinckrodt Veterinary Ltd). Data collection
from these animals was terminated 23 days post immunisation.
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Analysis of 2 ml EDTA blood tubes.
The 2 ml EDTA venous blood samples were used to assess the effect of immunisation
of the animals with the clones, upon the circulating erythrocyte and lymphocyte pools.
PCV was calculated using a Hawksley Microheamatocrit centrifuge and Hawksley
reader (Hawksley & son Ltd, Sussex). TLCs and TECs were calculated using a
Coulter Counter (Coulter Electronics). Blood was diluted to aid accurate counting,
with 20pl of blood being aspirated into a Dual Diluter III (Coulter Electronics) with
the addition of 20mls of Isotone (Coulter Electronics). This gives a dilution factor of
1:1000, for lymphocyte counting. To assess RBC numbers, lOOpl of diluted blood was
aspirated into the Double Diluter and 20ml of isotone were added, resulting in a final
dilution of 1:200000. Six drops ofZap-Globin (Coulter Electronics) were added to the
TLC samples and the suspension shaken. Zap-globin lyses erythrocytes for accurate
leucocyte counting.
The Coulter Counter (Coulter Electronics) used to obtain TLCs and TECs was zeroed
with 10 mis of fresh Isotone and the TEC samples passed through the machine, 0.5ml
of each sample was aspirated and TEC noted. Following this the TLC samples were
analysed using the same procedure. The counter probe had a 100 jum orifice and probe
blockages (due to dust of aggregates of cells) were cleared using fresh Isotone and a
soft brush. Each sample was counted twice and the mean number of cells counted
calculated. Taking into consideration the dilution factors of the samples and the
volume of each sample aspirated, the number obtained for each sample corresponded
to XxlO3 cells ml"1 for TLCs and XxlO6 cells ml"1 for TECs (X = number of cells
counted).
Detection of macroschizont and piroplasm infected cells.
The appearance of macroschizont infected cells was assessed by microscopical
examination of cytospin slides of PBM. Here 1-2XKP cells were centrifuged at
350rpm for 6 minutes using slide/filter assemblies (pre-wet with RPMI 1640 medium)
and a Cytospin II (Shandon). The slides were then air dried, fixed in methanol, and
stained for 30-40 minutes in Giemsa stain (Sigma) diluted 1:10 with "Gurr" buffer pH
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7.2 (BDH). Detection of piroplasms was carried out by microscopical analysis of air
dried blood smears, fixed in methanol also stained in Giemsa.
Isolation of infected cells from animals immunised with clones I or L.
Infected cells were isolated from immunised animals using the same method employed
to isolate PBM from whole blood. Sterile venous blood was layered over Lymphoprep
(Nycomed), centrifuged and washed. The isolated PBM/infected cells were then placed
in TC medium and cultured in 6 well plates (Nunc) at 37°C/5% C02. Daily
inspections were carried out to check for the presence ofmacroschizont infected cells.
These cells appear as large blasting cells which begin to form clumps within the
surrounding PBM. As infected cells overgrew the residual uninfected PBM, the
cultures were split and the dividing cells supplied with fresh medium. Once cell
density had reached approximately 5xl06-lxl07 infected cells well"1, the cultures were
transferred to 10ml culture flasks (Nunc) and treated as normal T.annulata infected
lines.
MHC class I /II typing and microsatellite analysis of infected cells.
The MHC class I & II types of vaccinating cell lines (clones I and L) and
macroschizont infected cells reisolated from animals after immunisation were analysed
as described in Spooner et al (1979) and Oliver et al (1989). Microsatillite analysis
was conducted by Mrs Janis Barr (Ziegle et al, 1992).
Challenge of immunised animals with T.annulata sporozoites.
Thirty days after the end of the initial immunisation trial, the six experimental animals
and two unimmunised control animals were each challenged with a potentially lethal
dose of 1 tick equivalent (1TE) of cryopreserved T.annulata sporozoites (Gharb stock).
Sporozoites were administered subcutaneously into the prescapular region. After
inoculation clinical signs were monitored as previously detailed.
84
Statistical analysis of data obtainedfrom immunisation study.
Statistical analysis was carried out with the aid ofMr D. Waddington, a statistician
at The Roslin Institute. Data were analysed using one and two sided t-tests carried out
on the Minitab computer program. The trial period of 23 days was divided up into 3
periods (days 1-10, 11-17, 18-23). This was based upon previous work which Mr
Waddington had conducted with Dr A. Nichani into the progression of the disease.
The three periods represent - (1) initial phase of infection (trends in this period were
studied using regression analysis, followed by a double sided T test), (2) the phase
during which signs are seen and (3) recovery phase. One sided t-tests were conducted
when the outcome of a particular part of the experiment been predicted. Two sided
t-tests were used to assess data when an outcome had not been predicted prior to data
collection. Data from the following days (11-17/18-23) were analysed by calculating
the mean values for the various parameters over these periods and performing single
sided t-tests on the resulting values. For instance, the mean temp of group I (days 11-
17) v.s. the mean temp of group L (days 11-17).
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Chapter HI.
Quantitation of MHC class II expression by Theileria annulata




Once infected with T.annulata sporozoites, cells form continuously growing,
macroschizont infected, MHC class II+ cell lines (Spooner et al, 1989; Glass et al,
1989). The exact identity of the cells infectable with T.annulata, which can then form
continuously growing cell lines has been a much investigated subject for some years.
The identity of the cells infected in vivo remain unknown, during the last 6 to 8 years
work concerning the identity of cells which become infected in vitro has provided
strong suggestive evidence for the identity of the cells.
Work in this laboratory (Spooner, et al, 1989; Glass et al, 1989) showed that of
mononuclear cells present in peripheral blood, those most easily infected and
transformed in vitro were MHC class II positive monocytes/M0s and B cells. Later
work by Campbell et al (1994) narrowed down the range of phenotypes which were
infectable in vitro, studying the infectabilitv of elastin receptor positive and
lipopolysaccharide (LPS) receptor positive (CD14+) cells (of the monocyte/M9
lineage). During this work Dr Campbell and myself performed studies into the
iftfectability of these cells and also into the infectability of purified B and T cells.
From the findings of these investigations we confirmed that the cells infected and
transformed in vitro with the highest efficiency by T.annulata sporozoites were of the
CD14+ monocyte/M9 lineage.
Log3 dilutions of peripheral blood mononuclear cells (PBM), T cell, B cell, elastin
receptor* and CD 14* cells were prepared and incubated with T.annulata sporozoites
(Brown et al, 1987). Elastin receptor* cells were included in this study after work by
Williamson et al (1989) and Hall et al (1992) suggested that the elastin receptor was
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a possible entry ligand for T.annulata sporozoites. Investigation of sporozoite surface
antigens revealed a molecule (SPAG-1) expressed by the infective stage of the parasite
contained an amino acid motif (Val-Gly-Val-Ala-Pro-Gly) characteristic of the elastin
molecule. It was then postulated that the parasite used this elastin like molecule to
bind to and infect elastin receptor* cells. However, data produced during in vitro
infection studies showed that T and B cells did not become infected/"transformed" by
sporozoites of T.annulata and the infectivity of elastin receptor and elastin receptor"
cells did not exhibit significant differences. The ratios at which CD14+ cells infect
and "transform" in vitro were 1:116 for CD14* cells and 1:6897 for CD14" cells
(Campbell et al, 1994). CD 14* cells, encompassing all monocytes and M9, are
therefore the principle cells transformed by T.annulata sporozoites in vitro.
During the studies conducted into the infectibility of MHC class II positive cells and
studies of the MHC class II expression of these cells after infection, it was observed
that T.annulata infected cells generally expressed higher levels of class II molecules
than uninfected cells (Glass and Spooner, 1990a). Infected cells act as functional Ag
presenting cells, presenting Ag via MHC class II to CD4+ T cells. However, Glass &
Spooner (1990a) also demonstrated that infected cells possessed "augmented Ag
presentation functions" as infected cells were capable of inducing activation of T cells
from animals which had not been exposed to theileria.
Proliferation of PBM when cultured with infected cells (Rintelen et al, 1990; Glass
and Spooner, 1990a) is associated with the activation of CD4* T cells (Campbell et
al, 1995; Campbell, 1995) and is totally dependent on contact between infected cells
and T cells (Campbell et al, 1995). In vitro, T cells activated by T.annulata infected
cells do not form anti-theilerial responses (Nichani, 1994; Campbell, 1995). The
"non-specific" T cell activation observed in vitro, also occurs in vivo, with T cells
becoming activated following contact with infected cells within the draining lymph
node (Campbell et al, 1995). These in vivo activated T cells are again not functional
(Nichani, 1994; Campbell, 1995). Understanding the mechanisms by which T.annulata
infected cells cause "non-specific" T cell activation are therefore of great importance
in understanding mechanisms of pathogenesis.
MHC class II expression is essential for the Ag-specific activation of CD4+ T cells
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(Harding and Unanue, 1990). T.annulata infected macrophages express high levels of
class II and possess augmented Ag presenting functions - the "non-specific" activation
of autologous T cells. Thus Glass and Spooner (1990a) suggested that the T cell
stimulatory ability of infected cells may be related to the high MHC class II
expression of infected cells.
This chapter investigates the relationship between the MHC class II expression of
T.annulata infected cells and their T cell stimulatory abilities. To further characterise
the high levels of MHC class II expression within a population of infected cells,
clones were derived and the levels of MHC class II expression within these discrete
populations investigated. Exact quantitation of MHC class II expression was carried
out using saturation binding analysis. The levels of MHC class II expressed by the
different populations was then related to T cell stimulatory ability.
Results.
Section 3.2.
Characterisation of urdifected CD14* monocytes.
After MACS isolation of the CD14+ population from PBM, aliquots of cells from the
initial unfractionated population, the second CD14" population and the final CD 14"
population were stained with anti mouse Ig (whole molecule) FITC conjugate (binding
to any VPM65 present). The purity of the resulting populations were assessed by FC
analysis. Fig 3.1a shows an FC dotplot of the initial PBM population prior to MACS
purification. This FC plot of forward scatter (FSC) vs side scatter (SSC) gives an
indication of the size and internal complexity of the PBM population.
The majority of the cells contained in PBM are small and of low internal complexity,
as signified by the low FSC and SSC shown by the main population. The cells
showing higher FSCs and SSCs are larger more complex cells which are either cells
of the myeloid lineage (ie, monocytes) or possibly small numbers of blasting
lymphocytes (these cells are also larger than the resting PBM). The following dotplots
of Log (FL1) fluorescence vs FSC (Fig 3.1 b-d) show the MACSed populations after
incubation with FITC conjugate. Figs. 3.1b and c result from the staining of the
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CD14 negative populations obtained subsequent to passage through the MACS
column. Fig 3.1b shows VPM65 (CD14) staining of the initial negative population,
whilst Fig 3.1c shows staining of the negative population following the second
separation. Both of these dotplots contain very few positively labelled cells. Fig. 3. Id
shows a predominantly VPM65 positive population (with approximately 90% of
population positive for CD 14).
Section 3.3.
Controls used during flow cytometry.
During FC analysis of macroschizont infected cells, negative control samples were run
along side samples specifically labelled with primary mAbs and secondary conjugates.
This allowed assessment of the extent of "nonspecific" binding of mouse
immunoglobulins to the cells being assayed.
Negative controls for samples labelled with murine mAbs consisted of cells incubated
on ice with normal mouse serum, at a dilution of 1:1500, followed by staining with
the secondary conjugate. The use of normal sera was necessitated due to the lack of
suitable isotype controls. Immunoglobulins contained in these sera act as a control for
nonspecific binding of mouse/rat immunoglobulins to bovine cells. Comparison of
negative control FC profiles to profiles produced after labelling with specific mAbs
allows the true level of binding of specific mAbs to be ascertained.
FC analysis of T.a 12929 and clonal lines.
Once macroschizont infected cell lines had been established from the CD14+
population, aliquots of one of these infected lines (T.a 12929) were soft agar cloned
(as outlined in Chapter II). Of the fourteen clonal cultures isolated three were chosen
for extensive study following preliminary FC analysis of MHC class II expression.
The four populations studied were T.a 12929 (uncloned parental line) and clones G,
I and L. All four macroschizont infected populations were analysed at the same time
three weeks after cloning.
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3.1 Flow cytometric analysis of CD14"and CD14+ cells
before, during and after MACS sorting.
(a) Flow cytometry dotplot showing forward scatter
(FSC) against side scatter (SSC) of whole PBM
before MACS separation of CD14+ cells, (b) dotplot
of unseparated PBM population, stained with
VPM65 showing log10 florescence against FSC, (c)
dotplot (log10 florescence against FSC) of the CD14"
population after the second MACS separation and
(d) dotplot of final CD14+ population after two
MACS purifications (log10 florescence v.s. FSC),
CD14+ cells are shown in the gated region to the
right.
Relative staining intensities of cell populations at stages
through the CD 14 cell purification.
Data shown as mean fluorescence.
(a) Whole unseperated PBM (unstained) = 5.51.
(b) Whole PBM stained with VPM65 = 6.51.
(c) CD 14" population after second MACS
separation = 6.05.
(d) CD14+ population after separation




Flow cytometric (FC) data produced during this investigation was used to compare the
expression of various molecules by the parental and clonal populations of infected
cells. Comparisons were based on the variation in fluorescence shown by the different
samples following staining with a range of mAbs/fluorescent conjugate. The mAbs
chosen for use in this part of the study are listed in Chapter II and were chosen either
to highlight the expression of molecules associated with monocytes/M0s or to show
the lack of expression of markers for other cells such as CD3 (a T cell marker).
Figures 3.2 to 3.6 show the size/internal complexity and expression of various
molecules on the surface of the parent population (T.a 12929) and the clonal lines
derived from this population (clones G, I and L). The size and internal complexity of
the cells within these different cell lines are all similar (Fig 3.2 a-d), and are
characteristic of cell lines produced by infection with T.cmnulata (Campbell et al,
1994). After in vitro infection of CD14+ cells with T. annulata sporozoites, the cells
rapidly assume a large size (high forward scatter (FSC)), this can be seen if Fig. 3.1
and Fig 3.2 (a-d) are compared. Figs 3.2 (a-d) also show the parent and clonal lines
contain cells of differing levels of internal complexity (e.g. mean FSC of PBM = 30,
mean FSC of infected cells = 75).
As the size of the cells alters so does the expression of various surface molecules.
These molecules include MHC class I and class II, CD 14 and the epitope bound by
the I.L.R.I. mAb IL-A24 (associated with antigen presentation and a mature M0
phenotype) (Ellis et al, 1987; Campbell et al, 1994). Infection of cells with this
parasite has markedly different effects on the expression of the two forms of MHC
molecules expressed on the cell surface. The expression of MHC class I (labelled with
the mAb IL-A19) by cells of the parent and clonal populations are very similar (Fig.
3.3 a-d), with all the cells of the four populations highly MHC class I positive. Also
the range of expression of MHC class I within these populations are low, shown by
the narrowness of the normally distributed positive histograms.
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Fig. 3.2 Flow cytometry dotplots of T.a 12929 and clonal
populations.
(a-d) Flow cytometry dotplots of T.a 12929 and
clones G, I and L respectively, showing FSC against
SSC. The four infected cell populations can be seen











This is very different from the expression of MHC class II molecules by the T.a
12929 cell line and the clones derived from it. These populations express varying
levels of MHC class II molecules, a phenomenon which has been observed before
during analysis of numerous other unrelated T.annulata infected cell lines (Campbell,
pers. comm.). In contrast to the narrow unimodal expression of MHC class I by the
parent line and clones, the MHC class II expression varies greatly between clones and
parent line and also shows variability within the individual cell populations (Fig 3.3
e-h). It can be seen that the parental population (T.a 12929) shows a broad expression
of MHC class II molecules, whereas the range of MHC class II expression on the
clonal populations appears narrower. Clone G appears to express the highest levels of
MHC class II molecules of the three clones, whilst clones I and L both express lower
levels of these molecules.
The levels of the two MHC class II molecules expressed on bovine cells were
assessed by staining with the mAbs VPM36 (binding MHC class II DQ) and VPM54
(binding MHC class II DR.) (Fig 3.4 a-d and e-h respectively) (Dutia et al, 1993; Dutia
et al, 1995). Analysis of the FC data obtained from staining of the parent line and
clones with these two mAbs (Fig. 3.4) shows that both these molecules are expressed
at similar levels within each population and that the variation in the levels of MHC
class II expression is not solely due to the higher expression of one or other MHC
class II molecule.
Following the infection of cells by the parasite, expression of the LPS receptor (CD 14)
decreases dramatically. Staining of the parent and clones with the mAb VPM65 after
infection with sporozoites shows that these cell lines do not express CD 14 (Fig 3.5 a-
d). The cells used to produce these lines were selected on the basis of CD14
expression, with infectivity of the CD14+ populations shown to be markedly higher
than non-CD14 expressing populations (Campbell et al, 1994). However, after these
populations became infected and formed established lines the expression of CD 14
decreased dramatically. These data showing that infection of monocytes and
macrophages with the parasite induces the loss of CD 14 expression. The possibility
that the parasite may have infected and "transformed" residual T cells in the purified
population was assessed by staining the parent and clonal lines with the anti-CD3
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mAb MM1A (Davis et al, 1993) (Figs 3.5 (e-h)). It can be seen that the expression
of CD3 by the infected cells is effectively zero, suggesting that T cells are not suitable
precursors for the production of T.annulata cell lines in vitro. Since the original
population is highly CD14+ (at approximately 90% positive) and taking into
consideration the infectivity data of Spooner et al (1989), Innes et al (1992) and
Campbell et al (1994), it seems highly unlikely that the parent and clonal lines contain
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Fig. 3.4 Flow cytometric data relating to the expression of
the two MHC class II molecules DQ and DR by T.a
12929 and clonal populations G, I and L.
(a-d) MHC class 11 DQ expression of T.a 12929 and
clones G, I and L. Blue profiles represent the
negative control samples, whilst red represent
samples labelled with the anti MHC class II DQ
mAb VPM36. (e-h) MHC class II DR expression of
T.a 12929 and clones G, I and L. Blue profiles
represent negative control samples and red represent
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Fig. 3.5 FC data relating to the expression of the surface
molecules CD 14 and CD3 by infected cell
populations, T.a 12929 and clones G, I and L.
(a-d) Expression of CD 14 (the LPS receptor) by
parent and clonal lines (G, I and L). Negative
control profiles are shown in blue, samples labelled
with the anti CD 14 mAb VPM65 are shown in red.
(e-h) Expression of the T cell marker CD3 by the
same four populations. Negative control samples are
blue, samples labelled with the anti CD3 mAb are
red.
Fig. 3.5
a. b. c. d.
e. f. g. h.
iuo-
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The mAb IL-A24 was used to investigate the expression of an epitope associated with
monocytes and M9s (Ellis et al, 1987) by T.a 12929 and the clonal lines. Previous
work has shown this epitope to be expressed on the CD14+ populations isolated from
PBM by MACS purification (Campbell et al, 1994). The epitope is also expressed to
varying degrees by T.annulata infected cell lines (Campbell et al, 1994; Campbell,
1995). The parental line and the clones express the epitope bound by IL-A24 but the
expression varies between these lines (Fig 3.6 a-d). Expression of this epitope by the
parental line and clones G and I, showed a smaller range of expression than clone L,
depicted by the broad peak seen in Fig 3.6d as opposed to those shown in Fig 3.6 a-c.
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Fig. 3.6 Flow cytometiy data relating to the expression of a
macrophage associated antigen by the infected cell
populations T.a 12929 and clones G, I and L.
(a-d) Expression of the macrophage associated
epitope bound by the mAb IL-A24, by
macroschizont infected cells of T.a 12929 and
clones G, 1 and L. Negative control profiles are
shown in blue and profiles of cells labelled with IL-




Saturation binding studies using 125I-SW73.2.
Table 3.1
Cell line. Mean No. of MHC class II
molecules/cell.
Range
Uninfected CD14+ cells. 2.65xl05 (S.D. ± 4.6xl04) 2.32xl05- 2.98xl05
clone I. 8.99xl04 (S.D. ± 8.2xl03) 8.00xl04 - 1.00x10s
clone L. 1.52xl05 (S.D. ± 4.5xl04) l.OOxlO5 - 2.00xl05
clone G. 1.16xl06 (S.D. ± 7.7xl05) l.OOxlO6 - 2.00xl06
T.a 12929. 2.40xl06 (S.D. ± 9.6xl04) 2.40xl06 - 2.50xl06
BL20 cell line. 2.50xl05 (S.D. ± 6.8xl04) 2.02xl03 - 2.98xl05
Table 3.1 MHC class H cell surface expression on T.a 12929 and cloned cell
lines determined by saturation binding studies.
Data produced during saturation binding analysis using 125Iodine
labelled SW73.2 A(ab')2 fragments. Aliquots of lxlO6 cells were
incubated with radiolabeled SW73.2 on ice for 30 mins. Unbound
label was washed from the sample and the amount of label bound
assessed by gamma counting. The average number of MHC class II
molecules expressed per cell were then calculated. The standard
deviations shown represents variation of data between separate SW73.2
saturation binding assays.
Table 3.1 shows data from the saturation binding studies in which triplicate aliquots
of lxlO6 cells of each cell line or clone were incubated with 125I-SW73.2 under
saturating conditions. The mean number ofMHC class II molecules expressed per cell
(Table 3.1) were determined from four independent experiments (except for the BL20
and uninfected CD14+ cells for which data are shown from two experiments). The
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parent cell line expressed higher levels of MHC class II than any of the clonal
populations. Clone G showed the highest expression of MHC class II of the clones,
whilst clones I and clone L expressed similarly low levels ofMHC class II. The BL20
cell line was included in the analysis to assess the efficiency of the saturation binding
technique, as this cell line has been shown to express approximately 2xl05 MHC class
II molecules per cell (Hopkins et al, 1989)
Statistical analysis (using the Student t-test), showed variation in MHC class II
expression within triplicate samples of the parent line and clones not to be statistically
significant. However, the expression of MHC class II by the parent line and clone G
(although not statistically different from each other) was shown to be significantly
different from clones I, L and uninfected cells (P<0.001). The MHC class II expression by
clone I was not significantly different from that of clone L. These experiments were
conducted over a period of 13 months, during which time the variation ofMHC class II
expression by the parental and clonal lines wasminimal (as shown by the standard deviations
of MHC class II expression by the parent and clonal lines in Table 3.1).
Section 3.5.
Assessment of T cell proliferation induced by contact with infected cells.
To optimise T cell proliferation experiments and investigate the kinetics of T cell
proliferation, infected cells (of either T.a 12929 or the clonal cultures) were cultured
with autologous PBM for up to seven days (Fig. 3.7). This assay was designed to
ascertain whether the day of peak proliferation did occur on day 5 (as shown by
Campbell (1995)) and from the graph it can be seen that this is the case.
The data is shown as corrected cpm (ccpm), corrected cpm = to: the cpm of the
proliferating cells minus the cpm of the infected cell control and the cpm of the PBM
control for each particular day. The data shows that the presence of infected cells does
not induce perceptible proliferation until day 3. From this day all the PBM cells
stimulated begin to proliferate, except those incubated with clone G, which only
begins to exhibit a positive net proliferation on day 5. It is at this point that the
proliferation of all PBM samples peak, with clone L showing the highest level of
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proliferation (at ccpm = 62031.4) and clone I the lowest (at ccpm = 4702.5). From
day 6 the amounts of 3H-thymidine incorporated into all the PBM samples begin to
decline, regardless of the infected cells used to stimulate the T cells present. At day
7 the proliferation of T cells has subsided in all cultures, with only T cells incubated
with the parent line showing a small amount of proliferation. These data agreeing with
the findings of Campbell (1995).
Fig. 3.8 shows the T cell proliferation induced in subsequent experiments, when
autologous PBM were incubated for 5 days in the presence of T.a 12929 or clones I,
G or L (data shown from four repeat experiment). Clone L induced the highest net
levels of proliferation (44066ccpm ± 4504), which was significantly higher than the
proliferation induced by the parent line and clone I (P<0.005). Both clone G and the
parent line induced similar levels of proliferation, with both cell lines inducing levels
of proliferation lower than clone L (22994ccpm ± 7565; 16636ccpm ± 6657
respectively). Whilst in contrast, clone I induced extremely low proliferation
(5727ccpm ± 1274), significantly lower than all other infected cells (P<0.005).
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Fig. 3.7 Six day time course experiment showing T cell
proliferation induced by autologous infected cell
populations T.a 12929 and clones G, I & L.
Data collected from a time course experiment
investigating T cell proliferation when PBM were
incubated/stimulated with either mitomycin C
treated cells of T.a 12929 or one of the clonal
cultures (G, I or L), on days 2 to 7 after
macroschizont infected cells are added to PBM at a
ratio of 1:10. Data is presented as the amount of
tritiated thymidine incorporated into proliferating T
cells (shown as corrected cpm) on days 2 to 7.
Counts obtained from samples of infected cells and
PBM incubated separately over the 5 day time
course were subtracted from those measured for
each proliferating population of infected cells plus
PBM. The figure produced is the amount of T cell
proliferation induced by the presence of each
infected cell population.
Uncorrected cpm of samples on day 5 of incubation (data
shown as mean values calculated from four replicate samples).
PBM alone= 4834.4cpm.
T.a 12929 cells= 13326.8cpm.
clone G cells= 10814.3cpm.
clone I cells= 8526.6cpm.
clone L cells = 4462.6cpm.
T.a 12929+PBM = 28614.1cpm.
clone G+PBM = 29005 .Ocpm.
clone I+PBM = 18063.5cpm.
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Fig. 3.8 T cell proliferation induced after autologous PBM
were incubated with infected cells of either T.a
12929 or clones G, I and L for five days.
T cell proliferation data from four repeat
experiments. PBM were incubated with mitomycin
C treated infected cells of the parent line or clones
(G, I or L) at a ratio of 10:1 and harvested on day
5. Data is shown as corrected cpm of tritiated
thymidine uptake by T cells proliferating following
stimulation with either the parent line or a clonal
population (error bars shown represent standard
deviations over the four experiments).
Fig. 3.8.
T cell proliferation after stimulation of autologous









A highly purified population of CD14+ monocytes and M0s were used to produce the
in vitro infected lines, ensuring infected cells were of the monocyte/M0 lineage,
shown by Forsythe et al (1997) to be infectable in vivo. The establishment and
subsequent cloning of these lines permitted investigation into the expression of a
number of cell surface markers (i.e. MHC class I/II molecules), without encountering
high levels of variation in expression, due to the heterogeneous nature of infected cell
populations derived after infection of whole PBM. The main area of study described
in this chapter investigated the in vitro expression of MHC class II molecules by
macroschizont infected cells and more briefly the expression of MHC class I
molecules.
Alterations in MHC molecule expression. - (I) MHC class II molecules.
Initial work by Dr E. Glass showed the T.annulata infected cell lines expressed high
levels of MHC class II and it was suggested that this may be linked to the ability of
macroschizont infected cells to cause high levels of proliferation, in cultures of naive
autologous T cells (Glass & Spooner, 1990). The work shown in this chapter suggests
that the presence of the parasite within infected cells does not simply result in an
upregulation of MHC class II expression but that the expression of these molecules
undergoes a "dysregulation" following infection.
MHC class II expression is upregulated following activation of monocytes and M0s
(Keller, et al, 1994), allowing the Ag presenting cells to interact with T cells and form
a suitable immune response. As is shown by the saturation binding assay data
concerning the expression of MHC class II by uninfected monocytes and M0s,
expression prior to infection is low. However, after infection with T.annulata the
expression of MHC class II molecules alters, with the majority of cultures exhibiting
an increase in expression. The changes induced by infection do not mimic those post
activation (Keller, et al, 1994), as class II expression does not simply rise. This can
be seen from the data of class II expression, which show that within the parent
population (T.a 12929) there are populations (which can be cloned out) that do not
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express high levels of class II after infection.
It was also found that the expression of MHC class II by the parental line (T.a 12929)
and the clonal lines was relatively constant. The populations investigated showed very
little variation with respect to MHC class II expression during the months over which
these cells were studied. The upregulation ofMHC class II expression by uninfected
professional APCs is generally transient (Unanue & Allen, 1987), with the expression
decreasing after the immunological reactions have peaked. In contrast the expression
ofMHC class II by the T.annulata infected cells studied does not vary, suggesting that
the alterations in MHC class II expression are long lasting and possibly permanent
following infection.
(2) MHC class I molecules.
The constant expression of MHC class II is paralleled by the constant expression of
MHC class I molecules by infected cells. MHC class I molecules are constitutively
expressed by the majority of mammalian cells (exceptions including, red blood cells
and cells of the central nervous system) and are involved in the recognition of
endogenous antigen in cells infected with intracellular pathogens. However, the range
of expression of MHC class I by T.annulata infected cells differs greatly from the
expression of MHC class II molecules. Data from this chapter shows MHC class I
expression to be very similar in all the populations investigated. The expression of
MHC class I by uninfected cells was not investigated, therefore it is not possible to
compare the expression of MHC class I before and after infection. However,
investigation of the expression of MHC class I molecules by FC analysis shows the
infected populations express very similar levels of these molecules, when stained with
the anti MHC class I mAb IL-A19. The peaks shown on the resulting histograms are
of a uniform shape and the degree of fluorescence is also similar.
Differences in class I and class II expression by infected cells.
The data concerning MHC class I expression differ markedly from that obtained for
MHC class II expression. The quantitation ofMHC class II expression by the parental
line and the clones yields the mean number of MHC class II molecules expressed per
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cell, within the whole population. On the other hand the non quantitative FC analysis
shows that within the populations the level of expression of MHC class I is much
more uniform than the expression ofMHC class II. The data showing that cells within
these populations express similar levels of MHC class I molecules but that there is a
wider range of MHC class II expression.
There are a number of reasons which could account for these differences, e.g. the
expression of MHC class I is not altered by infection or that the parasite does alter
expression of these molecules, producing uniform expression within a population. For
the parasite to produce such similar MHC class I expression between four populations
and also within other populations (produced from different parasite stocks and from
different animals) also investigated in our laboratory (J. D. M Campbell, pers. comm.
(data not shown)) would seem unlikely. This suggests that the MHC class I expression
observed is similar to that of uninfected cells. However, further work need to be
carried out in this area, with saturation binding techniques being applied to MHC class
I quantitation.
The data shown in this chapter suggests that the control of class I expression is
different from that of class II post infection. The parental population which gave rise
to the clonal cultures used in this investigation has a broad range of expression of
MHC class II. The spread of expression by the clonal cultures appears to be less than
the original population and this would seem logical, since each population is derived
from a single infected cell. However, the mechanisms by which the average level of
MHC class II expression approximately constant are unknown.
The expression of MHC class II varies within the parent population, the wide range
of this variation presumably arises in part from the fact that many different cells will
have become infected and expanded to form subpopulations within this non clonal
line. If the main cause of variation with respect to MHC class II was the different
cells which were infected by the parasite, then cloning should have greatly reduced
the variation of MHC class II expression within the clonal cultures. This does not
appear to be the case, with the clones still exhibiting variation in the levels of MHC
class II expression. A possible explanation for the variation of MHC class II
expression within infected cultures is that the levels of MHC class II expressed by
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cells may vary within different stages of the cell cycle, i.e. newly formed
macroschizont infected daughter cells may express lower levels of MHC class II than
do more phenotypically mature infected cells. FC analysis ofMHC class II expression
within cell cycle synchronous cultures, studying variations in expression levels as the
cultures mature and proliferate could explain why clonal cultures still express a wide
range of MHC class II.
Another possible reason for differences in class II expression could be that a single
cell can play host to more than one parasite. Work has shown that multiple infections
of single cells are possible and that cells containing parasite derived from more than
one sporozoite are viable (Jura, 1986). If this is the case it could be that differing
parasites within the clonal cultures are able to influence the range of expression of
MHC class II. This would suggest that during the expansion of the clonal population
individual parasites behave differently to cause variations in MHC class II expression.
The actual importance of the roles played by the parasite and the cell with respect to
the expression of MHC class II are not understood and there are conceivably many
ways in which the parasite could interfere with MHC class II expression. These could
include effects such as the production of molecules by the parasite which interfere
with transcriptional or translational regulation, thus altering MHC class II expression.
Whatever the mechanism employed by the parasite to alter class II expression it is
reversible, as treatment with theilericidal drugs returns infected cells to a non
proliferating, uninfected state (McHardy et al, 1984) (Rintelen et al, 1990).
Another possibility which exists is that infected cells are capable of inducing the
production of molecules which are stimulatory for cells of the monocyte/M0 lineage.
Nichani (1994) showed that during clinical cases of tropical theileriosis very high
levels of IFNy were detectable in efferent lymph. IFNy is a cytokine messenger
produced by activated T cells (generally of the Tl^ type) which has powerful effects
on monocytes and MGs (Ijzermans and Marquet, 1989; Mogensen et al, 1987). Also
high levels of IFNy mRNA have been detected within autologous T.annulata
stimulated T cells (Campbell, 1995). MHC class II expression is known to be
upregulated by treatment of macrophages with this and other cytokines. This could
mean that the expression of MHC class II molecules by infected cells is effected by
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levels of cytokines present in their environment. Investigation of the production of
cytokines by infected cells are discussed in Chapter IV.
The changes observed in the expression ofMHC class II molecules by infected cells
also appear to affect the DR and DQ class II products equally. The data concerning
this phenomenon is not quantitative, however, this is suggested by the similarities
between FC profiles produced by labelling with the mAbs VPM36 (DQ specific) and
VPM 54 (DR specific). These data suggest that interference of the parasite in the
expression of MHC class II molecules is not locus specific and that the whole MHC
class II region is targeted.
It has been suggested that the "nonspecific" proliferation induced by contact of
macroschizont infected cells with autologous CD4" T cells may occur through the
activity of a superantigen like molecule associated with MHC class II molecules
(Campbell, 1995). However, the data contained in this chapter shows that the levels
of MHC class II expression do not correlate to the levels of T cell proliferation
induced by infected cells. Since T cell activation by infected cells has been shown to
be contact specific it may be that infected cells do possess a superantigen like activity.
However, I suggest that this is not the only factor involved in autologous T cell
activation.
CD14 expression and A PC function of infected cells.
CD 14 is the glycophosphatidylinostitol linked surface receptor for bacterial
lippopolysaccheride, which is expressed on the surface ofmonocytes, M0s and a small
population of B cells (Goyert et al, 1988; Zeigler-Heitbrock & Ulevitch, 1993; Yang
et al, 1995). This receptor binds gram negative bacterial LPS, associated with LPS
binding protein (LBP) and initiates cellular activation (Wright et al, 1990) (Ulevitch
et al, 1994). The expression of CD 14 by monocytes and M0s is essential for their
function within innate protection, with rapid activation and production of
proinflammatory cytokines providing a first line of immunological defence. Activation
of these cells via this receptor causes cells to increase their metabolic rate and produce
detectable chemicals such as reactive oxygen intermediates (ROIs) (Emmendorffer et
al, 1990), which are necessary to destroy invading microorganisms following
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opsonisation and endocytosis.
CD14 has also been implicated in a negative feed back pathway which can inhibit
monocyte dependent T cell proliferation (Lue et al, 1991). Engagement of human
CD 14 (by an anti CD 14 mAb) prior to incubation with T cells appears to induce a
signal which is able to inhibit T cell proliferation. The signal strength appears to be
sufficient to inhibit PHA or ionophore-induced proliferation. Studies performed by
Grey et al (1994) show induction ofTNF-a production, down-regulation of CD 14, and
down-regulation of the other LPS-binding proteins CDllb and CD18, following M0
activation using either LPS or IFNy treatment. Presumably this receptor is down-
regulated after activation because the CD 14 signal is no longer required. It is also
possible that down-regulation of CD 14 is necessary to control cytokine production
from activated M9s, ie to prevent over-stimulation of M0s.
The loss of CD 14 expression by T.annulata infected cells may aid the parasite by
inhibiting negative feedback signals to T cells, allowing the T.annulata induced T cell
proliferation to proceed, thus subverting cell mediated immune reactions. Another
possibility is that the CD14 receptor is down-regulated to prohibit initiation of
secondary signal cascades within the infected cells due to LPS+LBP/CD14 binding on
the surface of infected cells. If legitimate signalling via CD 14 were possible within
infected cells, the intracellular reactions produced may prove deleterious for the
parasite.
The epitope bound by IL-A24 is associated with APC function (Ellis et al, 1987) and
data shown in Fig. 3.7 a-d shows that the macroschizont infected cell lines derived
from CD14+ cells, used in this study (T.a 12929 and clones G, I and L) express this
molecule. A study by Campbell et al (1994) showed T.annulata macroschizont infected
cell lines express this M0 associated epitope. As noted macroschizont infected lines
exhibit an augmented APC function (Glass and Spooner, 1990a). When these data are
viewed together it suggests that the presence ofmacroschizonts within monocytes/M9s
alters APC function. Whether alterations in the APC function of these cells are
specifically induced by the parasite or are an artefact following infection requires
further study.
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Changes in the growth/division of infected cells.
Macroschizont infected M0 populations are unusual with respect to the fact that they
are constantly proliferating. In vivo (Barnett, 1977; Melhorn and Schein, 1984) and
in vitro (Hulliger et al, 1964) infected cells are seen to proliferate and the infected
population to expand rapidly. This is also the case with the parent line and clonal
populations involved in this study, with it being necessary to reduce infected cell
cultures three times a week. The reduction of these cultures maintained the cells in a
state of healthy rapid growth, necessary for comparative experiments to be performed
(Campbell et al, 1994. This was presumably due to the loss of condition by the cells
and build up of cellular detritus within the culture (which became visible at the bottom
left hand corner of FC dotplots and could be gated out). However, it was observed
that the expression of certain molecules (such as MHC class I and class II molecules)
did not resemble that of freshly passaged cultures with peaks on the FC histograms
becoming diffuse and irregular. This is again presumably due to the loss of condition
of the infected cells.
These observations agree with work carried out in the Divisions of Veterinary
Infectology and Immunology and Molecular Immunology, Borstel, Germany. Here
Shayan showed that cells infected with T.annulata did not appear to possess a G0
phase in their cell cycle (Shayan et al, 1994). During this investigation a mAb known
as anti Ki-67 (Gerdes, et al, 1983) was used to investigate the expression of nuclear
antigens associated with the active part of the cell cycle by T.annulata infected cells.
Anti Ki-67 was originally used to observe the expression of proliferation associated
antigens in human cells. It was found that this antigen was expressed in the G,, S, G2,
and mitosis phases of the human cell cycle but was not expressed during the G0 phase.
Shayan investigated the expression of this antigen in macroschizont infected cells and
found expression of an antigen which reacted with Ki-67. However, after treatment
with the theilericidal drug, Buparvaquone (McHardy et al, 1985) expression of the
antigen decreased and was sometimes absent. Buparvaquone treatment led to parasite
death and the establishment of a G0 phase within the cell cycle.
Subsequent comparison of cDNA clones showed that the antigen expressed by bovids
showed a high degree of homology to human Ki-67. These data suggest that the
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bovine and human Ki-67 antigens are similar. From the lack of a G0 phase in the
infected cells cell cycle, which fails to express the Ki-67 antigen we can surmise that
infected cells do not express a G0 phase but are constantly kept in the active phases
of the cell cycle. Cells also appear to be in a state of permanent activation, suggested
not only by the lack of CD 14" (Grey et al, 1994) but also by the constant production
of a range of cytokine mRNA species (which will be discussed in Chapter IV). This
state of constant activation/proliferation may be linked to the lack of variation in the
expression of surface markers such as MHC class I and II after infection (when the
cells are maintained in a healthy condition).
The reason why T.annulata should cause alterations in the expression of MHC class
II is not known as yet. However, it may be that the dysregulation of MHC class II
expression is a mechanism for the general disruption of the immune system, allowing
the parasite to multiply within infected cells without interference by the hosts immune
system. It is known that infected cells have the ability to stimulate proliferation of
both naive (Glass & Spooner, 1990) and memory T cells (Campbell, 1995). Non¬
specific stimulation of these two subpopulations appears to lead to a T cell activation
state which is ineffectual with respect to T cell help. Quantitating the levels of class
II expressed by a number of cell lines meant that possible correlations between MHC
class II expression and the non-specific T cell stimulatory ability of T.annulata
infected cells could be studied.
T cell proliferation analysis.
The data contained within this chapter (section 3.5) shows that the ability to induce
autologous T cells to proliferate varies depending upon the infected cell population
used to stimulate the T cells, and although contact dependent (Campbell et al, 1995),
does not correlate with the levels of MHC class II expressed on the surface of
macroschizont infected cells. Also data presented in this chapter, show that infected
clonal cultures derived from CD14+ cells, stimulated similar kinetics of T cell
proliferation (proliferation peaking on day 5 (Fig. 3.7)) in autologous T cells, as did
infected cell lines produced by infecting whole PBM (Campbell, 1995).
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As shown in Fig. 3.8, clone I induced very low levels of proliferation when compared
to that induced by any of the other infected cultures. Also that the parent line was
unable to induce the same levels of proliferation as clones G or L. The reasons for this
phenomenon are not clear, however, it can be seen with respect to the data presented
in Table 3.1 and Fig. 3.8, that the levels of proliferation induced do not correlate with
the levels of MHC class II expressed by the stimulating cells. An infected cell line
expressing over 10 times more MHC class II (clone G, 1.58xl06 molecules cell"1) than
another cell line (clone L, 1.44x105 molecules cell"1) reproducibly induced lower levels
of T cell proliferation. This is again evident when one considers the level of MHC
class II expression of the uncloned parent line (T.a 12929), which expressed 2.45x10°
molecules cell"1 and that of clone G (clone G, 1.58xl06 molecules cell"1). Clone G
expresses lower levels of class II but still induces larger amounts of T cell
proliferation. Clone I differs from all of these cell lines, as this population of infected
cells expresses the lowest levels of class II and also induces the lowest levels of T cell
proliferation.
This data does not however, necessarily discount a role for MHC class II in the
activation of T cells by infected cells, as it has been shown by many groups that MHC
class II molecules play an integral role in T cell activation. (Unanue, 1984) and as
noted T cell activation by T.annulata infected cells is contact dependent (Campbell et
al, 1995). To test this hypothesis one would need T.annulata infected lines/clones
devoid of class II expression, which would allow the role played by class II expression
during T cell activation to be further dissected.
After these studies detailed above had been completed a supply of the anti MHC class
II mAb IL-A21 became available and during blocking studies of T cell activation by
T.annulata infected cells it was found that, blocking TCR/MHC class II interactions
prohibited T cell activation/proliferation (J. D. M. Campbell, pers. comm.). This
suggests that although the actual numbers of MHC class II molecules expressed by
infected cells may not correlate with the levels of T cell proliferation induced, MHC
class II molecules may play a role in "non-specific" T cell activation by macroschizont
infected cells. However, it may be that as long as there is a basal level of MHC class
II molecules expressed by infected cells, they will possess the ability to induce a
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certain level of "nonspecific" T cell proliferation.
The mechanisms which are inducing these different levels of T cell proliferation are
not known but one possible cause of this phenomenon could be the production of
cytokines by macroschizont infected cells. It is known that monocytes and M0s are
capable of producing T cell stimulatory cytokines (such as, IL-1 (DeFreitas et al,
1983, Dower et al, 1992) and IL-6 (Navarro et al, 1989; Van Snick, 1990)). The
possibility that the infected cells used during this study produce cytokines which then
effect the proliferation of responding T cells was investigated and the findings are
detailed in chapter IV.
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Chapter IV.
Cytokine mRNA expression by Theileria spy, infected cell lines and
correlation with autologous T cell proliferation.
Section 4.1.
Introduction.
The previous chapter of this thesis has shown that although infection with T.annulata
alters the levels of MHC class II expression of M9s, the actual levels of class II
expressed by infected cells do not correlate with the T stimulatory ability of the
infected cells. Activation of both memory and naive autologous T cells by infected
cells has been shown to be dependent upon infected cell/T cell contact (Campbell et
al, 1995) but the levels of T cell proliferation induced varies from one population of
infected cells to another. This suggests that there is another factor or factors which are
involved in the induction/maintenance of T cell proliferation. Cytokines are known to
play an essential role in T cell activation and proliferation (Morgan et al, 1976; Kaye
and Janeway, 1984). Therefore, the possibility that infected cells produce cytokines
which are involved in T cell stimulation was investigated.
Normally monocytes and M9s do not activate and induce the proliferation of CD4"
T cells, unless they are presenting a specific antigen to T cells in the context of MHC
class II molecules plus supplying a number of secondary messages to the T cells (ie,
via accessory molecules and cytokines). This therefore means that cells infected with
T.annulata, which possess the ability to activate and induce the antigen "non-specific"
proliferation of autologous T cells do not act in the same manner as uninfected
monocytes and M9s. The mechanisms by which the infected cells bring about T cell
activation/proliferation are not known. However, work described in this chapter
highlights some of the mechanisms which could be responsible for the T cell
responses induced by the presence of T.annulata infected cells.
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There are two groups of molecules which are essential for T cell/accessory cell
interactions - membrane bound costimulatory molecules and cytokines. Costimulatory
molecules are expressed on the surface of accessory cells and interact with ligands on
the surface of responding T cells during MHC class II/peptide/TCR interactions. One
important example of these receptor ligand pairs are B7-1/B7-2 and CD28/CTLA-4,
which are involved in T cell activation (Freeman et al, 1993; Hathcock et al, 1994).
Contact between costimulatory molecules such as these initiates transduction of signals
into the responding cell and results in molecular cascades which help initiate cellular
activation.
Due to the difficulties in obtaining bovine specific identification of the infected cell/T
cell contact requirements involved in T.annulata induced T cell activation and
proliferation proved impossible. The possibility that other factors were also involved
in these reactions were investigated. An area which I investigated was the production
of cytokines by infected cells. Cytokines are chemical messengers produced by various
groups of cells of the immune system, which have a wide range of effects on many
cell types within and outwith the immune system. These molecules are generally
released from the cell surface and diffuse into the extracellular milieu. As the
molecules diffuse outwards they contact the surface of responder cells, binding to
specific surface receptors, which transduce signals in to the responding cell.
The cytokines investigated included; Interleukin 1 (Dodds et al, 1994) (Mallardo et
al, 1994), Interleukin 6 (IL-6) (Navarro et al, 1989), Interleukin 10 (IL-10) (de Waal
et al, 1991) and Tumour necrosis factor alpha (TNFa) (reviewed by Beutler and
Cerami, 1988; Armitage, 1994). The production of IL-la, IL-6 and TNFa were
specifically investigated as they are known to be involved in T cell activation and are
produced by monocytes and MGs. Also as noted in chapter I, during cases of Tropical
Theileriosis symptoms are observed which are similar to those seen during sepsis
(such as, anaemia and cachexia), which are known to be associated with the over
production of these cytokines (Waage et al, 1989). Production of two major T cell
stimulatory cytokines are IL-2 and IL-4 (Mauer et al, 1984; Smith, 1988; Paul, 1991)
was also studied.
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An important group of cells known to produce IFNy are T cells of the T helper 1
(ThJ subtype (Mossmann and Coffman, 1989). Infected cells have been shown to
induce high levels of IFNy, both in vivo (Nichani, 1995) and in vitro (Campbell,
1995). In vitro this cytokine has been shown to be produced by T cells stimulated with
infected cells (Campbell et al, 1997), this is almost certainly also the case in vivo.
This cytokine is known to be an important stimuli for monocytes and M0s, therefore
the possibility that this molecule may be involved in the proliferation of infected cells
was studied. After infection with T.annulata, populations of infected cells begin to
rapidly increase in numbers both in vivo and in vitro (Barnett, 1977; Hulliger et al,
1964). IFNy is a powerful stimulator ofmonocytes and macrophages and the presence
of this cytokine may be involved in the rapid expansion of infected populations. IFNy
can act as a rescue signal for monocytes and M9s, by inducing these cells to produce
IL-1 and TNFa (Cotter et al, 1994; Mangan and Wahl, 1991). These two cytokines
are able to inhibit the controlled death of these cells by apoptosis (Mangan and Wahl,
1991). IFNy may therefore be an important message in the growth and development
of T.annulata infected cells.
Assessment of the expression of secreted cytokine proteins or biological activities of
any cytokines produced, would have been the most informative methods of
determining possible roles for cytokines during T.annulata infection. However, at the
time of study reliable assays for the detection of these bovine molecules were
unavailable. Therefore, reverse transcriptase polymerase chain reaction (RT-PCR) was
employed to investigate the production of cytokine mRNA. mRNA species specific
for the cytokines in question were amplified from the parental and clonal cultures,
including an unrelated line, infected with the related parasite T. parva (Naessens et al,
1985).
It was not possible to carry out fully quantitative PCRs for these cytokine transcripts,
due to the lack of suitable internal PCR standards, which would be required for each
PCR product. However, a semi-quantitative procedure was devised, which allowed
comparisons to be drawn between the levels of cytokine mRNA expressed by different
cell lines. This technique relies on identical PCR reactions being performed at varying
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numbers of amplification cycles.
Each PCR reaction was set up six times and the PCR performed identically, apart
from the number of amplification cycles performed. The samples were amplified at
cycle numbers between 20 to 30 (rising in increments of 2 cycles). Comparison of the
cycle number at which each PCR fragment becomes visible allows an estimation of
the relative abundance of the cytokine mRNAs. This technique only allows mRNA
expression levels to be compared between cell lines for the same primer pairs. The
levels of IL-la mRNA expressed by Ta. 12929 can be compared only to the expression
of IL-la mRNA by the other cell lines but not to the expression of other mRNA
species. This is due to differences in the priming efficiency between primer pairs and
the technique relies on the assumption that primer pairs behave with identical
efficiency in all PCR reactions. This method was used to investigate the expression
of; IL-la, IL-ip, IL-6, IL-10, TNFa and IFNy mRNA by infected cells.
Following the establishment of the identity of cytokine mRNAs produced by these
populations it was decided to investigate the relative levels of expression by
T.annulata infected cell lines. This was to determine if the differences in T cell
stimulatory ability (shown in chapter III) were due to variations in cytokine production
by the various infected cultures. Following analysis of the cytokine mRNA species
produced by these various infected cell populations, this technique was used in
preliminary assays of the cytokine mRNAs produced by autologous T cells stimulated
by either clone I or L. It was hoped that investigations into the production of
cytokines by T.annulata infected cell stimulated T cells may elucidate possible
mechanisms involved in parasite stimulated T cell proliferation and the




Cytokine mRNA expression determined by RT-PCR.
During the investigation of the expression of cytokine mRNA by cells infected with
T.annulata it was initially found that all the cell lines assayed possessed similar
mRNA expression profiles when amplified with a 30 cycle PCR program. Figures 4.1
a and b show representative profiles produced by the parental line and clone I. All the
T.annulata infected cells assayed expressed mRNA specific for; positive control, IL-
la, IL-1 p and IL-6. IL-10 and TNFa mRNA were also found to be produced by cell
line T.a 12929 and clones I and L. Clone G did not produce sufficient IL-10 or TNFa
message for PCR product to be detected at 30 cycles (the highest level of
amplification employed during these investigations).
The mRNAs specific for IL-2 and IL-4 were not detected from any T.annulata infected
cell line assayed. However, Fig 4.1(a) shows that mRNA specific for IFNy was
detected from the parent line. This was the only T.annulata infected cell line assayed
found to produce this cytokine mRNA (usually produced by T cells (Mossmann et al,
1989)). IFNy mRNA was only detected on two out of five occasions (both soon after
infection) suggesting that, although this infected cell line could produce IFNy mRNA,
it is not one of the cell line's major products. The production of cytokine mRNAs by
the parental and clonal lines were assayed on five different occasions and the detection
of the various mRNA species were constant.
A cell line infected with the related parasite T.parva was assayed for the same
cytokines as those infected with T.annulata (Fig 4.1(c)). It was found that this cell
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Fig. 4.1 Agarose gels containing cytokine products detected
following RT-PCR analysis of total RNA from
infected cells of T.a 12929 and clone I.
Photographs of agarose gels containing RT-PCR
products obtained from T.annulata macroschizont
infected cell lines, (a) T.a 12929, (b) clone I.
Products present are specific for P-actin (positive
control), IL-loc, IL-lp, 1L-2, IL-4, IL-6, IL-10,
TNFa and IFNy. Products specific for IL-2 and IL-
4 were never found during analysis of any
T.annulata infected cell line. Products were
produced from 5jug of total RNA per RT reaction
and 2jul of cDNA per PCR reaction after 30
amplification cycles. Size markers are produced by
a Hae III restriction enzyme digest of /.-phage
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line, produced by infection of cells with T.parva sporozoites (Dr G. Russell, pers.
comm), produced mRNA specific for not only the cytokines normally associated with
production by T cells (IL-2, IL-4, IL-10 and IFNy) but also mRNA specific for the
T cell stimulatory cytokine IL-la. However, the amount of IL-4 product produced was
low, resulting in only a very faint band being visible in Fig. 4.1(c)
Samples of all the different PCR products were subjected to restriction digestion
analysis and were shown to give the expected restriction patterns (Fig 4.2). These data
show that when the RT-PCR products are digested with various restriction enzymes,
the sizes of the digestion products match those which would be produced by digesting
pure samples of the sequences in question, i.e. the PCR products contained only DNA
sequences specific for the cytokines investigated.
Treatment ofAPCs with Mitomycin C is a standard practice during T cell proliferation
assays (Fraser et al, 96) and irreversibly blocks DNA replication and stops the infected
cells from overgrowing the T cells whilst in culture during proliferation assays.
However, it was also necessary to determine whether treatment with mitomycin C
inhibited cytokine mRNA production. Cytokine mRNA production by T.annulata
infected cells after treatment with mitomycin C is shown in Fig. 4.3. Cells were
harvested, washed and incubated in mitomycin C (see chapter II). Following this cells
were washed twice and placed in culture for 7 days. These cells were then harvested
and total RNA isolated as outlined in Chapter II, section 3. RT-PCR analysis showed
that the infected cells were still producing cytokine mRNA specific for; IL-la, IL-1(3,
IL-6, IL-10 and TNFa, 7 days after they had been incubated with mitomycin C.
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Fig. 4.1c RT-PCR analysis of a cell line infected with
macroschizonts of the related parasite T.parva.
Agarose gel showing RT-PCR products obtained
from a cell line infected with the related parasite
T.parva. Present are the products for, the positive
control (P-actin), IL-la, IL-2, IL-10 and IFNy.







Fig. 4.2 Restriction enzyme analysis of cytokine PCR
product sequences.
Restriction enzyme analysis of cytokine RT-PCR
products. The enzymes used and fragments expected
are as follows, IL-la (Taql) 161bp/204bp, IL-1 (3
(PvuII) 169bp/263bp, IL-6 (Bglll) 149bp/477bp, IL-
10 (Haelll) 306bp/439bp, TNFa (PvuII)
99bp/163bp/234bp, IFNy (Pstl) 114bp/425bp. 15pl
of each PCR product were digested for 2 hours at
37°C with the appropriate restriction enzyme. The
resulting fragments were visualised under U.V light



























Fig. 4.3 Analysis of the cytokine mRNA species expressed
by macroschizont infected cells following treatment
with the toxin mitomycin C.
RT-PCR analysis of cytokine mRNA expressed by
T.a 12929 on day 7 post mitomycin C treatment.
The infected cells were incubated with mitomycin C
at a concentration of lOOpg/ml for 30 mins at 37°C.
The cells were then washed twice in PBS and
placed in culture for 7 days, after which they were
harvested and total RNA collected for RT-PCR
analysis. Data shows that mRNA specific for,
G3PD, IL-la, IL-lp, IL-6, IL-10, TNFa and IFNy
continue to be produced 7 days after this treatment.
Fig. 4.3
Hae III G3PD IL-la IL-lp IL-6 IL-10 TNFa IFNy
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Section 4.3.
Quantitation of cytokine mRNA expression by infected cells.
A number of PCR fragments could be detected from T.annulata infected cells after
only 20-24 cycles (Fig 4.4 (a-d) and Table 4.1). The detection of products after these
low levels ofamplification means that the infected cell populations produce substantial
amounts of these cytokine mRNA species. The samples were run on agarose gels, in
groups of three, with increasing cycle number from left to right. (3-actin was used as
a positive control and it can be seen that all four infected populations produce (3-actin
mRNA detectable after only 20-22 cycles, with the intensity of these control bands
increasing steadily as the number of amplification cycles increases.
Total RNA was collected from the infected cell populations on 2 separate occasions
for use in limiting cycle analysis and the data produced showed that T.a 12929 and
the clonal lines stabley produce the same levels of cytokine mRNA. Shown in Table
4.1 are the cycle numbers (rounds of amplification) needed to produce visible product
from T.a 12929 and clone G, I and L. In general all of the cytokine mRNAs detected
appear at the lower end of the amplification scale.
Limiting cycle PCR was used to investigate the relative amounts of each cytokine
mRNA produced by each cell line (Fig 4.4 and Table 4.1). Fig. 4.4 a-d, show the
levels of expression of mRNA specific for P-actin, IL-la, IL-ip, IL-6, IL-10, TNFa
and IFNy by the parent line and clones G, I and L at different PCR cycle numbers
(between 20 and 24 cycles for Ta. 12929/clones G & L and 60 to 30 cycles for clone
I). Data concerning IFNy production by clone I is not included in Fig. 4.4c, however,
this PCR product was never detected during assay of any infected population except
T.a 12929.
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Fig. 4.4a Semi quantitative RT-PCR analysis of cytokine
mRNA expression by macroschizont infected cells
of the T.a 12929 cell line.
Data of limiting cycle RT-PCR analysis of T.a
12929 after 20-24 PCR amplification cycles showing
products specific for [3-actin, IL-la, IL-ip, IL-6, IL-
10, TNFa and IFNy. Constant amounts of RNA
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Fig 4.4b Semi-quantitative RT-PCR analysis of cytokine
mRNAs expressed by cells of clone G.
Data of limiting cycle RT-PCR analysis of clone G
after 20-24 PCR amplification cycles showing


































Fig. 4.4c Semi-quantitative RT-PCR analysis of cytokine
mRNAs expressed by cells of clone I.
Data of limiting cycle RT-PCR analysis of clone I
after 26-30 PCR amplification cycles showing
products specific for P-actin, IL-la, IL-ip and IL-6.
HaeIIImarkers 91».iNLL 2ZWtfNl 0£V&K1 9Z^LKl 83AINI oe^Ni HaeIIImarkers
L-1026 IL-1028 IL-10-30
TO n
Fig. 4.4d Semi-quantitative RT-PCR analysis of cytokine
mRNAs expressed by cells of clone L.
Data of limiting cycle RT-PCR analysis of clone L
after 20-24 PCR amplification cycles showing































PCR product. T.a 12929. Clone G. clone I. clone L.
(3-actin. 20 20 20 20
IL-lot. 24 24 26 20
IL-lp. 20 20 24 20
IL-6. 24 22 24 20
IL-10. 30 N.P. 28 24
TNFa. 22 N.P. 28 20
IFNy 30 N.P. N.P. N.P.
Table 4.1 Cytokine mRNA expression by T.anrudala infected cells.
Data produced from the semi-quantitative RT-PCR analysis of the
macroschizont infected parent and clonal lines. RT-PCR analysis was
carried out with constant amounts of mRNA (Spg per reaction) and
cDNA (2pl per reaction) but the numbers of amplification cycles varied
between 20 to 30 cycles (in steps of two). Products visible at low
numbers of PCR cycles result from a mRNA message of higher
abundance than those with are only visible after higher numbers of
cycles. The table shows the cycle number at which each product
became visible for each infected cell line. N.P.=PCR products not
present.
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Table 4.1 shows the cycle numbers at which the cytokine PCR products were
detectable. PCR amplifies DNA templates exponentially, therefore, a product which
becomes visible at 20 cycles results from a much more abundant source of mRNA
than a product visible at higher numbers of cycles. Clone L produced the highest
levels of mRNA for IL-la, IL-1 {3, IL-6 and TNFa (visible at 20 cycles) and IL-10
mRNA visible at 24 cycles. The parent line and clones G and I express much lower
levels of these mRNAs, with no detectable mRNA for IL-10 or TNFa being expressed
by clone G. mRNA specific for IFNy was detected from T.a 12929 on two out of five
occasions, this product was only detected once during limiting cycle analysis and on










1 2 3 4 5 6 7
G3PD. 20 20 20 20 20 20 20
IL-2. 24 24 24 22 26 26 26
IL4. N.P. 26 26 24 26 30 N.P.
IFNy. 22 20 20 20 20 26 20
Table 4.2 T cell cytokine mRNA expression post incubation with clone L
Semi-quantitative RT-PCR data produced by analysis of T cells
stimulated with cells of clone I. RT-PCR was carried out using 5pi
ofmRNA and 2pi of cDNA per reaction. PCR amplification cycles varied
in number from 20 to 30 (in steps of two). The table shows the number
of amplification cycles necessary to produce visible product on an






1 2 3 4 5 6 7
G3PD. 20 20 20 20 20 20 20
IL-2. 24 22 24 22 26 26 26
IL4. N.P. 26 26 26 26 N.P. N.P.
IFNy. 22 20 20 20 20 24 20
Table 4.3 T cell cytokine mRNA expression post incubation with clone L.
Semi-quantitative RT-PCR data produced by analysis of T cells
stimulated with cells of clone L. RT-PCR was carried out using 5pi
ofmRNA and 2pi of cDNA per reaction. PCR amplification cycles varied
in number from 20 to 30 (in steps of two). The table shows the number
of amplification cycles necessary to produce visible product on an
2% agarose gel stained with EtBr.
Tables 4.2 & 4.3 contain data obtained after autologous PBM were incubated with
infected cells of clone I or clone L. Seven cultures of autologous PBM and cells of
either clone I or clone L were incubated for between 1 -7 days. Cultures of cells
stimulated with either of these cell lines were harvested daily and total RNA isolated.
Following the same limiting cycle PCR protocol as previously described, the
abundance of T cell derived cytokine mRNAs were investigated. The data presented
above shows clone L stimulated T cells produce slightly higher levels of IL-2 and
IFNy and slightly lower levels of IL-4 than clone I stimulated T cells. However, the
133
differences are transient and generally very little difference in the levels of T cell
stimulatory, T cell derived cytokine mRNAs are detected between cells stimulated
with either clone I or L.
Section 4.5. Discussion.
The investigations detailed in the previous chapter show that the levels of MHC class
II expressed by infected cells do not correlate with the T cell stimulatory ability of
T.annulata infected cells. Once this had been determined, other stimuli which may be
involved in the "non-specific" T cell activation and proliferation were investigated.
The data presented in this chapter show that macroschizont infected cells constitutively
produce a wide range of cytokine mRNAs.
It is perhaps not surprising that Ta. 12929 and the clones derived from it express
cytokine mRNAs associated with monocytes and M9s, since the original infected cell
line was produced from CD14+ blood monocytes. However, the finding that these
cytokine mRNAs were constitutively produced at stable levels was unexpected, as
cytokine expression is usually under tight physiological control, with these molecules
only being expressed after recent stimulation. Also it was not expected that these lines
would be found to express so many cytokine mRNAs at the same time.
T cell activation.
The discovery that T.annulata infected cells produced a number of cytokine mRNAs
suggested possible mechanisms for induction of the T cell activation observed during
T.annulata infection (Glass and Spooner, 1990; Campbell et al, 1995). As previously
mentioned, studies showed the activation of T cells to be reliant upon autologous T
cell/infected cell contact (Campbell, 1995). This work involved the culture of freshly
isolated, autologous T cells with infected cells in the presence or absence of a semi¬
permeable membrane. It was found that when T cells were allowed to contact infected
cells, they quickly became activated and within 2-3 days expressed predominantly a
Th, (Mosmann and Coffman, 1989) phenotype (Campbell, 1995). This was in contrast
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to the culture of T cells separated from infected cells by a semi-permeable membrane,
where T cell activation/proliferation was not induced. The membrane allows free
diffusion of any soluble factors produced by the infected cells (such as cytokines) but
not contact of infected cells with the surface of the T cells.
Macroschizont infected cell derived cytokines & T cell activation.
As shown in this chapter the infected cells produce a wide range of cytokine mRNAs
and of these the majority are known to have affects upon T cells. Infected cells have
been shown to produce mRNAs specific for; IL-la, IL-ip, IL-6 and IL-10.
IL-1 has long been known to possess T cell stimulatory capabilities (Kaye et al, 1984),
with the ability to stimulate IL-2 production by T cells and upregulating the
expression of the IL-2 receptor (IL-2R). The exact roles of the two related IL-1
molecules (IL-la and IL-P) are still under investigation. However, it has been
suggested that IL-la binds more efficiently with the type I receptor (Dinarello et al,
1991), whilst IL-1 P binds better to the type II receptor (Dower et al, 1992). This data
along with that of Sims et al (1993) suggests that the majority of the biological
activities of IL-1 are due to IL-la/Type I receptor interactions. This is possibly due
to the fact that the cytoplasmic domain of the type I receptor is 215 amino acids (aa)
long (Sims et al, 1993), whilst that of the type II receptor is only 29 aa, suggesting
that this receptor is unable to transduce messages in to the cell. The T cell stimulatory
ability of IL-6 was discovered by two groups simultaneously (Lotz et al, 1988)
(Uyttenhove et al, 1988). Later studies have shown that IL-1 and IL-6 synergise
during T cell activation, IL-1 stimulating IL-2 production and IL-6 enhancing IL-2
responsiveness (Van Snick, 1990).
IL-10 is a cytokine which possesses regulatory abilities over a number of cellular
activities and like IL-6 can be produced either by monocytes/M0s or T cells
(Fiorentino et al, 1989; Mosmann and Moore, 1991). This cytokine has been shown
to down-regulate cytokine production by activated monocytes (de Waal et al, 1991)
and to inhibit the proliferation of all three groups of bovine T cells (Brown et al,
1994). It would appear that the main affects of IL-10 are upon the APCs involved in
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T cell stimulation, as this cytokine has not only been shown to down-regulate cytokine
production but also to directly effect the antigen presenting capacity ofmonocytes and
M0s (Fiorentino et al, 1991). Evidence also exists for the down-regulation of MHC
class II expression on M0s (de Waal et al, 1991) (Howard et al, 1992) and it has also
been suggested that the presence of IL-10 is responsible for the inhibition of
production or function of a M0-membrane bound costimulatory molecule involved in
the activation of T and NK cells (Moore et al, 1993). Workers have also shown IL-10
to be involved in the inhibition of surface expression of ICAM-1 (Leeuwenberg et al,
1994) and B7 molecules (Willems et al, 1994) and to down-regulate the synthesis of
the superoxide anion (Niro et al, 1992). IL-10 is therefore widely implicated in the
down-regulation of APC function and T cell activation.
During this investigation the production of IL-12 by infected cells was briefly studied
and some evidence was found for the production of this cytokine by infected cells.
However, it was later discovered that the primers used were specific for one of the
two IL-12 chains (Trinchieri, 95) the p35 chain of IL-12. Recent data suggests that
this part of the molecule is constitutively expressed by monocytes and M0s and the
data collected is therefore inconlusive as to whether this cytokine is actually
expressed. But in recent months whilst working with Dr J. Campbell at the Center for
Tropical Veterinary Medicine (Edinburgh University), we have found that infected
cells also express mRNA specific for the p40 subunit of IL-12. This shows that
infected cells are producing both mRNAs necessary for the production of functional
IL-12 and suggests that the cells are making this cytokine.
IL-12 is a potent activator of both T cells and NK cells and induces these cells to
produce IFNy which activates M0s (Ijzermans and Marquet, 1989; Bancroft et al,
1994). For M0s to be producing message specific for both IL-10 and IL-12 at the
same time is unusual and suggests that the immunoregulatory mechanisms are not
functioning as normal (Reed, 1995). Reed suggests that the presence of antagonistic
cytokines such as IL-10 and IFNy at the same time during T.cruzi infections is an
important factor in determining succeptibility.
The production of different cytokines within an immunological reaction allows the
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regulation of cellular immune responses. Following the initial activation of a cell by
cell/cell contact and cytokine stimulation, the production of cytokines can be used to
regulate the progressing immune response with great subtlety. Cytokines do not simply
produce reactions by their own actions, they are known to synergise with others, to
augment or decrease cellular activation and responses. An example of this is the
synergy showed between IL-1 and IL-6 during T cell activation (Houssiau et al, 1988).
Cytokines can also act antagonistically, one example of this can be seen between the
reactions induced by IL-10 and IL-12 during responses to L.donovani (Ghalib et al
1995). Here production of IL-10 has been shown to exacerbate the infection (by down
regulating Th, responses), whilst the induction of IL-12 production has been shown
to aid in clearance of this protozoan parasite (by inducing production of IFNy which
activates macrophages, leading to the removal of parasite).
The constitutive production of such a large number of cytokine mRNAs by T.annulata
infected cells suggests that immune responses induced by infected cell/autologous T
cell contact are not under the normal constraints observed during T cell activation. The
majority of the cytokine mRNAs found to be produced by T.annulata infected cells
are specific for T cell stimulatory cytokines (IL-la, IL-ip and IL-6). When data of
cytokine mRNA production by the parent line and clones is viewed in relation to data
collected following stimulation of T cells by these infected cells, it can be seen that
the infected cells producing higher levels ofmRNA (of cytokines known to stimulate
T cells), induce higher levels of T cell proliferation.
Clone L produces cytokine mRNAs specific for IL-la, IL-1 P and IL-6 at considerably
higher levels than clone I, with clone L cytokine mRNAs detectable approximately
four to six PCR cycles before those produced by clone I. These results correlate with
the T cell proliferation induced by these two clones (as shown in Chapter III). Clone
G and the parental line produce these three T cell stimulatory cytokine mRNAs at
levels detectable between those of clone I and clone L and also show induction of T
cell proliferation above that of clone I but below that of clone L. These results would
suggest that the amounts of mRNAs specific for IL-la, IL-ip and IL-6 are closely
linked to the levels of T cell proliferation induced by the different populations of
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infected cells. As noted we know that cell contact is essential for T.annulata induced
T cell proliferation but this is the first evidence to suggest that parasite infected cells
are able to produce cytokines which play an essential role in controlling non-specific
T cell proliferation, after infected cell/T cell contact. However, the exact role of each
cytokine and also the levels of translation of each mRNA species into product must
be investigated further, to allow us to delineate the reactions which are essential for
the control of T cell proliferation by infected cells.
IL-10 production.
The expression of IL-10 mRNA by all of these cells is generally low, with RT-PCR
product only being detected at high cycle numbers for the parental line (30 cycles),
clone I (28 cycles) and with no EL-10 product being detected by clone G.
Paradoxically clone L was shown to produce levels of IL-10 mRNA detectable at 24
cycles, with this result apparently contradicting T cell proliferation data produced
when clone L was used to stimulate T cells. IL-10 is a cytokine which is capable of
down-regulating the T cell stimulatory abilities of APCs (Leeuwenberg et al, 1994;
Willems et al, 1994). One would not expect to find cells expressing high levels of T
cell stimulatory and down-regulatory cytokines at the same time.
There are a number of possible reasons why this apparently high level of IL-10
mRNA expression may not effect the T cell proliferation induced by clone L. One is
that the levels of T cell stimulatory cytokines produced are such that they override the
effect of the IL-10 produced. Another is that IL-10 is only expressed as mRNA by the
cell lines and that these molecules are not translated into functional IL-10. It is also
possible that the presence of the parasite within the infected cells overrides the effect
of IL-10 and that costimulatory ability of infected cells is not altered by the presence
of this cytokine. The production of IL-10 mRNA by infected cells does not seem to
lower the expression of class II or other cytokine mRNAs by infected cells.
Unfortunately this hypothesis could not be tested further by analysis of accessory
molecule expression.. The role of IL-10 produced by parasitised cells may be to down
regulate activities of other uninfected cells, again in an attempt to subvert the immune
138
response.
From other work on the immune responses observed during T.annulata infections and
in vitro T cell proliferation/RT-PCR cytokine assays it is known that the T cell
response which predominates is that of a Tl^ type response (also that NK cells are
probably activated) (Nichani, 1994; Campbell, 1995; Campbell et al, 1997). These
data suggest that the cytokines which aid in determining the immune response in the
presence of T.annulata infected cells are those which induce and maintain Th[ type
responses. Therefore it would appear that, the presence of Th, T cell stimulatory
cytokines such as IL-land possibly IL-12 override those of other cytokines such as IL-
10.
T cell stimulation and IL-la production.
A T cell line infected with the related parasite T.parva produced a different range of
cytokine mRNAs, including IL-la, IL-2, IL-4, IL-10 and IFNy. The production of IL-
la by the T.parva infected cell line is surprising as T cells do not normally produce
this cytokine (Mossmann and Coffman, 1989). Cells infected with either of these
parasites induce contact dependent proliferation in naive autologous T cells (Campbell
et al, 1995; Goddeeris and Morrison, 1987), suggesting that these parasites share a
common mechanism for the stimulation of T cells. The contact dependency of T cell
stimulation and the presence of IL-la (which can be expressed in a membrane bound
form (Kurt-Jones et al, 1985)) mRNA in both types of infected cells suggests that this
cytokine may be of great importance in the induction of T cell proliferation by
infected cells.
The induction of T cell proliferation depended partly upon the state of growth of the
infected cells. If the infected cell lines or clones were not passaged approximately 18
hours before the non-specific proliferation assays were initiated, the levels of T cell
proliferation observed were considerably reduced. This suggests that the ability of the
infected cells to induce T cell proliferation may relate to the condition of the infected
cells, as passaging the culture 18 hours earlier stimulates growth of infected cells. As
was discussed in chapter III, cultures which are not passaged before use lose
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condition, as suggested by the accumulation of detritus within the culture and
alterations in the expression of surface molecules. This loss of condition may also
effect the expression of cytokines by the infected cells.
Due to the knowledge that the state of growth of the infected cells altered their ability
to induce T cell proliferation, RT-PCR analysis of cytokine mRNAs was only
performed on cultures supplied with fresh medium 14 to 18 hours before analysis.
Further studies are required to investigate whether the production of cytokine mRNAs
decrease as the length of time after passage increases.
Previous studies have shown that non-specific activation of T cells also occurs in vivo
(Campbell et al, 1995). During T.annulata infection, T cell blasts are found
surrounding foci of macroschizont infected cells in the medullary region of lymph
nodes draining the site of infection. These cells are unlikely to be stimulated by
classical antigen presentation mechanisms, as they appear in the wrong anatomical
location and much sooner than one would observe normally (Campbell et al, 1995;
Campbell, 1995) and are possibly stimulated by a superantigen like activity of infected
cells. Data shown in this thesis suggests that an important mechanism by which
T.annulata induces T cell activation in vivo is through the production of T cell
stimulatory cytokines by the infected cells. I have also shown that it is possible for
infected cells to produce mRNA specific for the cytokine IFNy, although this would
appear to be a minor product which is not produced by the majority of infected cells.
The identification of this cytokine mRNA within a culture derived from monocytes
and M0s is unusual. This suggests that the presence of the parasite has far ranging
consequences for cytokine production.
The two occasions when IFNy was detected within mRNA isolated from the parent
line were both soon after infection of the CD14+ cells with sporozoites. At this stage
it will be important for the parasite to successfully "transform" the cell, allowing
survival/proliferation. It may be that induction of IFNy production by infected cells
at these early stages are part of the mechanisms which allow the survival of the
parasitised cell and ensure the production of more macroschizonts (Campbell et al,
1997).
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For the T cell stimulatory ability of these different populations of infected cells to be
assessed in full and the importance of cytokine production by infected cells to be
gauged, actual levels of biologically active cytokines must be assessed. The roles of
individual or mixtures of cytokines within T. annulata induced T cell stimulation could
be investigated by the use of cytokine specific mAbs during blocking studies.
However, the data contained within this thesis suggest that cytokines produced by
infected cells are able to potentiate T cell stimulation induced by contact with infected
cells.
Assessment of T cell stimulatory cytokine production by T cells stimulated with
macroschizont infected cells.
To assess the possibility that proliferation of macroschizont infected cell stimulated,
autologous T cells involves an autocrine cytokine loop, the production of T cell
stimulatory cytokines by autologous T cells stimulated with the different T.annulata
infected lines/clones were assessed by limiting cycle RT-PCR analysis. These
experiments formed a preliminary investigation, conducted to assess T cell cytokine
involvement in macroschizont stimulated T cell proliferation.
The data collected from this experiment suggests that, although the infected cells
stimulating autologous T cells express very different levels of T cell stimulatory
cytokine mRNA and induce very different levels of T cell proliferation, they did not
induce responding T cells to produce different levels of T cell stimulatory cytokine
mRNA. One might hypothesise that T cells stimulated with clone L would produce
IL-2 at markedly higher levels, with IL-2 products being detected at lower cycle
numbers than from T cells stimulated with clone I, however, this was not the case.
Obviously much more detailed investigations into the mechanisms of T.annulata
stimulated T cell proliferation are needed but these data do suggest that it is the
infected cells which form the primary stimuli for macroschizont infected cell induced
T cell proliferation and that production of T cell derived cytokines, which have been
shown to enhance T cell proliferation are not responsible for the differences in T cell
proliferation induced by the clonal lines.
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Inflammatory cytokine production and T.annulata induced pathology.
Cytokines such as IL-1, IL-6 and TNFa have long been associated with the initiation
of inflammatory reactions and the induction and exacerbation of sepsis (Waage et al,
1989). Many of the clinical characteristics associated with Tropical Theileriosis
(reviewed by Neitz, 1957; Barnett, 1977; Samantery et al, 1980) are also observed in
the presence of high levels of inflammatory cytokines. These include fever, anaemia,
oedema, dypsnoea, loss of appetite, lethargy and in severe or protracted cases, bowel
necrosis.
Cells infected with T.annulata produce high levels of inflammatory cytokine mRNAs,
especially TNFa. This cytokine is a potent inducer of fever and has also been linked
to the production of anaemia, muscle wasting and necrosis (Sileghem et al, 1994;
Bielefeldt-Ohmann et al, 1989). These symptoms are observed in cases of acute
Tropical Theileriosis. Although the anaemia and fever observed have been linked to
the formation of piroplasms in RBCs (Uilenberg et al, 1993), followed by the lysis of
piroplasm infected cells, there are documented cases where infections have proved
fatal before the detection of piroplasms (Pipano et al, 1971). Interestigly the cell line
infected with T.parva does not produce mRNA specific for TNFa, and T.parva
infections are not characterised by high levels of anaemia (Wilde et al, 1967).
The role of cytokines in other parasitic infections.
There are a number of other intracellular parasites which are able to parasitise
monocytes and MGs, two examples being Leishmania sp and Toxoplasma gondii. The
cytokine profiles of cells infected by these parasites have also been implicated in
parasite growth and development. It has been suggested that IL-6 is involved in the
intracellular replication of T.gondii (Beaman et al, 1994). Work showed that the
presence of IL-6 could enhance T.gondii replication within murine peritoneal MGs but
that addition of IFNy to the culture medium resulted in killing of the parasites. Also
it was noted that addition of TNFa to the IFNy treatment enhanced parasite killing.
This is presumably due to the activation of the MGs by the IFNy or IFNy/TNFa,
leading to intracellular reactions which destroy the parasite. Also in cases of
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L.donovani (Ghalib et al, 1995) and L.major (Wang et al, 1994) the induction of M9
activation in the presence of IFNy, results in the destruction of the parasite within
infected cells.
The presence of these cytokines do not appear to have the same effects on T.annulata
infected cells as they do on Toxoplasma or Leishmania. My work has shown that the
infected cells themselves express numerous mRNAs specific for T cell activating
cytokines. It is also known that once T cells are activated by infected cells they begin
to express a number of cytokines, including IFNy (Campbell et al, 1995; Campbell,
1995). Experiments performed by Nichani (1994) showed that large amounts of
biologically active IFNy were present in efferent lymph samples taken from animals
infected with T.annulata. One can therefore assume that the presence of elevated levels
of IFNy do not have the same affect upon T.annulata infected MGs as they do for
Leishmania or Toxoplasma infected MGs. This suggests that the mechanisms by which
T.annulata controls infected cell function differ from those of these other intracellular
parasites. They are able to evade destruction even though there are probably high
levels of MG activating factors such as IFNy, IL-1, IL-6 and TNFa, within the
intercellular milieu.
One very important result of this work has been the discovery of a correlation between
the activation of naive autologous T cells and the levels of IL-1 a produced by the
infected cells used as a T cell stimuli. This however, remains a theory and further
work is required to prove a direct link between T cell activation/proliferation and
infected cell IL-la production. To do this one must possess anti IL-la Abs, which are
capable of blocking IL-la/IL-laR interactions. If incubation of infected cell lines
which produce high levels of this cytokine, in the presence of anti IL-la Abs results
in the abrogation of the high levels of T cell proliferation (as those observed post
incubation of T cells with clone L), one may conclude that IL-la is one of the main
T cell stimulatory signals involved in T.annulata T cell activation/proliferation. These
methods could also be applied to study the roles played in T cell proliferation and
pathogenesis by other cytokines.
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Chapter V.
In vivo assessment of the pathology and protection produced following
immunisation of cattle with clone I or clone L.
Section 5.1.
Introduction.
A molecular vaccine against T.annulata has proved difficult to produce. The only
suitable vaccines currently available rely upon attenuated macroschizont infected cells.
Vaccination with live attenuated infected cell lines produces solid immunity against
T.annulata and provides an extremely reliable method of protecting cattle against this
parasite. Vaccine regimes vary but generally consist of subcutaneously immunising
animals with l-2xl06 macroschizont infected cells (Pipano, 1971; Ouhelli et al, 1989).
Once attenuated cell lines generally provoke few clinical signs but do provide the
immunised animals with solid immunity against sporozoite challenge.
Cell lines are attenuated over 2 to 3 years of in vitro culture. The mechanisms
involved in attenuation are not well understood - there is evidence for alteration of
parasite gene expression, and the apparently random selection of clonal parasite
populations over time (Sutherland et al, 1996).The necessity of long periods of culture
involves much work and incurs high costs and results in poorly defined vaccine cell
line populations. Therefore, methods which could speed the attenuation/selection
process of putative vaccine lines would prove a boon to vaccine producers and users
alike.
Recent new work has lead to an increase in the understanding of factors underlying
the production of pathology of tropical theileriosis. Particularly - the induction of
non-specific T cell activation by T.annulata infected cells in vivo critically disrupts
the formation of normal immune responses (Campbell et al, 1995; 1997). Production
of very high levels of IFNg by these activated T cells may actively aid parasite growth
(Campbell, 1995). Also many of the signs associated with T.annulata infection such
as fever, cachexia and anemia may be attributable to the actions of proinflammatory
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cytokines such as IL-la and TNFa (Waage et al, 1989; Bielefeldt-Ohmann et al,
1989).
Aberrant T cell activation and the presence of high levels of cytokines may therefore
play important roles in the pathogenesis of tropical theileriosis. It was hypothesised
that a cell line which induced low levels of T cell proliferation and expressed low
levels of proinflammatory cytokines had the potential to be used as a vaccine line
without inducing pathogenic side effects. In this thesis cell lines were produced with
stabely produced different amounts of T cell proliferation and proinflammatory
cytokine mRNA species. Two of the clonal cultures previously characterised were
chosen for use in a small scale clinical trial. Of the clones available, clone I was
selected due to it's low T cell stimulatory ability/cytokine mRNA production and clone
L for it's high T cell stimulatory ability and cytokine mRNA production. This was
to compare the pathogenesis induced by a cell line inducing high levels of T cell
proliferation and expressing high levels of proinflammatory cytokine mRNAs, with a
low T cell activation/low cytokine mRNA producing cell line.
Due to the high costs incurred when working with cattle (ie, the cost of animals,
housing and feed) this initial trial consisted of two groups of three Hereford/Friesian
3 year old heifers. All animals were in good health prior to the trial and were housed
at Dryden Farm, Roslin. Each animal in each of the two groups of three, received a
subcutaneous inoculation of lxlO6 infected cells of either clone I or clone L into the
prescapular region. Following this animals were monitored for 24 days. Parameters
measured included, temperature, packed cell volumes (PCV), total erythrocyte count
(TEC), total leukocyte count (TLC), mean erythrocyte volume (mRBCv). The
appearance of macroschizont infected cells and piroplasms in the periphery were also
monitored and blood samples taken in an attempt to reisolate parasite material from
the recipient hosts. Lymph node biopsies would probably have proved a better
method of detecting infected cells. But this was not possible due to the large size of
the animals (approximately 750kg) and the lack of a suitable crush, which would have
allowed samples to be taken safely. After this initial period of study the animals were
rested for 1 month and then with the addition of two unimmunised control animals





The clinical signs of all six animals used in the initial immunisation trial were
monitored after administration of either clone I or L. Representative data from animals
within the two groups (No.s 13274 and 13271) are displayed in Fig. 5.1 (a-e), with
parameters shown including: temperature, PCV, TEC, TLC, and mRBCv. Data from
the remaining four animals is shown in Appendix section 5 (figures contained in the
appendix are designated App. followed by an identifying number, i.e. App 5.1.).
Included in each graph are the ranges of normal data for animals of similar age, sex
and breed (taken from Veterinary Haematology, Schalm, Jain & Carroll). Statistical
analysis was performed upon data collected from the six animals and consisted of 1
or 2 sided t-test analysis of data from days 1-10 (2 sided), 11-17 (1 sided) and 18-24
(1 sided), when comparing responses to clone I against those induced by clone L.
These time periods were chosen following analysis of data obtained post immunisation
of with cell line vaccines (Nichani, 1994). The data collected showed that the progress
of reactions post immunisation could be broken down in to these three periods.
One sided t-tests were implemented when the probable outcome of the experiment had
been predicted prior to immunisation and two sided tests used if the result of the
experiment had not been predicted before immunisation. Statistical analysis of the
period day 1 to 10 inclusive for all these parameters showed that there were no
significant differences between the responses of animals immunised with clone I and
those immunised with clone L. No animals became seriously ill after immunisation
with either clone I or L and all infections were self clearing. Checks of all animals
temperatures and blood counts were subsequently made on days 27, 31, 36, 38, with
parameters approaching those prior to immunisation by days 36/38 and all animals















Table 5.1 Statistical analysis of data collected after immunisation.
Student t test analysis of differences between data collected following
immunisation of cattle with either clone I or clone L. No significant
differences were found during the first phase of the trial (days 1 to 10).
During the second and final phase of reaction animals to the clones
differences were found between groups I and L. These included
differences in temperature, PCV and leucocyte counts.
Temperatures.
For the first 13 days of the trial five animals did not exhibit fever (Fig. 5.1a, App
5.1/5.2). Animal 13249 (group L) showed a temporary increase in temperature on day
7 (39.75°C), followed by a return to normal temperatures until day 12. However,
between days 13 and 14 the temperatures of animals immunised with clone L began
to rise and stayed above the febrile response level (39.5°C) until day 15/16, peaking
at between 40.4°C to 40.9°C on day 14. The temperatures of animals contained in
group I did not increase as much as those of group L, although animals 13274 and




Analysis of the PCVs (Fig. 5.1b, App 5.3/5.4) after immunisation showed that the
packed cell volumes of both groups began to decrease within 2-4 days after
administration of the infected cells. After immunisation with either clone I or L, PCVs
of all animals decreased steadily until day 14 but one can see both from Fig. 5.1b and
Table 1, that the PCV levels of animals immunised with clone I are significantly
higher than those immunised with clone L between days 13 to 16. Also only animals
immunised with clone L exhibited levels which fell to the lower end of the normal
range of PCVs for 3 year old heifers (day 14).
Total erythrocyte counts and mean RBC volumes.
Investigation of the total erythrocyte counts (Fig. 5.1c, App 5.5/5.6) of animals from
group I and L showed that there was little difference between the two groups'
reactions to the immunising cell lines. All six animals exhibit an initial rise in RBC
number, after which the TEC numbers in both groups fluctuate widely over the
following twenty days. The TECs of animals immunised with clone L are generally
lower than those immunised with clone I but there were no significant differences
between the two groups. The mean RBC volumes (Fig. 5.Id, App 5.7/5.8) did not
differ greatly between the two groups. Both groups of animals show a rapid initial
decrease in RBC volumes between day 0-4/5, after which cell sizes continue to
fluctuate for the remaining twenty days. However, an interesting point to note is the
apparently synchronous fluctuations in mRBC vol in animals of group L between days
0 to 10.
Total leukocyte counts.
The total leukocyte numbers of animals in both groups vary greatly over the first 13
days but there were no significant differences (P>0.05) in the levels expressed by the
two groups of animals (Fig. 5.1e, App 5.9/5.1.0). However, statistically different
differences do appear between the two groups during days 14-16 (P<0.05). Between
these days the leucocyte levels of animals in group L fall faster than those in group
1 and reach levels (3.0x103-5.lxl03 cells/mm3) well below the minimum normal range
of bovine leucocyte numbers (7.35xl03 cells/mm3). From day 16/17 the leucocyte
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numbers of animals in both groups begin to rise.
Detection of schizonts/piroplasms.
Examination of blood smears showed that macroschizont infected cells were detectable
at day 15 in all six animals but the levels of parasite were low at approximately 0.1%.
These levels remained the same until day 23 at which point schizonts were only
perceptible in the blood of animal 13249. At day 24 no schizonts were detectable in
the blood of any animals. Piroplasms were only detected in one animal (No.
13271/Group L) and only on one day (day 19), again the level of parasitemia was low
at approximately 0.1%.
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Fig. 5.1a, Temperature data from representative animals post
immunisation with cells of clones I or L.
Temperature data (°C) from animals 13274 (group
I) and 13271 (group L) after immunisation with
cells of either clone I or clone L.
Fig. 5.1b, PCV data from representative animals post
immunisation with cells of clones I or L.
PCVs of animals 13274 (group I) and 13271 (group
L) following immunisation with cells of clone I or
clone L.
(All data presented relates to representative animals
13274 (immunised with clone I) and 13271
(immunised with clone L). Data relating to all six
experimental animals is shown in the appendix).
Fig. 5.1a
Temperatures of animals immunised





















day after immunisation - clone I. clone L.
Fig. 5.1b








Fig. 5.1c, Total eiythrocyte counts from representative animals
after immunisation with either clone I or clone L
Total RBC count data after immunisation with cells
of either clone I or clone L.
Fig.5.1d, Mean eiythrocyte volume data from representative
animals after immunisation with either clone I or
clone L.
Mean RBC volumes after immunisation of animals
with either clone I (13274) or L (13271).
Fig. 5.1c
Total erythrocyte counts from animals in groups I and L.
7.46x10*6
I 5.06x10*6
day after immunisation. -clone I. clone L.
Mean RBC volumes of animals in groups I and L.
day after immunisation.
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Fig.S.le, Total leucocyte count data from representative
animals post immunisation with cells of either clone
lor clone L.
Data from animals 13274 (group I) and 13271
(group L) showing total leucocyte counts post
immunisation.
Fig. 5.1e




Following a rest period of thirty days animals were challenged with an approximate
LD50 dose of 1 TE of sporozoites (Gharb stock). Animals were assessed as before
with temperatures and blood samples taken periodically over 20 days. Both groups
I and L showed solid immunity to challenge and significant differences from the non-
immunised control animals (Figs. 5.2a and 5.2b). Both control animals became ill. One
animal 13050 became severely ill during this experiment, exhibiting classical signs of
tropical theileriosis. These included, lethargy, loss of appetite, increase in temperature,
frothing around the mouth and nostrils and a large fall in PCV. Due to the severity
of these signs, a two day course of the antitheilerial Butalex was administered
intramuscularly on days 9 and 10. During the following three days Butril (a veterinary
antibiotic) was administered intravenously to guard against opportunistic infections.
Temperatures.
Temperature of the control animal (13050) increases rapidly after day 6 and only falls
to the febrile response cut off point at day 15. Two group I animals exhibited transient
increases in temperature (13254 on day 8 and 13274 on days 14/15 (40°C/40.75°C)
(App 5.1.1). The animals of group L behaved in a similar fashion, with 13249
showing a fever on day 8 (39.5°C) and 13266 a temperature of 40.0°C on day 15 (App
5.1.2). From day 16 after challenge all six experimental animals, plus animal 13050
exhibited normal temperatures.
Animal 38B also showed an increase in temperature post challenge but did not exhibit
as severe a fever as animal 13050 (App 5.1.3). The body temperature of 38B peaked
at 40.75°C on day 10, however, following this day the temperature begins to fall back
towards normal levels. Animal 38B did not require Butalex treatment.
PCV analysis.
Following the challenge, the PCVs of the six animals from groups I and L vary
between 30 to 35% and 27 to 35% respectively over the 20 days of the trial (Fig.
5.2b, App 5.1.4/5.1.5), all staying within the normal PCV range of a three year old
heifer (38.8%-26.4%). The PCV of naive control animal 13050 fell from 35% to 24%
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over the first 12 days, with the animal treated with Butalex on day 9. After this animal
13050 began to recover after day 14, reaching 32% by day 20 (Fig. 5.2b). The data
collected from the second negative control animal 38B is unfortunately incomplete but
a general trend can be seen (App 5.1.6). At the start of the challenge this animal had
a PCV of 29%, half way through the trial this had decreased to 21% and on the final
day of sampling shown was 17%. The PCV of this animal remained low (17% on day
28) but the animal did recover naturally over the following 14 days.
Total erythrocyte analysis.
Investigation of the TECs of all six vaccinated animals show that the circulating RBC
pool of each animal is generally unaffected by sporozoite challenge (Fig 5.2c, App
5.1.7/5.1.8). This is not so for the naive control animals, animal 13050 exhibits wide
fluctuations in TECs over the 20 days of monitoring. An initial rise in the numbers
of circulating RBCs can be seen over the first 5 days after challenge, which is
followed by a fall in numbers until day 12 (post treatment), after which the numbers
of RBCs begin to increase and pass that observed at the beginning of the trial.
Again complete data for animal 38B is unavailable but the general trend discernible
would suggest that the pattern of fluctuation in the numbers of circulating RBCs over
the first 10 to 12 days of the trial are similar to those observed in animal 13050. After
day 12 the numbers of RBCs continue to fall and remain low until the end of the
monitoring.
Mean volumes of circulating RBCs.
Mean RBC volumes of the immunised animals remained generally unaffected by
challenge, with the average erythrocytic volumes remaining within normal limits
(40.4-57.2pm3) (Fig 5.2d, App 5.2.0/5.2.1). The control animals behaved very
differently from the immunised animals. Animal 13050 began the trial with a mRBC
volume of 57pm3, this fell rapidly over the next 5 days and showed a large degree of
fluctuation until day 11, after which the mean volume fell to well below the lower
limit for a healthy animal (40.4pm3) (Fig. 5.2d). No. 38B exhibited an initially low
mRBC volume of 38.5pm3which fluctuated between 35.5 and 40pm3 over first 14 days




Fig. 5.2a, Temperature data from representative animals
following challenge with 1 TE of Gharb sporozoites.
Temperature data (°C) collected post challenge of
control animals and animals preimmunised with
lxl06 cells of either clone I or clone L, with 1 TE
of sporozoites.
Fig. 5.2b, PCV data from representative animals following
challenge with 1 TE of Gharb sporozoites.
PCV data collected post challenge of control
animals and animals preimmunised with either lxlO6
cells of clone I or clone L, with 1 TE of
sporozoites.
(Data from representative animals in groups I and L
again collected from animals 13274 and 13271,
control data shown collected from animal 13050).
Fig. 5.2a
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Fig. 5.2c, Total erythrocyte count data from representative
animals following challenge with 1 TE of Gharb
sporozoites.
Total erythrocyte count data collected from animals
immunised with lxl06 cells of either clone I or L
and control animal 13050 after challenge with 1 TE
of sporozoites.
Fig.5.2d, Mean erythrocyte volume data from representative
animals following challenge with 1 TE of Gharb
sporozoites.
Mean RBC volume data collected from control
animal 13050 and animals preimmunised with lxlO6
cells of either clone I or clone L following
challenge with 1 TE of Gharb sporozoites.
Fig. 5.2c
Total erythrocyte counts of animals challenged with sporozoites.
day after challenge. ■clone I. - clone L. -control
Fig. 5.2d
Mean RBC volumes of animals after challenge with sporozoites.
8 9 10 11 12 13
day after challenge.
19 20
- clone I. - clone L. - control
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Total leucocyte analysis.
There are large fluctuations in the numbers of leucocytes present in the periphery of
immunised animals following challenge. All six animals show levels which drop
below normal (7.35x103cell/mm3), indicated by the representative data shown in Fig
5.2e. There would appear to be little difference in the severity of leucocyte
fluctuations of animals immunised with either clone I or clone L (App 5.2.3/5.2.4).
The TLCs of the control animal 13050 show marked variations over the 20 days of
the trial (Fig. 5.2e). An initial rise in TLC over the first 8 days of the trial was
followed by a dramatic fall of l.lxlO4 cell/mm3 in leucocyte number between days 8
to 12. After this large reduction in the circulating leucocyte pool the number begins
to rise over the next 8 days and by day 20 approaches the lower normal limit of this
parameter. The second control animal (No. 38B) showed a TLC profile which fitted
roughly in to that of animal No. 13050 (App 5.2.5). This is to say there was an initial
increase in leucocyte number, followed by a large decrease and subsequent rise back
towards normal levels towards the end of the trial. However, the variations in
leucocyte numbers by 38B are not as severe as those observed in 13050.
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Fig. 5.2e, Total leucocyte count data from representative
animals following challenge with 1 TE of Gharb
sporozoites.
Total leucocyte data collected from control animal
13050 and animals preimmunised with lxlO6 cells
of either clone I or clone L after challenge with 1








Detection of schizonts and piroplasms post challenge.
Following challenge of the six original animals and two naive controls, blood smears
and cytospin preparations of PBM were made every day. No schizonts or piroplasms
were detected in any of the immunised animals. Control animal 13050 became very
sick following infection, with fever starting between days 6-7. This animal was treated
with Butalex on day 9 and 10. Animal 38B was not treated and data shows that this
animal suffered a fairly high parasitemia. Schizonts were first detected on day 6 and
piroplasms on day 11. By day 14, No. 38B showed a parasitemia of 13.1% and by day
19 this had risen to 43.7%. This parasitemia remained high until the end of the trial
(i.e. 19% - day 28), however, the infection did was cleared, whilst the trial ran
No.38B also showed high levels of micro and macroschizonts present in the periphery
between days 7-24. This data showing that the 1 TE challenge of T.annulata (Gharb)
Osporozoites was capable of causing all the clinical signs of tropical theileriosis.
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Section 5.4.
Analysis of infected cells isolatedfrom immunised animals.
After macroschizont infected cells are inoculated into naive animals parasite material
is known to transfer from donor cells into cells of the recipient (Innes, 1989; Nichani,
1994). It is also known that parasite transfer from donor to recipient cells is necessary
for the production of immunity (Nichani et al, 1997). Transfer of macroschizont
material from one cell type to another, may result in changes in the behaviour of the
parasite/infected cell population, which in turn may affect animals post vaccination
(i.e. induce fever). To assess whether this is the case infected cells were isolated from
animals post immunisation and analysed to ascertain if parasite had crossed over from
donor to recipient cells. Also to ascertain if this process had altered the expression of
cytokine mRNAs by infected cells from those expressed by clones I and L.
MHC class I, II and genotype analysis.
Before macroschizont infected cells of clone I or L (produced from the same animal)
were administered to the experimental animals their MHC class II types were
investigated by polymerase chain reaction - restriction fragment length polymorphism
analysis (PCR-RFLP). This analysis was kindly performed by Robert Oliver of the
Roslin Institute. Table 5.2 contains the MHC class II types of the immunising cell





MHC class IIDR{33 type.
T.a 12929 (clone I). 14, unknown.
T.a 12929 (clone L). 14, unknown.
T.a 13274 (immunised with clone I). 1, 22.
T.a 13254 (immunised with clone I). 7, 27.
T.a 13260 (immunised with clone I). 7, 7 (homozygote).
T.a 13266 (immunised with clone L). 1, 18.
T.a 13271 (immunised with clone L). 8/9, 10.
T.a 13249 (immunised with clone L).
12, 14.
Table 5.2 MHC class II types of experimental animals determined by PCR-RFLP.
MHC class II types of the original infected clonal lines (I and L) and
those of the cell lines isolated from the six experimental animals after
immunisation. Only one of the newly isolated cell lines (T.a 13249)
shares an MHC class II allele with the clonal lines I and L.
Of the six experimental animals shown in Table 5.2 only one (No. 13249) shares an
MHC class II allele with the immunising cell lines (DR(33 type 14). MHC class I type
analysis and microsatallite analysis were also performed on these eight cell lines. It
was found that the MHC class I types of clones I and L did not match those of
macroschizont infected cell lines isolated after immunisation (micocytotoxicity MHC
class I typing tests were performed by Angela Gallagher of the Roslin Institute).
Also infected cells isolated from the experimental animals differed from clone I and
L with respect to five different bovine microsatellite markers. This work (kindly
performed by Janice Barr), investigated the sequences of five different microsatillite
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markers in each of the eight cell lines. Clones I and L contained the same satellite
sequences but those of the six newly isolated cell lines did not match those of clones
I and L. These three sets of data therefore show that the infected cells isolated from
the six experimental animals do not originate from animal 12929. The parasite
contained in cells of clone I and clone L has therefore passed from the immunising
cell lines, to infect cells of the recipient animals.
FC analysis of infected cells isolated post immunisation.
FC analysis was performed upon the six macroschizont infected cells lines produced
from the infected cells isolated after immunisation. The data obtained from this
analysis is presented in Fig 5.3a (I-iv) to Fig 5.6b (I-iv). The cell lines were
investigated for expression of the epitopes detailed in chapter III, section 3.3 (MHC
class I/II (Dutia et al, 93; 95, CD14 (Gupta et a\, 96) and the epitope bound by IL-
A24 (Ellis et al, 87)).
MHC class I & II expression.
The level of expression of class I expressed by clones I and L are shown in Figs 5.3a
(I) and Fig 5.3b (I) respectively. The expression of these molecules by the clonal lines
is very similar with a narrow range in class I expression (X-axis). All the newly
isolated cell lines again show high expression of MHC class I molecules (possibly at
higher levels than the original clones) but the ranges in expression have increased
following cross over into the recipient cells.
MHC class II expression of the six newly isolated lines is also different from the cells
used to immunise the experimental animals. Of the two clonal lines, clone I expressed
higher levels of class II molecules, than clone L (Fig 5.4a (I)). However, one can see
that infected cells isolated from immunised animals, express much greater ranges than
did the original clones (I & L). Clone L expressed very low levels of MHC class II
molecules but this is not the case for the newly isolated infected cells. Data contained
in Fig 5.4b (I) shows that class II expression by this clone to be much lower than the
levels expressed by the lines produced from animals 13266, 13271 and 13249 (Fig
5.4b (ii-iv)).
163
Fig 5.3a FC histograms of MHC class I molecule expression
by cells of clone I and infected cell lines derived
from animals immunised with clone I.
(i) MHC class 1 expression of clone I, (ii-iv) MHC
class I expression of cell lines isolated from animals
(13274, 13254 & 13260) immunised with clone I.
Negative control profiles are shown in blue and
profiles resulting from labelling with the anti class
I mAb IL-A19 are shown in red.
Fig 5.3b FC histograms of MHC class I molecule expression
by cells of clone L and infected cell lines derived
from animals immunised with clone L.
(i) MHC class I expression of clone L, (ii-iv) MHC
class I expression of cell lines isolated from animals
(13266, 13271 & 13249) immunised with clone L.
Negative control profiles are shown in blue and
profiles resulting from labelling with the anti class
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Fig 5.4a FC histograms of MHC class II molecule expression
by cells of clone I and infected cell lines derived
from animals immunised with clone I.
(i) MHC class II expression of clone I, (ii-iv) MHC
class II expression by cell lines isolated from
animals (13274, 13254 & 13260) immunised with
clone I. Negative control profiles are shown in blue
and profiles resulting from labelling with the anti
class II mAb IL-A21 are shown in red.
Fig. 5.4b FC histograms ofMHC class II molecule expression
by cells of clone L and infected cell lines derived
from animals immunised with clone L.
(i) MHC class II expression of clone L, (ii-iv) MHC
class II expression cell lines isolated from animals
(13266, 13271 & 13249) immunised with clone L.
Negative control profiles are shown in blue and
profiles resulting from labelling with the anti class
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CD14 expression by cells isolated post immunisation.
Data presented in chapter III showed that after infection of CD 14" cells by T.annulata
the expression of CD14 is drastically down regulated (Figs 5.5a (I) and 5.5b (I)). This
is also the case for the infected cells isolated from five out of six of the experimental
animals. The infected cells isolated from animals immunised with clone I all exhibit
low levels of CD 14 expression, similar to that of the immunising clonal line. Of the
three cell lines produced after immunisation of animals with clone L, two express
similar levels of CD14 to the original population (Fig 5.5b (iii,iv) but those produced
from infection of animal 13266 express slightly higher levels of this molecule (Fig
5.5b (ii)).
Expression of the epitope bound by IL-A24.
Both clones I and L express the epitope bound by IL-A24, however, not all of the
newly isolated cells from the recipient animals expresses this epitope to a similar
degree. Of the six macroschizont infected cell lines produced from the experimental
animals, four show levels of expression similar to those of the immunising clones.
However, two cell lines produced from animals immunised with clone I exhibited
levels of expression markedly lower than that of the immunising cell line (Fig 5.6a
(ii, iii).
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Fig. 5.5a FC histograms of CD 14 expression by cells of clone
I and infected cell lines derived from animals
immunised with clone I.
(i) CD 14 expression of clone I, (ii-iv) CD14
expression cell lines isolated from animals (13274,
13254 & 13260) immunised with clone I. Negative
control profiles are shown in blue and profiles
resulting from labelling with the anti CD14 rnAb
VPM65 are shown in red.
Fig. 5.5b FC histograms of CD14 expression by cells of clone
L and infected cell lines derived from animals
immunised with clone L.
(i) CD 14 expression of clone L, (ii-iv) CD14
expression cell lines isolated from animals (13266,
13271 & 13249) immunised with clone L. Negative
control profiles are shown in blue and profiles
resulting from labelling with the anti CD 14 mAb

























Fig 5.6a FC histograms of expression of the epitope bound
by mAb IL-A24 by cells of clone I and infected cell
lines derived from animals immunised with clone I.
(i) Expression of the epitope bound by IL-A24 by
clone I, (ii-iv) Expression of the epitope bound by
IL-A24 by cell lines isolated from animals (13274,
13254 & 13260) immunised with clone I. Negative
control profiles are shown in blue and profiles
resulting from labelling with IL-A24 are shown in
red.
Fig 5.6b FC histograms of expression of the epitope bound
by mAb IL-A24 by cells of clone L and infected
cell lines derived from animals immunised with
clone L.
(i) Expression of the epitope bound by IL-A24 by
clone L, (ii-iv) Expression of the epitope bound by
IL-A24 by cell lines isolated from animals (13266,
13271 & 13249) immunised with clone L. Negative
control profiles are shown in blue and profiles
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20 — 20 20 20 20
IL-la
20 — 22 20 20 24
IL-1 (3
20 — 20 20 20 22
IL-6
20 — 20 20 22 24
IL-10
N.P. — N.P. N.P. N.P. N.P.
TNFa
24 — 22 20 24 N.P.
Table 5.3 Preliminaiy limiting cycle RT-PCR analysis of cytokine mRNA
production by lines isolated from animals immunised with either clone
I or L.
Semi-quantitative RT-PCR analysis of cytokine mRNA production by
macroschizont infected cells isolated from five of the six experimental
animals. RT-PCR procedures used a constant 5 ,ug of total RNA and 2|ul
of cDNA, followed by between 20 to 30 amplification cycles
(increasing in step of 2). N.P.= PCR products not present at 30 cycles,
data from cell line T.a 13254 unavailable.
The data contained in table 5.3 above were produced during preliminary limiting cycle
RT-PCR analysis of the cytokine mRNA production of cell lines isolated on day 15
after immunisation of the six experimental animals. Unfortunately, data was not
obtained from cell line 13254. However, the data obtained from the other lines does
show that the production of the various cytokine mRNAs by the five other lines is
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remarkably similar, regardless of whether the lines were isolated from an animal




Vaccination with long term cell culture attenuated macroschizont infected cell lines
is currently the most effective control method for tropical theileriosis. However, the
production of these cell lines is problematic. Amongst these problems are: (1) cells
used to produce the putative vaccines are often poorly characterised, (2) production
and maintenance of the vaccine lines incurs high costs, (3) attenuation of infected cells
requires between 2 to 3 years of tissue culture and the mechanisms of attenuation are
poorly understood. Investigations which elucidate the mechanisms of attenuation and
shorten the production time of new vaccines would be extremely advantageous and
desirable.
It has been suggested that it is the macroschizont stage of T.cmnulata infections which
are responsible for the majority of pathology associated with this disease (Hooshmand-
Rad, 1976). Indeed instances have been documented where animals died before any
piroplasms have been detected in the periphery, underlining the fact that the
macroschizont stage is capable of producing illness and pathology (Hooshmand-Rad,
1976). Also the characteristics of pathology associated with tropical theileriosis, such
as fever, anaemia, inflammation, cachexia and inappropriate T cell activation may be
linked to the activities of infected cells, such as the possible production of
inflammatory and T cell stimulatory cytokines (Neitz, 1957; Barnett, 1977; Waage et
al, 1989; Campbell et al, 1995). The post vaccinal reactions observed often include
fever and anemia (Pipano, 1981) and the occurrance of these signs may be linked to
the T cell stimulatory ability and proinflammatory cytokine production by infected
cells.
The isolation of clones I and L from a cell line of known phenotype (as opposed to
a cell line obtained by infecting whole PBM), which showed marked differences with
respect to cytokine mRNA production and T cell stimulatory ability, provided an
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unique opportunity to investigate the relationship between cytokine production/T cell
stimulation and the induction of pathology by the macroschizont stage of this parasite.
The stimulation of T cells by T.annulata infected cells causes the production of
exceptionally high levels of IFNy (Campbell et al, 97). Campbell et al (1997) showed
efferent lymph leaving a lymph node containing infected cells could contain levels of
IFNy upto 20x those observed in a protective immune response. INFy from T cells
and other cytokines thought to be produced by infected cells (IL-1, IL-6 and TNFa)
are proinflammatory and can act in cascade mechanisms, leading to further production
of proinflammatory cytokines and other molecules such as prostaglandins (Waage et
al, 1989; Creasey et al, 1991). The production of cytokines by infected cells and
infected cell stimulated T cells may play an important role in T.annulata induced
pathology.
Section 5.6.
Post vaccinal reactions induced by clones I & L.
The severity of signs observed post immunisation with clones I and L did depend
upon which clone the animals received. Clone I was shown to induce low levels of
in vitro autologous T cell proliferation and also low levels of T cell
stimulatory/inflammatory cytokine mRNA species. Animals which received cells of
clone I experienced only mild fevers and fluctuations in PCV and TLCs. However,
animals which received cells of clone L, shown to induce higher levels of T cell
proliferation in autologous T cells and produce higher levels of cytokine mRNA
species exhibited significantly higher levels of fever and significantly greater falls in
PCV and leucocyte numbers. Therefore the reactions observed post immunisation
correlate with the data obtained from the T cell proliferation and limiting cycle RT-
PCR analysis of these clones.
Section 5.7.
Protection induced by immunisation with clones I & L.
Challenge of cattle after immunisation with these clonal lines showed that both lines
were able to vaccinate against a potentially lethal dose of sporozoites. The T.annulata
Gharb sporozoite stabilate provided by Professor Brown (C.TV.M) had been shown
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to produce an LD50 (at a dose of 1 TE) (Nichani, 1994) and induced severe signs in
both unimmunised control animals (animals 13050 and 38B). Animal 13050 required
Butalex treatment at day 9 post challenge. Animal 38B also showed signs classically
associated with tropical theileriosis and took approximately two months to recover
from the challenge. However, the responses of all the six immunised animals were
similar with only mild signs observed after inoculation with sporozoites.
A novel approach was used to select these putative clonal cell lines. Normally vaccine
lines are produced by the selection of clonal parasite populations of low virulence by
long term tissue culture. But long term tissue culture attenuation appears to act on the
parasite and can lead to over-attenuated cell lines, which do not provide satisfactory
protection, especially against heterologous challenge (Dargouth et al, 1996; Ilhan et
al, 1997). The method of cloning I employed, coupled with assessment of T cell
stimulatory ability and cytokine mRNA production of infected cells allowed the rapid
selection of cell populations with attenuated phenotypes, which were capable of
inducing strong protective immunity against a heterologous challenge.
A possible reason for the success of these two clonal lines as vaccines may be that
infected populations were selected with respect to the characteristics of the infected
cells and not the parasite they contained. This allowed the production of putative
vaccine lines (after only a matter months of tissue cutlure), which remained highly
immunogenic as they contain parasite unattenuated by long term tissue culture.
Section 5.8.
Isolation & characterisation of infected cells from animals prior to challenge.
Infected cells from each immunised animal were isolated and grown in tissue culture,
forming new infected lines. MHC class I/class II and microsatellite analysis showed
these infected cells to originate from the recipient animals and the donor. Thus
showing that the macroschizont material has "crossed over" to infect cells of the
recipient. FC analysis of the new cultures showed them to differ greatly from the
original infected cell populations. MHC class I and II expression of all the six newly
isolated lines was shown to be higher than the original clones. Also these molecules
showed a greater range of expression within the new populations, suggesting that the
newly isolated lines are not clonal in origin.
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MHC class I expression.
MHC class I expression can play a crucial role in vaccination against T.annulata
infection. Nichani (1994) showed that if animals had been previously exposed to the
MHC class I type of a vaccine line subsequently used to immunise them, then no
immunity was induced following immunisation. The reason for this remains unclear
but is probably connected to the fact that pre-immunisation with cells of a certain
MHC type will sensitise animals to the presence of those cells/MHC types. This being
the case immunising cells will be removed quickly, as a graft would be if an animal
had already received a graft from the same source. The rapid removal of the
immunising cell line before infected cells have established themselves within the
recipient, presumably inhibits the production of a protective immune response (Pipano,
1993). The use of soft agar cloning and selection of attenuated cell lines should allow
the rapid production of new lines. If this is the case then it will be possible to make
numerous cell line vaccines, avoiding the problem of revaccinating animals with the
same cell lines.
MHC class II & CD14 expression.
There are also differences between the original lines (clones I & L) and the newly
isolated lines with respect to the expression ofMHC class II molecules. Clones I and
L expressed particularly low levels of class II molecules. However, when one studies
the FC analysis data concerning class II expression by the newly isolated cell lines,
it is clear that the expression of these molecules are substantially greater than that of
clones I and L. Not only has the expression increased but the range in the amounts of
class II molecules expressed by cells within the new populations has also increased.
These data suggest that although the infected cells administered to the six animals
were clonal, parasite transfer produced non-clonal infected cells.
Although parasite transfer has occurred and the new populations of infected cells are
not clonal, CD 14 expression does not differ greatly between the clones and the newly
isolated lines. Both the original clones and the newly isolated lines express very little
CD 14, suggesting that expression of this epitope may be specifically down-regulated
by the parasite. This is a particularly interesting aspect of the alterations in expression
of surface molecules by macroschizont infected cells. The original line used to
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produce both clones I and L was produced from cells which had been specifically
selected for CD 14 expression. As noted in chapter III the expression of this molecule
decreases dramatically post infection/"transformation" and this is also the case when
macroschizonts have transferred from a donor cell to a recipient cell.
Only cells expressing CD 14 can become infected/"transformed" and produce
continuously growing T.cmnulata infected cell lines (Campbell et al, 1994), suggesting
that expression of this molecule may be important with respect to infection/infected
cell development. The reasons for down regulation of CD 14 post infection are not
understood but appears to be of great significance as we see very low CD 14
expression by cells infected with either sporozoites or macroschizonts, suggesting that
the down-regulation of this molecule may be essential to aspects of infected cell
behaviour.
CD 14 acts as a ligand for bacterial LPS (Wright et al, 1990) and is a potent activator
of the antimicrobial functions of M0s (Murray and Cohn, 1980; Emmendorffer et al,
1990; Moncada, Palmer and Higgs, 1991). This being the case, one possible reason
for the down regulation of the molecule could be to inhibit the subsequent activation
of infected cells by this signalling pathway and so prevent destruction of the
intracellular stage of the parasite.
Another possibility is that CD 14 is down-regulated due to its link with a negative
control pathway associated with the down regulation of T cell stimulation (Lue et al,
1991). If expression of this molecule decreases then it's activity with respect to the
down-regulation of T cell proliferative responses will be reduced, allowing infected
cells to alter normal T cell behaviour. However this phenomenon may simply be
associated with the down regulation of M0 activating receptors after normal cellular
activation, as an attempt to control innate responses (Grey et al, 1994).
Expression of the epitope bound by IL-A24.
In chapter III it was shown that both cells of clone I and L expressed the macrophage
associated epitope bound by IL-A24. The expression of this molecule by the newly
isolated cell lines generally mirrors that of the original cell lines but two lines, both
produced from animals immunised with clone I express very low levels of this epitope
(T.a 13274 & T.a 13254).
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The expression of this molecule has been linked with the "maturity" of APCs, with
Campbell et al (1994) suggesting that cells expressing high levels of this molecule
resemble mature M9s. Infected cells contained within lymph nodes were generally
found to express higher levels an epitope bound by the mAb IL-A109 (a molecule
expressed by monocytes/immature macrophages), than of the epitope bound by IL-A24
(Campbell, 1995). This may suggest that different populations of cells became infected
in vivo than were originally infected in vitro, producing the original lines. But these
differences may be an artefact, as placing monocytes/macrophages in culture can
induce alterations in cell phenotype. Therefore in vitro infection may produce cells of
a more mature phenotype than those infected in vivo and further work is necessary to
determine whether this is the case.
Section 5.9.
Parasite (macroschizont) transfer.
Analysis of the cell lines isolated post immunisation showed that the parasitised cells
isolated from the six immunised animals were different from the cells inoculated into
the animals. This shows that parasite contained within infected cells can "cross over"
to infect cells of the new host. This phenomenon has been shown before (Nichani,
1994 inter alia) but very little is known concerning the mechanism of parasite transfer.
There are a number of different ways in which this may occur, (1) parasite transfer
may be an active process, whereby macroschizonts leave infected cells and
subsequently infect new cells, (2) immune reactions aimed at removing infected cells
may damage parasitised cells, if the contents of the cells are released, macroschizonts
may then be able to infect new cells. The most likely process, (3) is that of
phagocytosis and destruction of infected cells by cells of the myeloid lineage (such
as M8s), followed by engulfed macroschizonts escaping degradation by phagocytes
and establishing infections in recipient cells, an hypothesis also held by Forsyth et al
(1997).
It is known that sporozoites are adept at gaining access to cells of the myeloid lineage
(Campbell et al, 1994). However, there are no proven receptor/ligand pairs for the
attachment and entry of sporozoites. There is also no evidence that macroschizonts
express similar surface molecules to sporozoites which may aid entry into cells.
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However, if one considers that during an immune reaction infected cells may be
attacked and engulfed by phagocytes, this facilitates entry of parasite material into the
very cells which T.annulata infects (Campbell et al, 1994; Forsyth et al, 1997). If this
is the mechanism by which cross over occurs, after ingestion the macroschizont must
escape the endosome/lysosome to prevent it's destruction. No work has been carried
out in this area, we simply know that the parasite starts off in the donor cells and end
up in cells of the recipient, which it subsequently "transforms". But theoretically one
may imagine that the macroschizont is able either to leave the newly formed vacuoles
or prevent fusion with lysosomes. Whatever happens we know that the macroschizonts
are capable of infecting/"transforming" new cells and establishing an infection in
recipient animals.
Characteristics of infected recipient cells & parasite transfer.
The cytokine mRNA profiles of the cell lines reisolated from the immunised animals
were all essentially identical, i.e. all newly isolated cell lines expressed high levels of
cytokine mRNAs, irrespective of the immunising cell line. Post vaccinal reactions
were observed around days 13-17, the period during which the cell lines were
reisolated. These newly isolated cell lines were of recipient genotype, showing that
parasite "cross over" had occurred prior to reisolation. However, the severity of the
reactions correlated with the cytokine profile of the immunising cell line and not with
that of the newly isolated line.
Given that post vaccinal reactions appear to be related to the presence of a high
cytokine producing/'T cell stimulating cell line (clone L) and are not related to the
"pathogenicity" of cells infected following parasite transfer, the following mechanism
for the induction of post vaccinal reactions may be proposed (Diagram. 5.1). Infected
cells administered to animals will continue to proliferate in vivo until cleared by the
immune system. Nichani (1994) showed that CTL responses against immunising cell
lines peaked at 11 to 12 days post immunisation and persisted until day 17/18. It is
therefore likely that the largest numbers of immunising cells are present during the
first part of this time period, coinciding with the peak of post vaccinal reactions. Post
vaccinal reactions decline from day 16 to 17 coinciding with the reduction in the CTL
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Diagram. 5.1 A possible time scale of responses to macroschizont infected
cell lines when used to immunise animals against T.aruudata
infection.
The time scale of host CTL responses against (1) the
immunising cell line (anti-MHC response), followed by (2) the
response to parasitised cells of the recipient (anti-parasite
response) (Nichani, 1994). Post vaccinal reactions to clone L
appear to coincide with the peak of the anti-MHC response and
wane as cells of the immunising cell lines are destroyed.
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Conclusion.
The data presented within this chapter shows that within the bounds of these
experiments, the two different cell lines (I and L, derived from the same parent line),
produce different levels of pathology when administered to animals but that both
induce protective immunity in these otherwise susceptible animals. Therefore, it is
possible using the techniques of soft agar cloning, RT-PCR analysis and T cell
proliferation studies to produce and assess the suitability of new T.annulata
macroschizont infected vaccine cell lines over a much shorter time scale than can
generally be accomplished. If these techniques can be developed further and more
information concerning the factors governing attenuation collected, then their
implementation in the area of vaccine production may greatly increase the efficiency
of vaccination programs throughout the developing world.
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Chapter VL
Conclusions and Future work.
Summary and conclusions.
Infection of cattle with the intracellular protozoan parasite T.annulata causes severe
illness, especially in exotic breeds (Robinson, 1982). This organism infects cells of the
immune system, namely monocytes and M0s (Glass et al, 1989; Spooner et al, 1989;
Campbell et al, 1994), transforming the cells it infects and inducing alterations in
infected cell behaviour. Soon after transformation infected cells possess the ability to
induce the activation and proliferation of autologous T cells. Possibly the most
important effect that T.annulata infected cells have upon T cells is to drive the T cell
response towards a non-protective Th, type response (Campbell et al, 1997). The
induction of this type of response in susceptible cattle is followed by destruction of
the architecture of the draining lymph node, production of high levels of cytokines
(such as IFNy) and ultimately the failure of the host to mount a protective response
against the parasite (Campbell, 1995; Campbell et al, 1997). To fully understand and
therefore develop protective strategies against this parasite one must decern the exact
mechanisms by which the infected cells alter T cell and immune function.
This thesis concentrates upon the effects which T.annulata has upon the cells which
it infects (moncytes and M9s) and details research into aspects of tropical theileriosis,
including the immunological functions of infected cells (T cell stimulatory ability and
cytokine production) and possible causes of the immunopathology observed post
infection. Protection of susceptible animals is possible by vaccination with long term
tissue culture attenuated cell line vaccines protects animals from infection in the field.
However, animals can suffer post vaccinal reactions, causing morbidity and reducing
productivity. Knowledge of the exact causes of the pathology associated with
T.annulata infection and post vaccinal reactions remains incomplete. A better
understanding of the mechanisms which induce pathology would allow the production
of more efficient vaccines, reducing the levels of morbidity post immunisation.
179
T.annulata infected monocytes and M0s possess enhanced antigen presentation
function and are also capable of inducing high levels of T cell proliferation (Glass &
Spooner, 1990; Campbell et al, 1995). The presence of inflammatory cytokines during
T.annulata infections has also been linked with the exacerbation of disease (Preston
et al, 1992b). Glass and Spooner (1990) also demonstrated that APCs generally
express elevated levels of MHC class II antigens following T.annulata infection. They
postulated that the increased levels ofMHC class II expression could account for the
enhanced antigen presenting function of infected cells and may be related to the
alteration of T cell function by infected cells.
During the course of this thesis Campbell et al (1995) highlighted possible
mechanisms involved in the immunopathology of this disease. Inappropriate T cell
activation and the contact specific induction of non-specific T cell proliferation by
infected cells produces a non-protective Th, helper like response (Campbell et al,
1997). This T helper response is accompanied by the presence of extremely high
levels of IFNy in the periphery (20x the levels observed in a protective immune
response) (Campbell et al, 1997).
With the identification of the mechanisms which may underlie pathogenesis, an
understanding of the factors driving these reactions became essential. The aims of the
thesis were therefore to (1) quantitate the expression of MHC class II molecules by
infected cells, (2) to relate this to T cell stimulatory ability and (3) investigate other
factors which may influence the stimulation of T cells by macroschizont infected cells.
Infected cell MHC class II expression & T cell stimulatory ability.
Clonal populations of T.annulata infected cells were produced from a defined
population of CD14+ cells, by the novel use of soft agar cloning. This allowed the
quantitation ofMHC class II expression by specific populations of infected cells and
investigation of links between class II expression and T cell stimulatory ability. MHC
class II expression varied between the four infected cell populations studied. The
uncloned parental line expressed the highest levels of MHC class II per cell, whilst
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of the clonal lines clone G expressed higher levels of MHC class II than clones 1 or
L (which expressed similar levels of these molecules). Quantitation of MHC class II
expression of these cultures also showed that there is little fluctuation in class II
expression by T.annulata infected cells over time in culture.
When these four different infected cell populations were used to stimulate autologous
PBM it was found that the levels of T cell proliferation induced did not correlate with
the observed levels of MHC class II expression. The line which reproducibly induced
the highest levels of proliferation was clone L. This line expressed similar levels of
MHC class II molecules to clone I. However, clone I induced much lower levels of
T cell proliferation. Clone G which expressed higher levels of class II than both clones
I and L induced levels of T cell proliferation between those induced by clones I and
L and the parent line which expressed the highest levels of class II induced similar
amounts of T cell proliferation to clone G. These results therefore show that the levels
of MHC class II expressed by T.annulata infected cells do not correlate to the levels
of T cell proliferation induced, meaning that enhanced expression of these molecules
can not be the only requirement for the induction of T cell proliferation.
A further point which should be noted is that all three clonal populations studied
expressed lower levels of MHC class II molecules than the original population of
infected cells. This may suggest that soft agar cloning selects for infected cell
populations which express low levels of these molecules. A further ten clonal
populations were produced by cloning of the parent line which were not studied due
to lack of time. However it would be interesting to know whether soft agar cloning
does impose selection pressures, which result in the isolation of infected cell
populations of similar phenotype (with respect to MHC class II expression).
There are a number of possible reasons for the differences in T cell proliferation
induced by these infected cell populations. When one considers the MHC class II
expression of the clonal cultures it is apparent that although they do possess narrower
ranges of MHC class II expression than the uncloned line (T.a 12929), variation does
remain within the clonal populations. Therefore one wonders if particular
subpopulations (which express different levels of MHC class II molecules) within
clones G, I and L, vary in the way in which they affect autologous T cells. The data
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in this thesis relating to the connection of MHC class II expression to T cell
proliferation does not address this question, as MHC class II expression was
determined as the average for the whole populations and does not shed any light upon
the ways in which inter-population variation in MHC class II expression may affect
T cell proliferation. This possibility could be addressed if the clonal lines were
subcloned by FACS sorting on the basis of MHC class II expression, followed by
investigation of the proliferative response of T cells to the subclones expressing
different levels of MHC class II.
Variation in MHC class II expression may also be produced as different cells within
the population move through the cell cycle. Attempts to minimise variation which may
result due to this phenomenon were made and involved the harvesting of infected cell
populations only whilst in the log phase of growth (12-18 hours after passage).
However, this possibility could be investigated further by using flow cytometric
analysis to assess the stage of the cell cycle which infected cells occupy and the levels
of MHC class II they express.
Another reason for the variation in MHC class II expression may be that although the
clonal cultures were derived from single infected cells variation in MHC class
expression may arise due to the presence ofmore than one parasite within the infected
cells. This would mean that although the cultures are clonal with respect to the cells,
they may not be clonal with respect to the parasite they contain. To remove this
variation and allow further investigation into the relationships between MHC class II
expressed by infected cells and autologous T cell proliferation one would need to
subclone cultures G, I and L, in an attempt to obtain infected cell lines with even
narrower expressions of MHC class II. Genetic analysis could also be carried out to
ascertain whether the clonal lines did contain more than one parasite per population.
If subcloning of the populations proved unsuccessful one would need to produce new
clonal lines which were produced from a single cell and a single sporozoite.
It must also be remembered that there are many other cell surface molecules apart
from MHC class II molecules, which play roles in T cell activation (i.e. B7 and
ICAM1). At the time that these investigations took place there were very few mAbs
available which bound specifically to bovine cell surface molecules involved in T cell
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activation. As a result the expression of T cell stimulatory accessory molecules by the
clonal lines were not investigated. It is therefore possible that the levels of accessory
molecules expressed by infected cell lines (along with cytokines produced by infected
cells (see below)) play a part in determining the levels of T cell proliferation induced.
Before one can decisively show which molecule or combination of molecules is
necessary to induce various levels of autologous T cell proliferation one must
investigate the expression of other important T cell stimulatory molecules by these cell
lines.
A further point of interest concerns the phenotype of the cells, which the infected cell
lines used during this study were produced from. Spooner et al (1989), Glass et al
(1989) and Campbell et al (1989) had shown that the target for T.annulata sporozoites
were monocytes and M0s. The infected cell lines produced for this study were
therefore produced from purified populations of CD141 monocytes. The cells
transformed by infection with this parasite were CD14+ prior to infection but rapidly
became CD14" after the establishment of an infected cell population. These findings
have since been confirmed by Sager et al (1997) who showed that
infection/transformation of cells by T.amutata induced a down regulation of CD14
expression at the level of the gene. This is an example of a parasite interfering with
transcriptional events and a similar mechanism may be employed by the parasite to
alter the levels of MHC class II expressed by infected cells. The actual mechanisms
by which the parasite brings about these changes remain unknown and much research
is therefore necessary to elucidate the factors produced by T.annulata which are
capable of altering mammalian gene expression. However, determination of the
mechanisms which T.annulata employs to alter gene expression may prove valuable
in the investigation of the ways in which other intracellular protozoan parasites affect
mammalian cells.
183
Cytokine mRNA production by Theileria infected cells.
RT-PCR analysis of the production of a range of T cell stimulatory and
proinflammatory cytokines by the four T.annulata infected lines showed that the
presence of this parasite within cells induces the constitutive production of cytokine
mRNAs specific for IL-lot, IL-ip, IL-6, 1L-10 and TNFa. All of the four T.annulata
infected lines produced similar cytokine mRNA profiles, however, a cell line infected
with the related parasite T.parva produced a different profile of cytokine mRNAs
(including, IL-lot, 1L-2, IL-4, IL-10 and IFNy). The finding that cells infected with
either T.annulata or T.parva produce mRNA specific for IL-1a suggests that this may
be an important part of the mechanisms involved in T cell activation by infected cells.
Limiting cycle RT-PCR analysis allowed comparison of the levels of cytokine mRNAs
produced by the different populations of infected cells. Clone I produced the lowest
levels of the majority of the cytokine mRNAs, whilst clone L expressed the highest
and clone G and the parent line made these cytokine mRNAs in roughly similar
amounts. These findings correlate with the levels of T cell proliferation observed after
incubation of autologous T cells with infected cells {i.e. clone L produces higher
levels of T cell stimulatory cytokines than clone I and also produces substantially
more T cell proliferation). A direct correlation was shown between the levels of
cytokine mRNAs produced by infected cells (with particular emphasis 011 production
of IL-1 a and IL-6 mRNAs) and the levels of T cell proliferation observed. This
suggests that although the T cell activation induced by macroschizont infected cells
is contact specific (Campbell et af 1995) the T cell proliferation maybe driven by
cytokines.
JTowever, one must remember that the analysis carried out on these infected cell lines
only investigates the presence ofmRNA species specific for various cytokines and not
functional proteins. It is therefore possible that even though T cell proliferation levels
do correlate with the expression of cytokine mRNAs specific for IL-1a and IL-6,
some or all of these cytokines may be expressed only at the mRNA level. To obtain
a clearer picture of the causes of T.annulata induced T cell proliferation one needs to
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use bovine specific bioassays to ascertain the functional expression of the cytokines
in question.
Recent findings by Sager et al (1997) show that T.annulata infected cells are capable
of producing both IL-1 and TNFa but that the TNFa produced is not secreted from
the infected cells in vitro. Biologically active TNFa was only found within cell lysates
and may suggest that this cytokine is present only in an intracellular or membrane
bound form, possibly playing a role as a autocrine signal. Another possibility is that
TNFa is produced and released in vivo, possibly when infected cells interact with
other cells of the immune system. However, IL-1 activity was found and this may
have relevance, as IL-1 is capable of inducing both pyrexia and cachexia via its effects
upon other cells of the immune system. This confirmation that T.annulata infected
cells are capable of producing biologically active proinflammatory and cachexia
inducing cytokines strengthens the evidence for a link between the production of such
cytokines by infected cells and the induction of pathology and disease within
T.annulata infected animals.
Another facet of tropical theileriosis is the induction of the production of IFNy by T
cells stimulated with macroschizont infected cells, shown both in this thesis at the
mRNA level (also Campbell et al, 1995) and at the protein level (Campbell et al,
1997). This cytokine generally acts in a protective way during protozoan infections
(i.e. T. gondii and Leishmania. spp. infections). However, the non protective Thi type
response and high levels of IFNy induced by the presence of T.annulata infected cells
appears to exacerbate the infection not clear it, possibly by inducing large scale T cell
activation and disruption of the immune response (Campbell et al, 1997). This thesis
therefore shows T.annulata to be a novel parasite which does not conform to the
established rules concerning the immunology and immunopathology of the majority
of intracellular protozoan parasites.
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Use of clones I & L to immunise naive susceptible animals.
In vitro characterisation showed clones I and L possessed markedly different abilities
to stimulate autologous T cells and produced different amounts of T cell stimulatory
and proinflammatory cytokine mRNA species. These characteristics are thought to be
of great importance in the production of pathology and the inhibition of a protective
immune response during a T.annulata infection (Campbell, 1995; Campbell et al,
1997). There is also a possibility that these characteristics are responsible for the
production of the post vaccinal reactions sometimes observed after vaccine
administration, which can include fever, anemia, lethargy and loss of appetite (Pipano,
1981).
When animals were immunised with cells of these two clonal cultures the reactions
observed post immunisation correlated with the in vitro characteristics of the
immunising culture. Clone L which produced the highest levels of T cell proliferation
and stimulatory cytokines also induced signs of greater severity than clone I, including
greater rises in temperature and greater falls in PCV and leucocyte numbers. The
Gharb sporozoites used to challenge these animals produced severe signs in both
control animals (also when used in experiments by Dr Anil Nichani (1994)). However,
all six cattle (irrespective of the immunising cell line) were protected by vaccination
with these low passage cell lines.
The major difference between the selection procedure I employed and the traditional
methods of cell line selection is that of soft agar cloning. This method does not rely
upon the long term culture of infected cells to produce attenuated clonal populations
of parasite and cells. It selects single infected cells containing unattenuated (low
passage) parasite which can then be grown on to form populations which can be
screened for an attenuated phenotype.
The long term attenuation of cell line vaccines can lead to their over attenuation,
producing reduced levels of protection (Dargouth et al, 1996; Uhan et al, 1997). The
rapid production of cell lines using this new method circumvents these problems,
allowing the preparation of vaccine lines from cells with an attenuated phenotype
which contain unattenuated/immunogenic parasite material. The importance ofcellular
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phenotype, with respect to the virulence of infected cell lines is indicated by the
results obtained after RT-PCR analysis of cytokine mRNA production of the newly
isolated cell lines. These cell lines were produced by in vivo parasite "cross over",
during which non clonal populations of cells became infected. All of the newly
isolated cell lines assessed produced high levels of T cell stimulatory/proinflammatory
cytokines. This suggests that the virulence of infected cells depends not only upon the
parasite they contain but also upon the cells which become infected. Therefore
selection of future vaccine lines on the basis of cellular phenotype and not necessarily
parasite alone, may dramatically increase the efficiency of vaccine
production/selection.
I have shown that the in vitro T cell proliferation induced correlates with the levels
of T cell stimulatory cytokine mRNA produced by macroschizont infected cells. It also
appears that the levels of post vaccinal reactions induced also correlate with the levels
of cytokine mRNA produced by the immunising cell line. I therefore feel that this
validates the use of limiting cycle RT-PCR to aid in predicting the virulence of
putative cell line vaccines and shows that the criteria upon which these two
immunising cell lines were chosen may be suitable for the selection of vaccines
against tropical theileriosis. Also that this technique could possibly be used to screen
putative vaccine lines in a fraction of the time normally required.
However, before this method can be used on a practical basis more detailed
investigations must be carried out into this techniques ability to predict the virulence
of new cell line vaccines. It must be remembered that this was a small scale study and
the differences detected between the reactions of the two groups of animals to the two
cell lines, although statistically significant for three parameters (temperature, PCV and
TLC) were not particularly different and none of the six animals required treatment.
Also if one studies the data relating to the changes in PCV and total RBC numbers
one sees that the PCV falls (indicating loss of RBCs and approaching anemia) but the
actual numbers of RBCs do not fall as might be expected. Therefore further study of
the affects of immunisation with these two cell lines should be carried out using a
larger number of animals, with particular detail payed to variations in blood
composition. Base line measurements for all the parameters should be taken for around
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six to eight days prior to immunisation and the numbers of animals in each group
should be increased, to ease statistical analysis of resulting data. Differential cell
counts should also be performed on daily blood samples during the experiment. This
would allow fluctuations in the numbers of different cell types (i.e. lymphocytes,
neutrophils and eosinophiles) in the peripheral circulation to be calculated while the
animals respond to the presence of the theileria parasite.
One factor which I would have liked to study would have been the response of
animals to the cell lines derived from clone I, which were isolated post parasite
transfer and found to express higher levels of cytokine mRNA than the original clone
I. If the hypothesis that cytokine production by the immunising cell line plays an
important role in the induction of pathology and the determination of the course of
infection proved correct, one may expect to observe that animals immunised with the
cell lines produced following parasite transfer (which possessed cytokine mRNA
profiles resembling that of clone L) would suffer more severe signs than those induced
by immunisation with the original clone I. This would suggest that the phenotype of
the cells infected and not simply the phenotype of the parasite is important with
respect to attenuation and also in determining the behaviour of the cells after infection
and therefore the severity of disease which they are capable of inducing. This differs
from the traditional ideas of why cell lines may be virulent or avirulent, as virulence
is normally attributed to the characteristics of the parasite alone.
Further investigation into the relationships between the cytokine production of infected
cell populations and the induction of immunity versus pathology is necessary before
limiting cycle RT-PCR analysis can be used to safely assess cell line vaccines.
Flowever, the data in this thesis suggests that this method of analysis ofmacroschizont
infected lines, if found reliable, would prove a much cheaper and quicker method of
characterising putative vaccines for use against tropical theileriosis.
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Future work.
Much investigation into the immunopathology of tropical theileriosis still remains to
be done before we have a true picture as to the exact mechanisms which the parasite
employs to interfere with the host immune system and induce pathology. However,
the evidence to date suggests that cytokines including, IL-1, IL-6 and TNFa, derived
from infected cells play a crucial role in the induction of both the inappropriate T cell
activation and pathology (including fever, anemia and cachexia) observed following
infection. However, before we are able to fully understand the roles of each cytokine
produced by infected cells in the induction of in vivo responses to T.annulata
infection, experiments must be conducted to delineate the reactions observed post
infection/immunisation.
Two possible routes which would allow the dissection of the highly complicated
interactions involved in T.annulata infection are (1) the development of bovine specific
cytokine bioassays and (2) the production and characterisation (both in vitro and in
vivo) of more early passage clonal cell lines. Assessment of the production of
biologically active cytokines is necessary before one can be totally certain of the
production/secretion of active cytokine molecules by infected cells. This could also
aid the development of blocking assays to determine the specific roles of individual
or combinations of cytokines, with respect to non-specific autologous T cell activation.
To assess the specific roles of cytokines with respect to the induction of pathology,
the production and characterisation of a range of clonal lines, expressing different
ranges of cytokines and the immunisation of cattle with these lines, would facilitate
study of which cytokines/combination of cytokines are important in altering in vivo
immune responses and inducing pathology. If these studies were to prove successful
they would not only greatly improve our knowledge of this parasite but could also
allow T.annulata vaccine production to be earned out using a sound scientific basis
and dramatically increase it's efficiency.
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Limiting cycle RT-PCR analysis could also be used to study the production of
cytokine mRNAs by established vaccine lines and would show whether lines which
are routinely used to immunise animals against T.annulata also produce low levels of
inflammatory cytokines. If these cell lines do produce low levels of these molecules
it would be further evidence to suggest that cytokine production may be linked with
the induction of pathology. However, if these cell lines do not produce low levels of
inflammatory cytokines then it may suggest that the attenuation of the parasite plays
a bigger role in the induction of immunity and pathology, than the phenotype of the
infected cells. Also that the attenuation of early passage lines (as is seen in this thesis)
may occur by a different mechanism than in lines produced by traditional long term
tissue culture methods. Cytokine production may not be as an important a
characteristic in cell lines where the parasite has been attenuated over long periods in
culture. However, much more information is needed before possible differences in the
mechanisms of attenuation can be identified. However, isolation and study of infected
cells from animals following immunisation with conventionally produced vaccine
lines, may reveal if cytokine mRNA expression generally increases after parasite cross
over from donor to recipient cells (as in the case for clone I) and whether this does
relate to the state of attenuation of infected cells.
This technique of assessing the production of cytokine mRNAs could also be utilised
in other systems where infected/parasitised cells induce pathology. Allowing analysis
to be carried out upon animals of the host species and possibly removing some of the
reliance on model systems. T. gondii and Leishmania. Spp, both infect macrophages
and although they do not "transform" the cells infected they are able to induce
changes in the expression of cytokines by the infected cells (Khan et al, 1996;
Chakkalath and Titus, 1994). This method of limiting cycle analysis could prove
useful in investigating cytokine production by infected cells and delineating the
immune reactions induced by the presence of other parasites. One example of this
concerns the investigation of the ruminant intra-macrophage parasite Cowdria
ruminatum (Allsopp et al, 1997). This parasite causes the disease heartwater and
affects many animals in the third world. The presence of infected cells appears to
induce the production of a Th2 response (Dr K. Sumption, pers. comm.), a
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characteristic they share with Leishmania infected cells (Chakkalath and Titus, 1994)
Limiting cycle analysismay allow any involvement of cytokine production by infected
cells within the bovine immune system to be investigated. This is one example where
use of this technique could help delineate immune reactions within the host, without
the need to use model infections in mice or rats, which may produce data not pertinent
to the real infection.
As stated T.annulata infected cells possess the ability to alter the behaviour of T cells
which they come into contact with (Campbell, 1995; Campbell et al, 1997). This is
not unique amongst protozoan parasites, as others including, Plasmodium yoelii (Pied
etaf, 1997), Trypanosoma cruzi (Gomes ei al, 1996), Leishmaniamajor (Zimmermann
et al, 1994) and Toxoplasma gondii (Khan et al, 1996) have all been shown to possess
the ability to alter T cell responses. Two of these examples show parasites able to
induce T cell unresponsiveness (Gomes et al, 1996; Khan et al, 1996). However, there
is evidence to suggest that L. major and P. yoelii possess superantigen like activities.
L.major has been found to share an epitope with the murine CD3-T cell receptor
complex and the ability to activate T cells (Zimmermann et al, 1994). Whilst both
sporozoites and erythrocytic stages of P. yoelii have the ability to induce large scale
T cell activation and the deletion of Vp9 T cells (Pied et al, 1997). T.annulata infected
cells share this ability but whether T cell activation occurs via a similar mechanism
remains to be seen.
The identity of the molecule expressed on the surface of T.annulata macroschizont
infected cells, which is responsible for the contact specific T cell activation signal and
the roles played by particular cytokines during this process remains unknown.
However, further study of this and other parasites may provide clues as to the way in
which T.annulata is able to activate such a large proportion of the circulating T cell
pool during an infection (Nichani, 1995). Therefore, further studies should investigate
the expression of a wide range of surface molecules by infected cells, such as the B7-
1 and B7-2 molecules, to assess those which may play a part in the contact specific
activation of autologous T cells. Also the expression of biologically active cytokines
and the specific roles which they play in T.annulata induced T cell activation should
be investigated.
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Although there are some similarities between certain characteristics of T.annulata and
those of other protozoan parasites, T.annulata is the only one known which is able to
cause the dedifferentiation and "transformation" of infected monocytes and
macrophages (Campbell et al, 1994; Sager et al, 1997), whilst also inducing septic
shock like immunopathology, severe enough to kill the animal within twelve to twenty
days post infection (depending on parasite dose). Therefore, it is I feel very important
for all the molecules involved in the production of the non protective Th, type
immune response to be elucidated before we can obtain a clear picture of how this
protozoan parasite disrupts the immune system and produces the severe signs
associated with tropical theileriosis. This knowledge could hopefully then be used to
produce a molecular vaccine which could induce the immune system to form a
protective response to T.annulata infection. Thus the need for the costly production
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SUMMARY
A major feature of the pathology induced by Theileria annulata is acute lymphocytic proliferation,
and this study investigates the mechanisms underlying the intrinsic ability of T. annulata-infected
monocytes to induce naive autologous T cells to proliferate. Different T. annulata-infected clones
expressed different but constant levels of MHC class II, varying from < 1-0 x 105 to 1-5 x 106
molecules/cell, as measured by saturation binding. However, no correlation was found between the
level of MHC class II expression and levels of induced T cell proliferation. Theileria annulata-
infected cell lines and clones were assayed for cytokine mRNA expression by reverse transcription-
polymerase chain reaction (RT-PCR). The infected cells assayed produced mRNA specific for
IL-la, IL-1 j3, IL-6, 1L-10 and tumour necrosis factor-alpha (TNF-a), but not IL-2 or IL-4. One
clone (clone G) did not produce mRNA for TNF-a. The degree of T cell proliferation induced by
infected cells was directly correlated with the amount of mRNA produced for the T cell
stimulatory cytokines IL-la and IL-6, as assessed by a semiquantitative technique. In contrast,
cells infected with the related parasite T. parva produced mRNA for IL-la, IL-2, IL-4. IL-10 and
interferon-gamma (IFN-7). Since T. parva-infected cells also induce naive autologous T cell
proliferation, it seems likely that the production of IL-la by cells infected with either parasite is a
major signal for the induction of non-specific T cell proliferation.
Keywords Theileria annulata bovine cytokine macrophage MHC class II
INTRODUCTION
Theileria annulata is a tick-transmitted protozoan parasite of
cattle and causes the severe lymphoproliferative disease, tropi¬
cal theileriosis, endemic in Southern Europe, North Africa,
Southern Russia, India and the Middle East. In vitro, infective
sporozoites invade MHC class II+ cells, particularly cells of the
monocyte/macrophage lineage which are able to form continu¬
ously growing cell lines in vitro [1,2]. Theileria species appear to
be unique among intracellular protozoan parasites, as no other
species is known to exist within the cytoplasm ofmacrophages
and induce their replication. Upon infection, cells acquire a
uniform phenotype irrespective of their origin [3]. Infected cells
can act as professional antigen-presenting cells (APC), capable
of presenting exogenous antigens to CD4f T cells [4], How¬
ever, these cells are also capable of activating naive autologous
T cells in the absence of exogenous soluble antigen in a contact-
dependent manner [5], This property of infected cells has
Correspondence: D. J. Brown. Division of Molecular Biology,
Roslin Institute, Roslin. Midlothian EH25 9PS, Scotland, UK.
recently been shown to play a major role in disease pathogen¬
esis, bypassing normal T cell-APC interactions within draining
lymph nodes [5],
MHC class Il-restricted antigen presentation and cytokine
secretion are essential for APC function (at least in the activa¬
tion of CD4 cells), and alteration of either component may
play an important role in the altered APC function of infected
cells and thus pathogenesis.
In this study we have generated clonal T. annulata-infected
cell lines, quantified the levels of expression of MHC class II
molecules upon them, and examined whether there is a correla¬
tion between MHC class II expression, cytokine production of
infected cells, and T cell stimulatory ability.
The related parasite T. parva infects T cells and causes a
disease known as East Coast Fever which is endemic to the East
coast of Africa [6], There are a number of similarities between
these two parasites. Theileria parva-infected cells are also MHC
class II + and also induce T cell proliferation [7], Therefore the
cytokines produced by a T. parva-infected cell line were also
investigated and compared with the cytokines produced by
T. annulata-infected cells.
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MATERIALS AND METHODS
Theileria annulata-i'w/ected cell lines and clones
A T. annulata (Ankara strain)-infected cell line (Theileria
annulata 12929 (T.a 12929)) [8] was established from CD14 +
peripheral blood monocytes (PBM) and macrophages of a
6-month-old Friesian calf as previously described [3,4,7],
Clonal cell lines were produced from this line by soft agar
cloning of the T.a 12929 cell line generated above [9], At a cell
density of 2 x 105 cells/well, cells were then transferred to
10-ml Nunc tissue culture flasks and treated in an identical
manner to standard T. annulata cultures [10],
Theileria parva cell line
The T. parva cell line (B641L4.14 TpM) was used in this work
(a kind gift from 1LRI).
Quantification ofMHC class II expression
Cell cultures were passaged the day before use to maintain the
cells in exponential growth phase. The MoAb used during this
assay was the rat anti-ruminant MHC class II (DR/J-specific)
MoAb SW73.2 [11], F(ab')2 fragments of MoAb SW73.2 were
iodinated with '^iodine (Amersham Int., Aylesbury, UK)
using the Iodobeads iodination protocol (Pierce, Rockford,
IL) [12]. The level of expression ofMHC class II molecules was
measured by saturation binding using 125I-labelled SW73.2
F(ab')2 as previously described [13,14], except that cells were
labelled on ice for 30 min before unbound F(ab')2 was
separated from the cells by washing with aliquots of PBS.
The results obtained from assays of the cloned bovine B cell
lymphoma line BL20 were identical to those previously
described [15],
Flow cytometric analysis
Flow cytometric analysis of T. annulata-infected cells was
performed to assess the expression of MHC class 1 and class
II molecules [3]. This analysis was performed using the MoAbs
SW73.2 and IL-A21 [16] which recognize monomorphic deter¬
minants on bovine MHC class II molecules and the anti-bovine
MHC class I MoAb IL-A19 [17],
Proliferation assays
T cell proliferation induced by the infected cell lines was
measured as previously described [4], The T. annulata-'mkcicd
cells used in these experiments were passaged 24 h before use;
2 ml of the cell culture were added to 8 ml of fresh medium.
Briefly, autologous naive peripheral blood mononuclear cells
(PBMC; 4 x 105/well) were incubated with irradiated (cells
exposed to 75 Gy) autologous T. annulata-infected cells
(4 x 10 /well). Assays were harvested on day 5 (the day of
maximum proliferation [5]) following a 6-h pulse of tritiated
thymidine (TI-TdR) (Amersham). Proliferation was measured
by liquid scintillation counting using a Wallac 1450 Microbeta.
Background ct/min were < 1500 for irradiated PBMC alone and
< 2500 ct/min for irradiated T. annulata-'mltctcd cell lines alone.
Reverse transcription-polymerase chain reaction analysis of
cytokine transcripts
Total cell mRNA was isolated from various T. annulata cell lines
and clones using RNAzol B (Biogenesis, Poole, UK) according
to the manufacturer's instructions. Briefly, 107 cells were
Table 1. Cytokine primer sequences used in this study
Primer
mRNA direction Size, bp 5'-sequence-3'
P-actin + 288 CTGGCACGACACCTTCAACGAG
- AGCCAAGTCCAGACGCAGGATG
IL-la + 332 TCACCGATGATGACCTGGAAGCC
- GATTTTGGGTGTCTCAGGCATCTCC
IL-1 p + 432 CCGACGAGTTTCTGTGTGACGCACC
- CGAAAATGTCCCAGGAAGACGGGC
1L-6 + 655 ATGAACTCCCGCTTCACAAGC
- TACTTCATCCGAATAGCTCTC
IL-10 + 733 GCTCAGCACTACTCTGTT
- GTTCACAGAGAAGCTCAGT
TNF-Q + 500 CTCAGGTCATCTTCTCAAGCC
- CAGGGCGATGATCCCAAAGTAGACC
IFN-y + 531 GGAGCTACCGATTTCAACTACTCCG
- GCAGGCAGGAGGACCATTACG
Primer orientation (+ or -) is given in relation to the direction of
transcription. The /3-actin, IL-2, and IL-4 sequences have already been
reported [18],
suspended in 1 ml of RNAzol B and the RNA extracted using
ice-cold chloroform/isoamylalcohol (24:1). The RNA was pre¬
cipitated at —20°C in isopropanol, followed by two washes in
75% ethanol. RNA was then dried under vacuum, resuspended
in a suitable volume of sterile dH20, and the yield determined by
spectrophotometry (OD taken at 260 nm). Samples of 5 p.g
RNA were used for reverse transcription of cDNA using the
Superscript preamplification system (Gibco BRL, Paisley, UK)
with oligo dT as a primer, according to the manufacturer's
instructions. Polymerase chain reaction (PCR) reactions were
performed using 2 p\ of the resulting cDNA. Primers specific for
bovine cytokine sequences (Table 1) were used to amplify
cytokine cDNA, during a 30 cycle PCR programme (Taq poly¬
merase and buffers from Gibco). Primers specific for (3-actin, IL-
2 and IL-4 were used as previously described [18]. The products
of the reverse transcription (RT)-PCR reactions were visualized
by UV transillumination, following electrophoresis on a 2%
agarose (Sigma, type 1-A; Poole, UK)/1X TBE gel containing
()• 1 /ig/ml ethidium bromide.
Quantification ofmRNA
Limiting step PCR was performed to ascertain the relative
expression levels of the various cytokine mRNAs. The PCR
protocol remained the same apart from the number of cycles
used to amplify the cytokine cDNA. Cycle numbers ranged
from 20 to 30, in increments of two cycles. Comparison of the
cycle at which the PCR products became visible was used to
assess the relative expression of the cytokine mRNA species.
/7-actin expression was used as an internal standard for these
reactions.
Restriction digest analysis ofPCR products
The identity of the PCR products was determined by restriction
enzyme analysis, using five enzymes: Taq 1 (Pharmacia,
Uppsala, Sweden), Pvu II (Boehringer-Mannheim, Lewes,
UK), Bgl II (Boehringer-Mannhiem), Hae III (New England
Biolabs, Herts, UK), Pst 1 (Pharmacia). PCR product (15 p\)
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was digested with the selected restriction enzymes. The frag¬
ments obtained after digestion were visualized as in Fig. 3, and
their sizes matched those expected from the known sequences.
Statistical analysis of MHC class II quantification and T eel!
proliferation assays
The data obtained from MHC class II quantification and T
cell proliferation assays were assessed using Student's /-test.
Statistical analysis was carried out on the MINITAB statistical
program.
RESULTS
Preliminary flow cytometric analysis showed that the uncloned
parent line (T.a 12929) had a wide distribution of MHC class II
expression (Fig. 1). Fourteen clones were produced by soft agar
cloning. Initial analysis of these clones showed them to express
varying levels of MHC class II. Three clones (clones G, I and L)
were selected which expressed levels of MHC class II molecules
ranging from below, to approaching that of the original culture
(T.a 12929). Uninfected monocytes, the parental population
T.a 12929 and clonal lines G, I and L derived from this cell line
were assayed for the amount of MHC class II expressed at the
cell surface (Fig. 1 and Table 2).
Flow cytometric analysis ofMHC class I and II expression
The parent line and the clones all showed a normal distribution
of MHC class I expression with a small range (Fig. 1). In
contrast, the expression of MHC class II by the parent line
and the clones was not normally distributed, even though these
cells were part of a clonal culture and the range of expression of
MHC class II was much greater than that of MHC class I. All











Cell line molecules/cell Range
Uninfected monocytes 2-32 x 105 ND
clone I 8 0 x 104 8 0 x 104- 10 x 105
clone L 10 x 105 10 x 105—2-0 x 105
clone G 10 x 106 10 x 106-2-0 x I06
T.a 12929 2-4 x 106 2-4 x 106—2-5 x 106
The number of MHC class II molecules expressed per cell given are
the result of a representative experiment. The range given is for three
experiments, except for the uninfected monocyte sample (ND).
and clone G expressed higher MHC class II levels than the
other clones.
Saturation binding studies
Table 2 shows the data produced from saturation binding
studies. The parent cell line expressed higher levels of MHC
class II than any of the clonal populations. Clone G showed the
highest expression ofMHC class 11 of the clones, whilst clones I
60 000
50 000 -
^ 40 000 -
o> 30 000
IS 20 000 -
10 000
10 10 10 10
Log fluorescence
T.a 12929 Clone I Clone G
Stimulator cells
Clone L
Fig. 1. Flow cytometric analysis of MHC class I and II expression from
(a) clone I, (b) clone L, (c) clone G, and (d) T.a 12929. Profiles include
MHC class I profile (^) cells stained with the anti-bovine MHC class I
MoAb IL-A19, and a profile of the MHC class II expression (U), cells
stained with the anti-bovine MHC class II MoAb IL-A21.
Fig. 2. Proliferation assays using the cell lines (T.a 12929, clones I, G
and L) to stimulate freshly isolated peripheral blood monocytes (PBM).
Data shown as Act/min (Act/min = ct/min of proliferating stimulated
T cells - (ct/min of T. annulata-infected cells alone + ct/min of PBM
alone)).
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and L expressed similar levels of MHC class II. Statistical
analysis showed that the variation in MHC class II expression
within triplicate samples of the parent line and clones was not
statistically significant. However, the expression of MHC class
II by the parent line and clone G was shown to be significantly
different from clones I and L (P < 0-001).
Proliferation of naive T cells
Clonal cell lines and the uncloned parent line (T.a 12929) were
used in proliferation assays to assess the level of non-specific T
cell proliferation induced when naive autologous T cells were
incubatedwith each clone and proliferation was measured on day
5 (Fig. 2). Clone L induced the highest net levels of proliferation
(45 565 ± 4504 ct/min), which was significantly different from
the proliferation induced by the parent line and clone I
(P 0-005). Both clone G and the parent line induced similar
levels of proliferation, lower than clone L (31 588 ± 6792 and
26 091 ± 7326 ct/min, respectively). In contrast, clone I induced
extremely low proliferation (4908 ± 1527 ct/min), significantly
lower than all other infected cells (P ^ 0-005). No correlation
was found between the expression of high levels of MHC class II
on the surface of infected cells and the levels of proliferation
induced by the parent line and the clones.
Cytokine production from infected cells
The possibility that the production of T cell stimulatory
cytokines by the infected cells led to the activation of naive T
cells was investigated using RT-PCR analysis of cytokine
mRNA. Restriction enzyme analysis of the PCR products
showed that the sequence of the RT-PCR products matched
the known bovine cytokine sequences (Fig. 3). The cytokines
produced by the uncloned parent line {T.a 12929) and a T.parva-
infected cell line are shown in Fig. 4a and b, respectively. The
T. annulata-infected cell line and clones expressed mRNA
specific for the monocyte and macrophage-associated cyto¬
kines: IL-la, IL-1/7, IL-6, IL-10 and tumour necrosis factor-
alpha (TNF-a). Clone G did not produce detectable levels of
TNF-a. The parent line was also found to produce interferon-
gamma (IFN-y) mRNA on two out of five occasions. None of
the clones was found to produce mRNA specific for IFN-7.
The T. parva-infected cell line expressed the T cell-associated
cytokines IL-2, IL-4 and IFN-7, as well as IL-la and IL-10.
Limiting cycle PCR was used to investigate the relative
amounts of each cytokine mRNA produced by each cell line
(Fig. 5 and Table 3). Figure 5 shows the levels of expression of
mRNA specific for (3-actin, IL-la, IL-1 j3 and IL-6 by the
parent line and clones at different PCR cycle numbers (between
20 and 24 cycles). Table 3 shows the cycle numbers at which the
cytokine PCR products were detectable. PCR amplifies DNA
templates exponentially, therefore a product which becomes
visible at 20 cycles results from a much more abundant source
of mRNA than a product visible at higher numbers of cycles.
Clone L produced the highest levels of mRNA for IL-la,
IL-l/I, IL-6 and TNF-a (visible at 20 cycles) and IL-10
mRNA visible at 24 cycles. The parent line and clones G and
I expressed much lower levels of these mRNAs, with no







Fig. 3. Restriction enzyme analysis of the cytokine reverse transcription-polymerase chain reaction (RT-PCR) products. The enzymes
used and fragments expected are as follows, IL-la (Taq 1) 161 bp/204 bp, IL-1/3 (Pvu II) 169 bp/263 bp, IL-6 (Bgl II) 149 bp/477 bp,
IL-10 (Hae III) 306 bp/439 bp, tumour necrosis factor-alpha (TNF-a) (Pvu II) 99 bp/163 bp/234 bp, IFN-7 (Pst 1) 114 bp/425 bp.
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Fig. 4. (a) Cytokine gene expression determined by reverse transcription-polymerase chain reaction (RT-PCR) analysis of mRNA
from the parental line {T.a 12929). Other T. annulata-infected cell lines tested so far also expressed rnRNA for the listed cytokines
except IFN-7 (data not shown). The analysis of mRNA from the T.a 12929 cell line was carried out on five separate occasions, but
IFN-7 mRNA was detected on only two occasions, (b) Cytokine gene expression in a T. parva-infected line.
DISCUSSION
Our previous studies have shown that T. annulata-infected cells
have enhanced APC function [4] and also induce aberrant T cell
activation and proliferation in vitro and in vivo [4,5]. Originally
we attributed this to the high levels of MHC class II expressed
on the surface of infected cells [4]. Our results here indicate that
this is unlikely to be the case. Interestingly, although all of the
uncloned T. annulata-infected cell lines which we have exam¬
ined to date expressed higher average levels of MHC class II
molecules than the original uninfected CD14+ monocytes, we
were nevertheless able to clone several cell lines which expressed
fewer MHC class II molecules on a per cell basis than the
original uninfected cells. Also it can be seen from the flow
cytometry profiles in Fig. 1 that the expression of M HC class 11
molecules by the clones is not normally distributed. This
dysregulation does not appear to alter MHC class I gene
expression, suggesting that the parasite within infected cells
induces a highly specific dysregulation of MHC class II
expression.
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Tabic 3. Cytokine gene expression assayed by limiting cycle polymerase
chain reaction (PCR)
Cytokine T.a 12929 Clone I Clone L Clone G
d-actin 20 20 20 20
IL-lo 24 26 20 24
IL-1/3 20 24 20 20
IL-6 24 24 20 22
IL-10 30 28 24 NP
TNF-Q 22 28 20 NP
IFN-y 30 NP NP NP
The cycle number at which the PCR product becomes visible is given
above. NP, The product was not visible after 30 PCR amplification cycles.
Parent
Fig. 5. Limiting cycle reverse transcription-polymerase chain reaction
(RT-PCR) analysis of /3-actin, IL-la. IL-18 and IL-6 expression for
clones I, G. L and T.a 12929.
In this study we have shown that cells infected with T.
annulata constitutively produce mRNAs for a number of
macrophage-associated cytokines, including IL-lct, IL-1/3,
IL-6, IL-10 and TNF-a. By isolating a number of T.
annulata-infected clones and carrying out limiting cycle
RT-PCR, we were able to show that the levels of T cell
proliferation induced by infected cells correlated with the
levels of expression of the T cell stimulatory cytokines, IL-la,
IL-1/3 and IL-6. Clone L, which expressed the highest levels of
these cytokines, induced the highest levels of T cell prolifera¬
tion. In contrast, clone G, which expressed lower levels of these
cytokines, induced less proliferation, despite expressing 15
times more MHC class II molecules than clone L, and clone
I, which expressed the lowest levels of these cytokine mRNA
species, induced the lowest levels of naive autologous T cell
proliferation.
A T cell line infected with the related parasite T. parva
produced a dilferent range of cytokine nrRNAs, including
IL-la, IL-2, IL-4, IL-10 and IFN-*y. The production of IL-
la by the T. parva-infected cell line is surprising, as T cells
do not normally produce this cytokine [19], Cells infected
with either of these parasites induce contact-dependent pro¬
liferation in naive autologous T cells [5,7], suggesting that
these parasites share a common mechanism for the
stimulation of T cells. The presence of IL-la mRNA in both
types of infected cells suggests that this cytokine is the most
important in the induction of T cell proliferation by infected
cells.
The induction of T cell proliferation also depended on the
state of growth of the infected cells. If the infected cell lines or
clones were not passaged 24 h before the non-specific prolif¬
eration assay was initiated, the levels of T cell proliferation
observed were considerably reduced (data not shown). This
suggests that the ability of the infected cells to induce T cell
proliferation may relate to the growth phase of the cell, as
passaging the culture 24 h earlier stimulated growth of infected
cells.
We have previously shown that non-specific activation of T
cells also occurs in vivo [5]. During T. annulata infection, T cell
blasts are found surrounding foci of macroschizont infected
cells in the lymph nodes draining infection. These cells are
unlikely to be stimulated by classical antigen-presentation
mechanisms, as they appear within 2 days post-infection. Our
data suggest that the primary mechanism by which T. annulata
induces T cell activation in vivo is through the production of T
cell stimulatory cytokines by the infected cells.
Cells infected with T. annulata also produce high levels of
inflammatory cytokines, especially TNF-a. This cytokine is a
potent inducer of fever and has also been linked to the
8Q 1995 Blackwell Science Ltd, Clinical and Experimental Immunology, 102:507-514
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production of anaemia, muscle wasting and necrosis [20,21],
These symptoms are observed in acute cases of tropical theiler-
iosis. Although the anaemia and fever observed have been
linked to the formation of piroplasms in erythrocytes, followed
by the lysis of the infected cells, there are documented cases
where infections have proved fatal before the detection of
piroplasms [22], In addition, the cell line infected with T. parva
does not produce mRNA specific for TNF-a, and T. parva
infections are not characterized by high levels of anaemia [23],
We suggest that the production of TNF-a by the T. annulata-
infected cells directly causes the pathological reactions observed
during T. annulata infections.
Analysis of the parent cell line showed that I FN-7 mRNA
was produced on two out of five occasions, but none of the
clones or other cell lines assayed was found to produce mRNA
specific for this cytokine. Although high levels of IFN-7 are
detected in the efferent lymph during T. annulata infection
[24], the IFN-7 produced presumably originates mainly from
T. annulata-stimvilated T cells and not from the infected cells
themselves. We have shown that T cells stimulated by T. annulata-
infected cells in vitro produce IFN-7 mRNA (J. D. M. Camp¬
bell, manuscript in preparation). The production of IFN-7 by
activated T cells may exacerbate the infection by stimulating
macrophages to produce more TNF-a and so increase fever.
In conclusion, infection of leucocytes with the related
parasites, T. annulata and T. parva, induces the secretion of
numerous cytokines by the infected cells. Theileria annulata
induces the production of various T cell-stimulatory and
inflammatory cytokines which may be responsible for the
immunopathological symptoms observed during infection.
Also, the production of a range of antagonistic cytokines
such as IL-1 and 1L-10 in vivo [25,26] may reduce the efficiency
of immune responses against infected cells, whereas the pres¬
ence of certain cytokines (such as IL-1 and IFN-7) may
promote the development of infected cells. Alteration of cyto¬
kine expression is also seen in leishmania-infected macrophages
[27,28]. However, this parasite appears to down-regulate
production of several cytokines, including IL-la, IL-6, IL-10
and IL-12 [27,28],
We plan to investigate the cytokine profiles of attenuated
and virulent lines as the levels of cytokine expression may relate
to the pathology induced by these cell lines. The low levels of
cytokine mRNA and low T cell stimulatory ability found in
clone I and the lack of TNF-a produced by clone G may mean
that these are possible candidates for use as cell line vaccines.
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Brief communication
Theileria annulata sporozoite targets
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SUMMARY INTRODUCTION
Bovine peripheral blood mononuclear cells (PBM)
infected in vitro with Theileria annulata sporozoites
have previously been characterized as MHC class 7/+
mature macrophages. The ability of T. annulata sporo¬
zoites to infect different subpopulations ofMHC class II+
bovine monocytes was investigated. Cells were labelled
with monocyte specific monoclonal antibodies (MoAb)
and isolated using magnetic cell sorting (MACS). Spor¬
ozoites infected both immature andmature monocytes, but
more readily infected the mature population. A potential
ligandfor sporozoite entry is the elastin receptor which is
expressed mainly on the immature population of mono¬
cytes and not on B cells or T cells. T. annulata sporozoites
infected elastin receptor positive and negative cell popula¬
tions equally well. Infected immature cells lost the expres¬
sion of elastin receptors and the immature marker,
subsequently expressing the mature marker. All mono¬
cytes lost the expression of CD14 (the LPS receptor)
upon infection with sporozoites. The infection of specific
populations and subsequent alterations in phenotype may
alter the function of these cells andplay an important role
in disease pathogenesis.
Keywords T. annulata monocytes, FACS analysis,
MACS separation, limiting dilution
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Theileria annulata is a tick transmitted protozoan para¬
site which affects cattle in Southern Europe, North
Africa, India, the Middle East and Southern Russia,
causing tropical theileriosis, a life threatening disease.
We have shown in vitro that sporozoites invade major
histocompatibility complex (MHC) class II+ cells, parti¬
cularly cells of the macrophage/monocyte lineage and
also, though much less efficiently, B cells (Spooner et al.
1989, Glass el al. 1989). Whatever the origin of the initial
infected cell, all cell lines apparently had a similar
phenotype as judged by the available markers. Infected
cells were nonspecific esterase"1" plus MHC class II+ and
surface IgM" and T cell marker" (Spooner et al. 1988,
1989, Glass & Spooner 1990). The monoclonal antibody
(MoAb) IL-A24 detects a determinant on macrophages
associated with antigen presentation (Ellis et al. 1987).
This ligand is also expressed upon sporozoite infected
cells, which can present antigen via MHC class II (Glass
& Spooner 1990).
Distinct ligands upon the surface of the target cells
may be required for sporozoite attachment and invasion.
Identification of these ligands and further characteri¬
zation of the primary cells which sporozoites infect
could be of prime importance in understanding the
pathogenesis of this disease and the variation seen in
responses to currently used cell line vaccines (Ouhelli et
al. 1989).
This study extends our previous findings and more
fully characterises the phenotype of cells infected by T.
annulata, using three recently available MoAbs to ,
potentially relevant surface antigens. The MoAbs are
IL-A109, VPM65 and BCZ.
IL-A109 recognizes monocytes and macrophages
and is thought to recognize an antigen analogous
to CD64 (FcRl) (MacHugh, McKeever & Goddeeris
1990).
VPM65 recognizes ovine CD14 (VK Gupta, personal
communication) and crossreacts with bovine macro-
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phages and B cells, although cell sorting using this MoAb
isolates only monocytes/macrophages (see below)
(D.J.Brown, unpublished observations). In humans,
CD14 is a 55kDa glycoprotein expressed as a cell
surface molecule on macrophages and a small popula¬
tion of B cells, and acts as a receptor for LPS (reviewed in
Zeigler-Heitbrock & Ulevitch 1993).
BCZ recognizes the elastin receptor (Mecham et al.
-1989). Elastin binds to its receptor via a repeating
hexapeptide: Val-Gly-Val-Ala-Pro-Gly (VGVAPG)
(Mecham et al. 1989). Recently, the gene coding for a
T. annulata sporozoite surface antigen (SPAG-1)
involved in invasion of cells has been isolated, expressed
in E. coli (Williamson et al. 1989), and found to contain
VGVAPG (Hall et al. 1992). Thus the elastin receptor is a
candidate ligand for sporozoite binding.
Using these novel MoAbs, bovine monocyte/macro¬
phage cells from PBM were characterized, their sus¬
ceptibility to sporozoite infection assessed, and the
subsequent phenotype of the infected cells examined.
Characteristics of peripheral blood monocyte populations
Peripheral blood mononuclear cells (PBM) from Fresian
cows were obtained by Ficoll-Hypaque separation
(Spooner et al. 1989). T. annulata does not infect T
cells (Spooner et al. 1989, Glass et al. 1989), and
preliminary studies showed that CD4+ and CD8+ T
cells are not stained by BCZ, VPM65, IL-A109 or IL-
A24 (results not shown). In order to enrich cells of
interest in PBM, T cells were removed by lysis with
MoAbs CC8 (CD4) and CC63 (CD8) (Howard et al.
1991), and rabbit complement (Seralab) according to the
method of Teale et at. (1986). The resulting T cell"
population was enriched for B cells and monocytes.
T cell-PBM were stained by indirect immuno¬
fluorescence and analysed with a FACScan essentially
as described previously (Glass & Spooner 1990). Double
staining was performed by first incubating with both
MoAbs (of different isotypes) followed by appropriate
fluorescent secondary reagents: Goat anti mouse (GAM)
IgM-FlTC; GAM IgG-PE (Sigma, Poole, UK); GAM
IgGrFlTC; GAM IgG2a-PE (Seralab).
The size of the populations stained by the MoAbs was
determined by the cells' forward scatter (FSC) upon the
FACScan. The majority of IL-A109+ monocytes were
small monocytes (mean FSC = 33; Figure la) whereas
IL-A24t monocytes were large (mean FSC = 77; Figure
lb). VPM65 recognized both 1L-A109+ and IL-A24+
cells. MACS sorted VPM65+ cells (see below) contained
three distinct populations in terms of size—small, inter¬
mediate and large monocytes respectively (see Figure
Id). Phenotyping of these cells confirmed that three
distinct phenotypes were present IL-A109+/IL-A24~
(small); IL-A109+/IL-A24+ (intermediate); IL-A109~7
IL-A24+ (large). It is likely that the small IL-A1094"
monocytes are immature, becoming larger and IL-
A24+ upon activation and maturation.
BCZ stained approximately 16% of T cell depleted
PBM, and the majority of these cells (82%) had a
distinctive low FSC (mean FSC = 31; Figure lc) similar
to IL-A109+ cells. Double staining with BCZ and
macrophage markers revealed that this population was
identical to the IL-A109+/IL-A24~ cells described above.
The remainder of the BCZ+ cells were contained in both
IL-A24+ populations. B cells were negative for BCZ
(results not shown). Thus the elastin receptor is mainly
expressed on a discrete population ofmonocytes and not
T or B cells in peripheral blood.
Purification and infection of monocytes
The populations identified by BCZ, VPM65 and IL-
A109 were purified using magnetic cell sorting (MACS
sorting: see Miltenyi et al. 1990 for a review of this
method), of T celF PBM. The cells were labelled using
either VPM65 or BCZ at 1/100 dilution of ascitic fluid,
followed by the appropriate MACS bead conjugate (e.g.
rat anti-mouse IgGl). The magnetic cells were run
through the column twice, and the purity of the
separated cells was always > 90%, and usually > 95%.
Insufficient IL-A109 was available for MACS sorting.
Therefore IL-A109+ monocytes were produced by nega¬
tive selection in the following way: B cells and T cells
were removed by MACS sorting using IL-A30, CC15,
CC8 and CC63 (anti slgM, WC1, CD4 and CD8
respectively. Howard et al. 1991). The resulting pure
monocytes were subsequently MACS sorted using IL-
A24. The IL-A24" population was 100% IL-A109"1" and
is referred to in the text as IL-A109+.
The positive and negative cell populations obtained
were infected with sporozoites of T. annulata (Gharb &
Ankara strain) (Brown 1987) in log3 dilutions, and
infection was assessed as previously described (Spooner
et al. 1989). Frequencies of cells which were transformed
were calculated according to Lefkovits & Waldmann
(1979) and Brett, Kingston & Colston (1987). Statisti¬
cally significant differences between cell populations were
calculated using analysis of variance. Transformation
frequencies of the sorted cells are detailed in Table 1.
Although T cell depleted PBM (T cell ) were not
significantly more infectable than PBM (P <()•!),
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Figure 1 FACS analysis of T cell depleted PBM and CD 14" MACS sorted cells, a-c: Dot plots of T cell depleted PBM stained with a—
IL-A109. The majority of cells (arrow) have a low forward scatter (FSC). Mean FSC = 33. b—IL-A24. Stained cells (arrow) have a much
larger mean FSC (77) than IL-A109+ cells, c—BCZ. The majority of BCZ" cells (arrow) have a similar mean FSC (31) to IL-A109.
Positive/negative regions are set upon negative controls, d—FSC v. SSC contour plot of VPM65" MACS sorted cells showing small (S),
intermediate (I) and large (L) cells.
removing T cells did substantially increase the precursor
frequency of infectable cells. Both BCZ+ and BCZ" cells
were highly infectable with T. annulata. Thus although the
elastin receptormay be a ligand for sporozoite attachment
it certaintly is not the only ligand. Sporozoites efficiently
infected CD14+ cells, IL-A24+ monocytes and IL-A24"
monocytes but not CD14" cells (primarily B cells). Taken
together, these results confirm the parasite's marked
preference for bovine monocytes. We have previously
shown that IL-A24+ cells are major targets for T. annu-
lata with a very high infection frequency (1:9 within an
individual experiment) (Glass et al. 1989). The results in
this paper show that T. annulata preferentially infects
these mature monocytes, although it also efficiently
infects the more immature IL-A109+ monocytes. Many
monocytes within bovine lymph nodes are IL-A109+
(J.Campbell, S.Howie, E.Glass, manuscript in prepara¬
tion). As the draining lymph node is a major site of
parasite development in vivo the demonstration of cells
within lymph nodes which are potentially infectable with
sporozoites is an important finding.
FACS analysis of sporozoite infected cell lines
Cell lines generated from the above cell subpopulations
were phenotyped once sufficient infected cells had
grown—usually within two weeks. All cells lines were
from individual 200 wells but not necessarily clonal.
All cell lines produced from in vitro infections had the
phenotype 100% IL-A24"1" and MHC class II+. These
results are similar to those reported previously (Spooner
et al. 1989, Glass et al. 1989). Thus even the cell lines
derived from the IL-A109+ population had become IL-
A24+. Only one of three IL-A109+ cell lines examined
contained any IL-A109"r/IL-A24+ cells (approximately
25%). Within ten days of first being analysed, this line'
became IL-A109". All infected cells were found to be
completely negative for CD 14 despite this marker being
expressed on all monocytes and the CD14+ cells being
> 95% VPM65+ when infected. In addition, four
T. annulata infected cell lines derived previously from
in vitro infection of PBM had similar phenotypes (results
not shown). None of the lines expressed CD14 as
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Table 1 Frequency of cells transformed by T. annulata as
determined by limiting dilution analysis
Cell Frequency of
Experiment population transformed cells P value Parasite
PBM 1:1055 a











'Within each experiment the same letter denotes no significant
difference between frequencies; different letters denote significant
differences between frequencies (P < 0 05).
& Spooner 1990). We are currently investigating some of
these phenotypic changes as they may play an important
role in the pathogenesis and outcome of the disease.
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detected by VPM65. Low numbers of IL-A109+ and
BCZ+ cells were detected in two of the cell lines (11%
and 18%) and this expression was only seen at low
passage. Thus it appears that whatever the initial
phenotype of the monocytes infected, infected cells
become IL-A24+, IL-A109", BCZ" and VPM65".
Since expression of the determinant recognised by IL-
A109 and elastin receptors appears to be restricted to
immature monocytes, this evidence suggests that sporo-
zoite infection and subsequent transformation may
induce differentiation to a specific phenotype similar to
mature monocytes with concomitant loss of 'immature'
markers. Alternatively, since the infected cells were not
clonal, IL-A24+ cells may be the only cells transformed,
subsequently out growing all others. We favour the
former, as the loss of CD 14 expression shows that
sporozoite infection does induce phenotypic change. As
IL-A109+ cells were produced by removing IL-A24+
cells, infection cannot be attributed to 1L-A109+/IL-
A24+ cells. In addition, the 12% of IL-A24+ cells in
PBM (see Figure lb) gave a precursor frequency of
1:330, the precursor frequency of 1 :52 observed in the
IL-A109+ cells would require an extremely high number
of contaminating IL-A241" cells.
The loss of particular markers may alter the function
of parasitized monocytes. For example the loss of FcR
may affect the cell's ability to take up antigen and the loss
of CD 14 may alter the ability of parasitized cells to
respond to activation through the LPS receptor path¬
way. Indeed, we have previously shown that parasitism
by T. annulata alters antigen presenting function (Glass
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Sutherland, I. A., Shiels, B. R., Jackson, L., Brown. D. J., Brown, C. G. D., and Preston,
P. M. 1996. Theileria annulata: Altered gene expression and clonal selection during continuous in
vitro culture. Experimental Parasitology 83, 125-133. Kept in continuous in vitro culture, the pro¬
tozoan parasite Theileria annulata gradually loses virulence when inoculated into cattle. These
attenuated cell lines form the basis of the in vitro live vaccines which have been used successfully
to control tropical theileriosis in several endemic regions. In the study reported here, events occurring
during in vitro culture of an Indian (Hisar) cell line, which may be associated with the reduction in
virulence, have been investigated. Hybridization with two polymorphic DNA probes following
Southern blotting showed that selection of particular parasite genotypes occurs very rapidly with
culture; a novel hybridization pattern is observed with both probes after 50-100 passages in vitro. In
addition to this selection process, immunofluorescence studies using a monoclonal antibody which
specifically recognizes virulent T. annulata revealed alterations in antibody reactivity following in
vitro culture. This loss of reactivity was observed in three cloned cell lines derived from the early,
virulent Hisar line and implies that phenotypic changes resulting from alterations to parasite gene
expression are taking place during the attenuation process. When considered with the results from in
vivo infections with serial passages of this cell line, it can be proposed that both altered gene
expression and selection may be involved in the loss of pathogenicity of T. annulata during con¬
tinuous in vitro culture. © 1996 Academic Press, Inc.
Index Descriptors and Abbreviations; Theileria annulata; attenuation; selection; gene expres¬
sion.
Introduction
The apicomplexan protozoan parasite Theile¬
ria annulata is the causative agent of tropical
theileriosis, an important constraint on cattle
production in Asia, north Africa, and southern
Europe (Purnell 1978). Transmission occurs via
feeding ticks, which inoculate the infective spo-
rozoite stage of the parasite. Sporozoites invade
mononuclear leucocytes which subsequently
become immortalized to divide in synchrony
with the parasite macroschizonts (Hulliger
1965; Jura et al. 1983). Further development of
the parasites into merozoites results in the de¬
struction of the host leucocytes (Melhorn and
1 To whom correspondence should be addressed at AgRe-
search Grasslands, Private Bag 11008, Palmerston North,
New Zealand.
Schein 1984) and invasion of the red blood
cells, followed by differentiation into the tick-
infective piroplasm stage (Conrad et al. 1985).
The ability of the parasites to immortalize
host mononuclear cells makes it possible to
grow T. annulata in continuous in vitro culture
without the addition of external growth factors
(Brown 1980) This continuous passage results
in attenuation of the pathogenicity of the disease
following parenteral administration of infected
mononuclear cells to cattle (Pipano 1981). The
observation that these attenuated cell lines con¬
tinue to afford protection from heterologous
challenge has been used in the development of
live attenuated vaccines (Subramanian et al.
1986). This method of vaccination, however,
has drawbacks, not least in the length and ex¬
pense of the development period and the neces-
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sity to develop vaccine cell lines for each geo¬
graphical area, due to restrictions on the move¬
ment and administration of bovine material.
/While the process of attenuation is well es-
' tablished and documented in T. annulata, little
is known of the molecular mechanisms in¬
volved. In other apicomplexan protozoa, both
the selection of avirulent subpopulations and
marked genomic rearrangement have been re¬
ported as resulting in a reduction of virulence.
In Babesia bovis, a live attenuated vaccine was
obtained following rapid syringe passage in
splenectomised calves. This is known to be as¬
sociated with the progressive enrichment of a
minor, avirulent subpopulation present at low
levels in the original isolate (Cowman et al.
1984; Carson et al. 1990) and it is assumed that
the selection process favours rapidly growing
subpopulations (Carson et al. 1990). In Plasmo¬
dium berghei, however, large chromosomal de¬
letions occur following continuous in vivo
asexual multiplication which have a profound
effect on cytoadherence and gametocytogenesis
of the parasites (Janse et al. 1992). As this
would result in reduced pathogenicity of the
parasites, it is possible that such alterations lead
to attenuation. In T. annulata, while no evi¬
dence has been presented indicating an associa¬
tion between genetic alterations in the popula¬
tion with loss of virulence, observations of the
selection of subpopulations are available. It has
been demonstrated that T. annulata cell lines
contained a number of isotypes of glucose phos¬
phate isomerase (GPI) and that both the parent
lines following continuous in vitro culture and
cloned cell lines derived from the original popu¬
lation contained a single isotype of the enzyme
(Melrose et al. 1991).
It may be hypothesised, however, if selection
of avirulent subpopulations is occurring in T.
annulata, that this may not be entirely respon¬
sible for attenuation. The observation that cell
lines continue to lose virulence and eventually
infectivity when cultured over long periods of
time (Preston, unpublished data) suggests the
involvement of a further process, such as altered
gene expression, in the loss of virulence. No
evidence for altered gene expression has been
available in T. annulata. A reduction in the level
of production of metalloproteases by infected
cells following culture has been reported (Bay-
lis et al. 1992). It was not shown, however,
whether this reduction was due to population
selection or alterations in the control of parasite
or host cell gene expression.
In this study, different passages of an Indian
(Hisar) cell line were compared using indirect
immunofluorescence and Southern blotting. Al¬
terations associated with in vitro culture were
then correlated with data generated following in
vivo infection with different passage numbers of
this cell line in an attempt to define the molecu¬
lar and cellular events linked to the attenuation
of this parasite.
Materials and Methods
Lymphoblastoid cell lines. The T. annulata Hisar S45 cell
line used in these experiments was derived from the periph¬
eral blood of calves infected with an Indian (Hisar) cell line
as described by Brown (1980). Cell lines were maintained in
continuous in vitro culture at 37°C, 5% C02 in RPMI 1640
(Gibco) containing 10% foetal calf serum (FCS) (Gibco)
and 2 mM glutamine. 100 p.g/ml streptomycin, 100 gig/ml
kanamycin, 100 units/ml penicillin (all Sigma) and buffered
with 2 mM Hepes, pH 7.2. Cloned cell lines were derived
from passage 4 of the parent cell line by limiting dilution.
Cells were serially diluted in 96-well flat-bottomed plates
with conditioned medium removed from the parent cell cul¬
ture. Wells in which growth occurred but which were bor¬
dered by empty wells were then maintained in vitro. To
confirm that the lines were indeed clonal, GPI patterns were
compared with those of the parent cell line (Melrose et al.
1991). Following infection of calves with serial passages of
Hisar S45, cell lines were established from infected cattle as
above (Brown 19S0).
Assessment ofpathogenicity in cattle. Passages 5, 50, and
128 of Hisar S45 were used to infect groups of Hereford/
Freisan cattle of various ages. Each calf was inoculated by
syringe with 5 x 106 macroschizont-infected cells subcuta-
neously in the right shoulder. Blood samples were taken at
regular intervals and examined for the presence of macro-
schizonts and piroplasms in the peripheral blood. Rectal
temperatures were taken daily to determine the onset of
clinical disease. Cell lines were established from infected
animals and used in immunofluorescenl studies.
Analysis of restriction patterns. Southern blotting was
performed using standard protocols (Southern 1975) follow¬
ing FcoRI digestion. Macroschizont dna from serial pas¬
sages of the Hisar S45 parent cell line, from early passages
of clones 3,21, 54. and 66 and from passages 5 and 25 of
clones 18 and 49 was compared following hybridization
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with two polymorphic cDNA probes. Probe Tarns 117 rec¬
ognizes the gene encoding a major internal merozolte anti¬
gen while Tarns 30 recognizes the gene encoding a 30-kDa
merozoite surface antigen (Shiels et al. 1994). To determine
whether any novel restriction pattern observed was present
in a mixed Hisar infection, piroplasm DNA from a T. an¬
nulate! Hisar-infecled cow was included in the analysis.
Monoclonal antibodies. Monoclonal antibody (mAb)
EL'106 was prepared using a standard protocol (Pearson et
al. 1980) following intraperitoneal inoculation of mice with
Hisar S45 passage 3, three times at I I-day intervals (5 x 106
cells). Four days after the final boost, spleen cells from the
mice were fused with NSO myeloma cells. Resulting hy-
bridomas were selected in hypoxanthine/aminopterin/
thymidine (HAT) medium. Culture supernatants of antibody
producing hybrids were collected and stored at —70°C until
required.
Indirect fluorescent antibody test (IFAT). Fixed cell
preparations were prepared using standard protocols (Shiels
et al. 1986). Cells were washed twice in phosphate-buffered
saline (PBS), pH 7.2, and fixed with 3.7% paraformalde¬
hyde in PBS at a density of 5 x 107 cells/ml on ice for 10
min. Cells were then washed three times in PBS, spotted
onto multiwell slides, and air dried at 37°C for 2 hr. To test
for reactivity, mAb EU106 was added in 10-/xl volumes to
wells. Following a 30-min incubation at ambient tempera¬
ture. slides were washed three times in PBS. Fluorescein-
isothyocyanate (FITC)-conjugated sheep anti-mouse IgG
(SAPU) diluted 1:40 with PBS was then added to each well
and the slides were incubated in the dark at room tempera¬
ture for 30 min. Following three washes in PBS, slides were
mounted in 25% glycerol in PBS and examined by fluores¬
cence microscopy (Leitz Dialux 2000).
Results
Assessment of pathogenicity in cattle. Pas¬
sages 5, 50, and 128 of the Hisar S45 cell line
were used to infect groups of cattle, followed by
monitoring of the blood for the appearance of
macroschizonts and piroplasms. Those calves
inoculated with passage 5 developed severe
clinical reactions. Two of the four calves in this
group were humanely destroyed. None of the
cattle inoculated with either passage 50 or pas¬
sage 128 of Hisar S45 developed severe symp¬
toms (Preston, unpublished data). The measure¬
ment of the time to appearance of piroplasms in
the peripheral blood was found to be a good
indicator of virulence reduction of the cell line
following passage in vitro. In calves inoculated
with passage 50, the mean time to detection of
piroplasms was 16 days, while the figure for
those calves given passage 128 was 17.75 days
(Table I). No significant lengthening of the time
to detection of macroschizonts was observed
between the passages, although two out of four
calves inoculated with passage 128 did not pro¬
duce detectable levels of macroschizonts in the
bloodstream. In those calves given passage 5,
piroplasms were detected in the bloodstream of
each 7 days postinfection.
TABLE I
Period to the Detection of Macroschizonts and Piroplasms in the Pe¬
ripheral Blood of Cattle Infected with Serial Passages (5, 50. and 128) of
T. annulata Hisar S45.
Time to detection (days)
Cell line Passage No. CALF No. MACROSCH. PIROS.
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Fig. 1. (a) Restriction pattern of serial passages and
clones ofHisar S45 and piroplasm DNA from a mixed Hisar
infection following Southern blotting and hybridisation with
cDNA probe Tamr 117. 1, S45 passage 5; 2, S45 passage
12; 3, S45 passage 25; 4, S45 passage 50; 5, S45 passage 80;
6, S45 passage 100; 7, S45 passage 128. (b) Restriction
pattern of serial passages and clones of of Hisar S45 and
piroplasm DNA from a mixed Hisar infection following
Southern blotting and hybridisation with cDNA probe Tarns
30. 1, S45 passage 5; 2, S45 passage 25; 3, S45 passage 50;
4, S45 passage 128.
Analysis of restriction patterns. The compari¬
son of restriction patterns following hybridiza¬
tion with both of the polymorphic cDNA probes
showed that significant alterations took place
during in vitro passage of Hisar S45. Following
hybridization with Tamrll7, the early, virulent
passage of the cell line displayed two restriction
fragments of 21 and 2.6 kb. This pattern was
altered by passage 12 to three fragments of 2.1.
2.6, and 5.9 kb and by passage 50 to a single
fragment of 5.9 kb. This novel pattern was
maintained up to passage 128 (Fig. la). An al¬
teration in banding pattern was also observed
following hybridization with Tams30. From a
single visible band of 5.5 kb at passage 4. the
pattern was altered to two bands of 5.5 and 4.1
kb by passage 12, to three bands of 5.5, 5.2, and
4.1 kb by passage 50, and to a single band of 4.1
kb by passage 128 (Fig. lb). As it has been
established that parasite populations derived
from cattle consist of a mixture of subpopula-
tions (Melrose et al. 1991), it was decided not
only to confirm the heterogeneity of the popu¬
lation of the early, virulent parental cell line, but
also to attempt to isolate clones with a restric¬
tion pattern similar to the later passages of this
cell line. Furthermore, cloned cell lines would
be used to determine whether alterations in re¬
striction patterns occurred in cloned cell lines as
well as in the parent population. Of the clones
examined, each had a single restriction frag¬
ment of either 2.1 or 2.6 kb following hybridi¬
sation with Tamrll7, with the exception of
clone 18, which had a single fragment of 3.3 kb.
The two smaller fragment sizes are represented
in the early passage of the parent cell line while
passage 12 of the parent line contains a frag¬
ment of 3.3 kb. Clone 3, passage 4, had a single
fragment of 2.1 kb, while clones 21, 49, and 52
(passage 4) had a single fragment of 2.6 kb.
Passages 25 of clones 18 and 49 were also ex¬
amined for alterations in restriction patterns
with culture. Clone 18 had a single band of 3.3
kb at both passage numbers; however, at pas¬
sage 25, the single fragment of 2.6 kb seen in
clone 49 at passage 4 had altered in size to 5.9
kb (Fig. 2a). A similar alteration of fragment
size in clone 49 was also observed following
hybridisation with Tams30, in this case from a
single band of 5.5 kb to one of 4.1 kb. Clone 18
had a single fragment of 4.1 kb after both pas¬
sage 4 and passage 25 in vitro (Fig. 2b).
As none of the clones examined were ob¬
served to have a restriction fragment of 5.9 kb
following hybridisation with Tamrll7 at the
earliest passage examined, the possibility ex¬
isted that this fragment represented a novel re¬
arrangement due to long-term in vitro culture
and which may be associated with the observed
loss in virulence. To determine whether this was
the case, piroplasm DNA derived from cattle
infected with a mixed Hisar infection was ex¬
amined to determine whether this fragment was
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Fig. 2. (a) Restriction pattern of clones 18 and 49 (pas¬
sages 4 and 25) following Southern blotting and hybridisa¬
tion with cDNA probe Tamr 117. 1, Clone 18, passage 4; 2,
Clone 18, passage 25; 3, Clone 49, passage 4; 4, Clone 49,
passage 25. (b) Restriction pattern of clones 18 and 49
(passages 5 and 25) following Southern blotting and hy¬
bridisation with cDNA probe Tarns 30. 1, Clone 49, passage
5; 2, Clone 49, passage 25; 3, Clone 18, passage 5; 4, Clone
18, passage 25.
in fact due to culture conditions or preexisted in
an in vitro parasite population. Southern blot¬
ting showed that the RFLP of 5.9 kb associated
with macroschizont cultures following long-
term passage was represented in piroplasm
DNA following hybridisation with Tamrll7
(Fig. 3) and was therefore unlikely to be a novel
rearrangement.
Indirect fluorescent antibody tests. Monoclo¬
nal EU106 was used on fixed slides of serial
passages of the parent Hisar S45 cell line, and
also on serial passages of three clones derived
from the early passage of the parent line. Re¬
sults presented in Table II are expressed as a
percentage of cells staining for parasite schiz-




Fig. 3. Comparison of restriction size of passage 128 of
Hisar S45 with piroplasm DNA from a mixed Hisar infec¬
tion following hybridization with either Tarns 30 or Tamr
117. 1, Piroplasm Tarns 30; 2, S45 pi28 Tarns 30; 3, Piro¬
plasm Tamr 117; 4, S45 p 128 Tamr 117.
the parent line, however, 100% of schizonts
showed positive, strong fluorescence (Fig. 4).
Following culture, this reactivity was progres¬
sively lost until no fluorescing schizonts were
observed in preparations of cells at passage 50
(Table II). When serial passages of the three
clones were examined for reactivity with the
antibody, 100% of schizonts were stained in
each of the early passages. In clone 18, this
reactivity was rapidly lost with passage; no
schizonts were stained on slides prepared with
passage 10 of the cloned line. Reactivity of
TABLE II
Percentage of Schizonts of Serial Passages of Hisar S45
and Clones Derived from Passage 3 of the Parent Line
Stained Positive with mAb EU106 Following IFAT
% Positive
Cell line Passage No. with EU106








Clone 18 Passage 5 100
Passage 10 0




130 SUTHERLAND ET AL.
Fig. 4. Fluorescing schizonts of Hisar S45 passage 5 following IFAT using mAb EU106.
clones 3 and 54 with EU106 was also lost with
passage, although the process took significantly
longer than in clone 18. In both clones, around
50% of schizonts were stained in slides pre¬
pared from passage 25 while reactivity was
completely lost by passage 50.
DISCUSSION
While the attenuation of T. annulata follow¬
ing maintenance in continuous in vitro culture is
well documented (Brown 1980; Subramanian
1986) it was unknown whether the loss of viru¬
lence was due to the selection of preexisting
avirulent subpopulations of the parasite or to
genetic alteration of a parasite type within the
population, presumably followed by the selec¬
tion and predominance of the altered genotypes.
Both alternative mechanisms have been shown
to occur in apicontplexan parasites, leading to
an actual or proposed reduction in virulence. In
B. bovis, the gradual enrichment of an avirulent
subpopulation has been observed, and this is
presumed to be a result of faster growth rate of
this parasite type during passage in splenec-
tomised calves (Carson, et al. 1990). In P.
berghei, however, rapid asexual multiplication
in vivo results in the deletion of regions of the
parasite chromosomes, which adversely affects
cytoadherence and gametocytogenesis (Janse et
al. 1992). These faster growing mutants are then
selected in culture and are considered to be less
virulent. Previous observations of alterations in
lines of T. annulata kept in continuous in vitro
culture (Melrose et al. 1991; Bay lis et al. 1992)
and the study by Shiels et al. (1992), where
cloned lines with differing ability to differenti¬
ate were represented by distinct genotypes pro¬
vided circumstantial evidence that selection of
parasites with different virulence phenotypes
may be taking place, but little indication that
any alteration of gene expression may occur.
The aim of the present study was therefore to
compare serial passages of a cell line to provide
evidence that either of these processes was as¬
sociated with, if not responsible for, attenuation
of the parasite.
When serial passages of Hisar S45 were used
to infect cattle, it was apparent that virulence
was being lost with in vitro passage. As the
passages used to infect the cattle were available
in the laboratory, a good comparison was pos¬
sible between the amelioration of pathogenicity
and molecular alterations observed in vitro.
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While detailed clinical measurements of fever
and parasitemia are not reported here, the time
to appearance of macroschizonts and piro-
plasms in the peripheral blood was found to
provide a good indication of virulence. It should
be noted, however, that in addition to a length¬
ening of the period to detection of the parasites,
2/4 calves infected with passage 5 developed
terminal infections (Table I). While it would be
interesting to evaluate the virulence of interme¬
diate passages, the results imply that a major
part of the virulence has already been lost by
passage 50.
Comparison of the passages of this cell line in
vitro has demonstrated a number of differences
that are correlated with the reduction in viru¬
lence observed in vivo. Evidence of whether se¬
lection and/or alterations in gene expression are
responsible for these alterations was also ob¬
tained. Following Southern blotting of rnacro-
schizont DNA, hybridisation with two polymor¬
phic cDNA probes showed that rapid selection
of minor subpopulations occurs during continu¬
ous passage of T. annulata. The restriction pat¬
tern observed following hybridisation with
cDNA probe Tamrl 17, which recognises a gene
encoding a merozoite rhoptry protein (Shiels et
al., 1994), showed that the initial population of
Hisar S45 consisted primarily of two popula¬
tions with single restriction fragments of 2.1
and 2.6 kb. From the initial two bands, the pat¬
tern was altered to show three fragments of 2.1,
2.6, and 5.9 kb by passage 12, four bands of 2.1,
2.6, 3.3, and 5.9 kb by passage 25, and finally a
single band of 5.9 kb by passage 50, a pattern
maintained at passage 128 (Fig. la). Similarly,
with probe Tams30, which hybridises with a
gene encoding a 30-kDa merozoite surface an¬
tigen (Shiels et at., 1994), an initial single frag¬
ment of 5.5 kb was replaced by two fragments
of 5.5 and 4.1 kb by passage 12, three fragments
of 5.5, 5.2 and 4.1 kb by passage 50 and a single
fragment of 4.1 kb by passage 128 (Fig. lb).
One possible explanation of these alterations is
that the novel fragments represent changes to
the restriction sites caused by genotypic alter¬
ations. However, it was also possible that very
minor preexisting subpopulations were being
selected during in vitro culture. For this reason,
a number of cloned cell lines, derived from the
early, virulent parent line, were examined by
Southern blotting. As expected, the majority of
clones contained one restriction fragment of ei¬
ther 2.1 or 2.6 kb following hybridisation with
Tamrl 17 (data not shown). It would appear,
therefore, that the virulent cell line primarily
consists of two major subpopulations. It is ap¬
parent, however, that at least one other subpop-
ulation is present, as clone 18 contains a frag¬
ment of 3.3 kb, a band size apparent by passage
12 of the parent cell line. None of the clones
examined contained a band of 5.9 kb, corre¬
sponding to the fragment observed in the late
passage of the parent cell line. This may be due
either to the selection of a subpopulation present
in the initial population at an undetectable level
using the analysis employed, or the production
of novel restriction fragments via a mechanism
of genetic rearrangement. Examination of serial
passages of clones 18 and 49 provided mixed
evidence for the possibility that a process other
than selection was occurring. While no changes
were observed in clone 18 by passage 25 in
vitro (vide infra), clone 49 showed an alteration
in banding patterns following 25 passages in
vitro, from a single band of 2.1 kb to one at 5.9
kb, similar to that observed in the later passages
of the parent cell line (Fig. 2a). Recent evidence
(Preston, unpublished data) from GPI analysis
has. however, suggested that this cell line is not
in fact clonal in nature and appears to have con¬
tained more than one genotype, at least at the
early passage. This does raise the question of
why, if more than one parasite genotype was
present in the early passages of clone 49, only
one band was observed after hybridisation. In
addition to the possibility of cross contamina¬
tion in the laboratory, other possible explana¬
tions may arise from the continual adaptation
and eventual selection pressure for in vitro
growth of one of the original genotypes, either
present in a second cell or possibly following
multiple infection of a single cell. /'
Furthermore, when the fragment sizes ob¬
tained with macroschizont DNA were com¬
pared with DNA derived from piroplasms ob-
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tained from an animal infected with Hisar spo-
rozoites of the parental cell line, bands identical
in size to the novel late passage fragments ob¬
served in macroschizont DNA were detected.
' As the probability is low that rearrangement
would occur to produce fragment sizes which
already existed in the Hisar stock, it would ap¬
pear likely that the results of the comparison of
restriction patterns from the serial passages il¬
lustrate the rapid selection of a minor subpop-
ulation of parasites present in the early passage
of the parent line.
Evidence of rapid selection was also appar¬
ently derived from immunofluorescence studies
using mAb Eul06. This antibody, which stains
both the parasite schizont, as seen by IFAT (Fig.
3), and the surface of the infected host cell,
visualised by FACS analysis (Preston, unpub¬
lished results), gradually loses reactivity for the
Hisar S45 cell line following in vitro culture
(Table II). Reactivity for the schizont and the
host cell are both lost around passage 50, when
the process of selection, as seen after hybridi¬
sation with Tamrl 17, is apparently complete,
although selection does appear to be still occur¬
ring from the results of hybridisation with
Tams30. However, while the loss or alteration
of this antigen from the parent cell line indi¬
cated the selection of a preexisting subpopula-
tion with no reactivity for the antibody could be
occurring, similar studies carried out using se¬
rial passages of three clones derived from the
early passage of the parent cell line established
that the process may be more complex. In all
three clones examined, reactivity for EU106
was gradually lost during in vitro culture from
both the parasite schizonts and the surface of the
infected cells. In clones 3 and 54, this loss of
reactivity progressed on a similar time scale to
the loss of staining in the parent line. In clone
18, however, in which the restriction pattern
seen with Tamrl 17 is unaltered by passage 25,
reactivity with EU106 is completely lost by pas¬
sage 10 (Table II). While no biological role has
been established for the antigen recognised by
EU106, and therefore no causative link estab¬
lished with a loss of virulence, an alteration in
gene expression during culture has been identi¬
fied. As reactivity is also lost from the parent
cell line during in vitro passage, it may be hy¬
pothesised that selection occurs through an ad¬
vantage in culture, such as increased prolifera¬
tion, in those parasites displaying alterations in
gene expression. Interestingly, it has recently
been found that a parasite cloned cell line which
shows limited ability to differentiate to the
merozoite in vitro has a reduced ability to up-
regulate gene expression in the initial phase of
the differentiation process (Shiels et al., 1994),
raising the possibility that similar mechanistic
events may be occurring in these two systems.
This alteration in gene expression seems to be
maintained following the infection of cattle and
the transfer of the parasite to a new host back¬
ground as cell lines derived from those cattle
infected with either passage 50 or 128 of Hisar
S45 do not react with the antibody (data not
shown). While on a genetic basis this is unsur¬
prising, as no sexual recombination has oc¬
curred, this observation lends weight to the
view that attenuation is primarily a function of
alterations in the parasite rather than the host
cell. However, it is unclear whether the alter¬
ation of these parasites is fixed genetically, and
whether the observed alterations are reversed
following tick passage, as has been observed
with attenuated lines of B. bovis (Carson et al.
1990)
While these observations have provided evi¬
dence that both selection and altered gene ex¬
pression occur during the continuous in vitro
culture of T. annulata, a number of questions
remain. While changes in the cultures have been
observed, these seem to occur too rapidly to
account for the continued loss of virulence over
long periods of time. Also, the direct relation¬
ship of these changes and previous observations
of reduced differentiation and production of
metalloproteases to the loss of pathogenicity is
not known. Furthermore, the relationship be¬
tween genetic alterations and selection remains
to be established, although the results presented
in this study suggest that parasites which have
an altered ability to control gene expression
may eventually predominate following continu¬
ous in vitro culture.
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SUMMARY
Theileria annulata is a protozoan parasite which infects and transforms bovine macrophages. Infected
macrophages possess augmented antigen presentation capabilities, as they are able to activate the
majority of T cells from unexposed animals. In vivo, T cells in the draining lymph node (principal site of
parasite development) are activated 'non-specifically' by the parasite. This event is followed by failure
of the immune response to control the infection. Protective immune responses against intra-macrophage
protozoa are usually mediated by T helper 1 (Thl) T cell responses. Here we examine the cytokine
responses made by T. annulata-activated T cells. We show that the outcome of in vitro activation of T
cells by parasitized macrophages is a skewing of their cytokine responses towards preferential
expression of interferon-gamma (IFN-7) ntRNA. The in vitro response is mirrored during in vivo
infection, as greatly elevated amounts of IFN-7 protein are found in lymph efferent from infected lymph
nodes, while expression of IL-4 ntRNA within the node stops. IFN-7 production does not correlate with
protection against the parasite, as infected cells flourish during peak IFN-7 production, and only very
small amounts of IFN-7 are produced during the effective immune response of an immunized animal.
Overproduction of IFN-7 and loss of IL-4 expression are also likely to account for the failure of B cells
to reach the light zone of germinal centres, a developmental step which is tightly regulated by cytokines.
Keywords Theileria annulata cytokines T cells interferon-gamma
INTRODUCTION
The protozoan parasite of cattle Theileria annulata resides in
macrophages during the pathogenic macroschizont stage of its
life cycle [1-3]. This tick-borne parasite is of particular interest, as
European cattle are extremely susceptible to disease caused by the
parasite—Tropical Theileriosis—and this proves a serious barrier
to improvement of cattle in endemic areas such as North Africa and
India. The macroschizont stage of T. annulata does not reside in
the endocytic system of the macrophage [4], and differs from
other well characterized intra-macrophage protozoans such as
Leishmania and Toxoplasma by 'transforming' the parasitized
macrophage into continuous cell cycle. The parasite induces an
aggressive infection in susceptible cattle, characterized by expan¬
sion of parasite-infected cells in the lymph node draining the tick
bite site, accompanied by fever, anaemia, cachexia and anoxia
[5,6], The host immune response is apparently unable to contain
the rapidly growing parasite, naive susceptible animals do not
Correspondence: Dr J. D. M. Campbell, Centre for Tropical Veterinary
Medicine, Royal (Dick) School of Veterinary Studies, University of
Edinburgh, Easter Bush, Roslin, Midlothian EH25 9RG, UK.
develop effective immunity, and death from experimental infection
often occurs within 2-3 weeks, depending on the dose of parasite
[7,8],
Intracellular protozoan parasites which reside in myeloid line¬
age cells are now recognized to be controlled largely by T helper-1
(Thl) cytokine responses. In particular, resolution of infection with
both Leishmania spp.. To. gondii and Trypanosoma cruzi depends
on the action of IFN-7, which may either have direct anti-parasite
effects or induce activation of the parasitized macrophage to reject
the parasite [9-13]. Both anti-T. annulata cytotoxic T lymphocytes
(CTL) [14,15] and lFN-7-mediated induction of nitric oxide (NO)
production by macrophages [16] can be demonstrated from ani¬
mals either rendered immune by treatment with the napthoquinone
drug Butalex, or immunized with attenuated macroschizont
infected cells (CTL responses only). However, T. annulata-
susceptible animals are unable to produce similar effective
responses during primary infections.
The principal candidate mechanism for immune response
failure is the augmented T cell-activating capability displayed by
T. annulata. Macroschizont-infected macrophages are able to
activate most peripheral T cells from unexposed animals in a
© 1997 Blackwell Science 463
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contact-dependent mechanism, with IL-1 production by the
infected cells implicated in driving T cell activation [17-19],
Although the antigenic element responsible for T cell activation
has yet to be identified, the stimulatory element is unlikely to be a
mitogen, as the kinetics of T cell responses to infected cells is
similar to antigen-stimulated cells [18],
We have recently shown that this altered T cell-activating
ability associated with infected cells disrupts normal T cell
activation during in vivo infection—the vast majority of draining
lymph node T cells are activated 'non-specifically' by infected
macrophages. This is followed by failure of T cells to enter normal
immune response pathways [18], The clearest evidence to date that
this disrupts normal immune mechanisms is the loss of germinal
centre morphology in the infected lymph nodes [18],
An understanding of the effects of this early T cell activation by
the parasitized macrophages is an essential step towards an under¬
standing of disease pathology, and ultimately the design of new
therapies. Here we show that infection of susceptible animals with
T. annidata sporozoites induces a rapid production of IFN-7, and
this response is not tightly controlled and damped down as found in
immune animals. We further show that parasite-activated T cells
preferentially produce IFN-7 mRNA. As well as having no
inhibitory effect on the growth of infected macrophages, the
unregulated IFN-7 response is associated with local failure of B
cell responses, with B cells failing to reach the light zone of
germinal centres in infected lymph nodes.
MATERIALS AND METHODS
Animals
Peripheral blood for in vitro studies was obtained from normal,
healthy Friesian or Friesian cross female or castrated male cattle
aged 6 months or older. Calves used for lymph node studies were
aged 2 months or older (see individual sections below).
Theileria annulata-infected cell lines
Theileria annulata macroschizont-infected cell lines (TaCL)
(Hissar or Ankara strain [20,21]) from the animals tested were
prepared as previously described [17], Cell lines were used at low
passage number (2-20).
Cell preparation
Peripheral blood mononuclear cells (PBMC) were separated using
Ficoll-Hypaque (Lymphoprep; Nycomed. Oslo. Norway) as pre¬
viously described [22]. Complete tissue culture medium was used
throughout the experiments [23],
Culture of PBMC
PBMC were cultured with TaCL essentially as described pre¬
viously [18,19]. Briefly, PBMC were cultured with autologous
irradiated (75 Gy) TaCL in 6 x 10 ml well plates (Life Tech¬
nologies, Paisley, UK). PBMC (8 x 106/ml):TaCL ratios were
either 10:1 or 20:1 (optimum stimulation ratios were determined
previously (results not shown)). A total of seven different TaCL
from four unrelated cattle were examined. PBMC (2-5 x 106/ml)
were stimulated with 5 /rg/ml concanavalin A (Con A; Sigma.
Poole. UK) to provide a 'control' population of activated T cells.
Stimulated cells were harvested at various times (1-7 days)
for reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis.
Theileria annulata-infected lymph node material
Archival frozen or paraffin-embedded lymph nodes from T. annu
Zato-infected animals were used to examine cytokine profiles ant
for more detailed examination of the previously reported germina
centre breakdown [18]. Animals had been infected with T. annu
lata sporozoites in the shoulder, and nodes excised during tht
course of infection [18], Normal prescapular lymph nodes wert
examined alongside draining (i.e. site of parasite development) anc
non-draining lymph nodes removed from calves 2, 4, 8 and 10 day:
post-sporozoite infection. Thin (2-5-3 /jm) sections were cut fron
paraffin blocks and used for immunohistology. Lymph node:
stored at —70°C in sterile OCT medium (BDH-Merck, Lutter¬
worth, UK) were used for RT-PCR analysis (see below). In addi¬
tion, cells isolated using a tissue homogenizer (Jencons Scientific,
Leighton Buzzard, UK) from lymph nodes at the time of excision
were assessed for cytokine mRNA.
Immunohistochemistry
Immunohistochemistry using the ABC system was carried out on
lymph node sections using MoAb VPM30 (germinal centre B cells
[18]), MIB 1 (Ki-67 proliferation antigen [24]) and anti-human
CD3 (Dako A452; Dako, Glostrup, Denmark), as previously
described [25], with the following modifications: sections to be
stained with MoAb MIB 1 were microwave-treated as previously
described [24]; sections for use with anti-human CD3 were treated
with pronase as previously described [25], Double staining was
carried out by first staining sections with VPM30 or CD3 followed
by microwave treatment and staining with MIB 1 (microwave
treatment effectively 'kills' residual avidin-biotin or antibody
activity from the first round of staining). Staining was visualized
using diaminobenzidine (DAB) as a substrate for horseradish
peroxidase (HRP) and vector red (Vector Labs, Peterborough,
UK) as a substrate for alkaline phosphatase.
Efferent lymph samples
Cryopreserved cell-free bovine efferent lymph samples [27] gen¬
erated during a previous study (A. K. Nichani et al., manuscript in
preparation) were examined for IFN-y. Briefly, two of the animals
were untreated and efferent lymph was collected for 5-6 days to
monitor baseline IFN-y levels. Two animals were infected with 0-1
TE (tick equivalent) of Gharb strain [28] T. annulata sporozoites
and developed severe clinical theileriosis. The animals were
treated with Butalex (2-5 mg/kg body weight: Pitman-Moore.
Uxbridge, UK) as soon as feed intake declined, making a full
recovery. Efferent lymph was collected for 10 or 11 days post¬
infection before drug treatment was necessary. One animal which
had been rendered immune by infection with sporozoites and
treatment with Butalex was re-infected with 2 TE Gharb strain
sporozoites and monitored over the same period.
IFN-y assay
IFN-y was assayed in efferent lymph using a commercially
available ELISA assay (bovine y-interferon kit; CSL Diagnostics,
Victoria, Australia) according to the manufacturer's instructions.
Highly positive lymph samples were diluted up to eight times in
PBS in order to obtain results within the range of the detection
system. Quantification of IFN-y was performed by titrating known
quantities of recombinant bovine IFN-y diluted in PBS in the
ELISA plate alongside lymph samples. (Recombinant IFN-y,
activity 4 x 106 U/mg, kind gift of Dr R. A. Collins, IAH.
Compton, UK.)
© 1997 Blackwell Science Ltd, Clinical and Experimental Immunology, 108:463-470
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Day 2 Day 5
Fig. 1. Reciprocal of mean numbers of polymerase chain reaction (PCR)
cycles required to detect glyceraldehyde-3-phosphodehydrogenase
(G3PD), IL-4, and IFN-y cDNA from Theileria annulata macroschizont-
infected cell line (TaCL)-stimulated peripheral blood mononuclear cells
(PBMC) after 2 days (n = 6) and 5 days (n = 7). Error bars = s.e.m. Where
no error bars are present no variance was found between samples. *n = 6,
one cell line did not induce any detectable IL-4 product in PBMC.
RT-PCR analysis
Although a bovine IFN-y ELISA was used in this study, this kit is
designed for use with serum products, and results with tissue
culture samples were found to be unreliable. Also, a bioassay
was unavailable for IL-4. As a result, cytokine production was
assayed using RT-PCR analysis. In vitro stimulated PBMC or
lymph node tissue were examined for the levels of expression of
mRNA for IL-2, CD25, IL-4 and IFN-y using a previously
described semiquantitative RT-PCR technique [19,26], Total
RNA was isolated using the RNeasy system (Quiagen, Dorking,
UK) according to the manufacturer's instructions. In vitro stimu¬
lated cells (>107 cells) were washed twice in PBS before RNA
isolation, frozen cells were allowed to thaw at 37°C and washed
twice in PBS. Frozen lymph nodes were cut from the OCT medium
using sterile scalpels and approximately lOOmg of tissue used for
RNA isolation.
Total RNA (5 /xg) was reverse transcribed using the Superscript
system (Life Technologies). cDNA (2 /z.1) was subjected to differ¬
ent numbers of amplification cycles (20-30) and the products were
examined on 2% agarose gels. Comparison of the cycle at which
the PCR products became visible was used to assess the relative
expression of the cytokine mRNA species [19], Although this
method does not allow direct comparison of mRNA abundance
across cytokine primer pairs, it does afford a good estimate of the
same mRNA expression after different treatment of cells. The
expression of /3-actin or glyceraldehyde-3-phosphodehydrogenase
(G3PD) was used as an internal control for these reactions. Primer
sequences for /3-actin have been previously described [26], primer
sequences for G3PD were the kind gift of Dr B. Mertens (ILRI,
Kenya).
RESULTS
Incubation with T. annulata macroschizont-infected cells induces a
dominant IFN-y response in peripheral blood T cells
When T cells are activated by autologous TaCL, peak levels of
surface activation marker expression (CD25 and MHC class II) are
achieved within 48 h, with maximum proliferation at day 5 [18].
The cytokine profiles of cells responding to TaCL were examined
at these timepoints in this study (Figs 1 and 2). All seven TaCL
cell lines consistently induced higher levels of IFN-y mRNA
H3 G3PD IL-4 IFN-y
22 24 26 28 22 24 26 28 22 24 26 28
Fig. 2. Limited cycle analysis (cycles 22-28) from a representative animal after 5 days stimulation of peripheral blood mononuclear cells
(PBMC) with an autologous Theileria annulata macroschizont-infected cell line (TaCL). While glyceraldehyde-3-phosphodehydrogenase
(G3PD) and IFN-y are easily detected after 22 cycles, IL-4 is only faintly detected at cycle 28 (arrowed). H3. Hoe 111 markers.
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Table 1.
Cycles to Cycles to
Animal Treatment detect IL-4 detect IFN-y
12 929 TaCL NP 20
Con A 22 20
13 050 TaCL 28 20
Con A 22 20
10814 TaCL 28 20
Con A 20 20
NP, No product detected; TaCL, Theileria annulata macroschizont-
infected cell line; Con A, concanavalin A.
production than IL-4 in responding PBMC, with the former
product easily detectable after 20 cycles in all but one case (22
cycles, 48 h incubation). IL-4 products were never detected until at
least 26 cycles of amplification. One cell line did not induce any
detectable IL-4 message at day 5.
Working at maximum efficiency, PCR amplification is loga¬
rithmic, indicating that each molecule of IFN-y cDNA, when
detected at 20 cycles, required 218 (262 144) amplifications to
detect a product. When IL-4 was detected at all, 26-30 cycles
were required—224 (4194 304) to 228 (268 435 456) amplifica¬
tions. IFN-y cDNA is therefore present in far greater amounts
than IL-4 cDNA in TaCL-activated PBMC.
The consistent low abundance of IL-4 mRNA was not due to
primer inefficiency, but specifically associated with the activation
of PBMC by TaCL. When levels of IL-4 versus IFN-y mRNA
production by T. annulata-activated PBMC from three animals
were compared with Con A-stimulated PBMC at their time of peak
proliferation (5 and 3 days, respectively), Con A activation induced
140
3 4 5 6 7
Days post-infection
10 11
Fig. 3. Levels of IFN-y protein detected in the efferent lymph of two naive
Theileria annulata-infected animals and one previously immunized animal.
■. Naive 1; ♦. naive 2; A. immune.
very similar levels of IL-4 mRNA and IFN-y mRNA, whereas
incubation with parasite-infected cells always induced far highet
levels of IFN-y mRNA production than IL-4 (Table 1). Simple
'activation' of PBMC therefore does not lead to noticeable differ¬
ences in levels of IL-4 and IFN-y mRNA amplified, suggesting
that incubation with TaCL is specifically inducing higher IFN-y
production.
In vivo infection induces an extremely strong Thl response
To determine whether high IFN-y levels were also found during in
vivo infection, lymph efferent from infected nodes was examined-
by ELISA. Lymph from uninfected resting lymph nodes showed no
H3
Normal lymph node
G3PD IL-2 CD25 IL-4 IFN-y
Day 4 sporozoite-infected lymph node
A IL-2 CD25 IL-4 IFN-y
Fig. 4. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis
of bovine lymph nodes. In a normal node. IL-2, CD25, IL-4 and IFN-y
mRNA are present. Four days after infection with Theileria annulata, IL-4
and CD25 products can no longer be detected in the draining lymph node.
G3PD. glyceraldehyde-3-phosphodehydrogenase. H3, HaeIII markers.
Fig. 5. Germinal centre within a non-draining lymph node 8 days post-sporozoite infection. Both MIB-1+ dark zone cells (D, stained brown)
and VPM30+ light zone B cells (L, stained red) are present. (x400, DAB and vector red.)
Fig. 6. Residual germinal centre within a day 8 sporozoite-infected draining lymph node (same animal as Fig. 5). Despite the continued
presence of both a CD3 ' T cell zone (T. stained red) and M IB 1+ dark zone (D. stained brown), no VPM30 staining was found in the germinal
centre. Mantle zone marked with dotted line. (x650. DAB and vector red.)
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Figure 6
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elevation of IFN-7 levels (results not shown). Lymph efferent from
nodes draining the site of sporozoite infection in two naive
susceptible animals showed very large increases in IFN-7 produc¬
tion (Fig. 3). Over a 6-day period (days 4-9 of infection) a total of
>2 x 106 U of IFN-7 was detected in the efferent lymph of both
naive infected animals. In contrast, lymph efferent from infected
draining lymph nodes of an immune animal showed only transient
increases in IFN-7 levels (Fig. 3), containing 1-1 x 105U of the
cytokine over the same 6-day period. IFN-7 production in the
immune animal appeared to 'shut down' quickly, as the small peak
of cytokine production present 7 days post re-infection quickly
dropped.
Draining lymph node cytokine mRNA production was assessed
by RT-PCR during the peak period of IFN-7 production. Easily
detectable in normal lymph nodes, IL-4 mRNA or CD25 mRNA
was not detectable in draining lymph node cells within 4 days of
sporozoite infection (Fig. 4). This loss of IL-4 mRNA production
was found both in fresh preparations from isolated lymph node
cells and archival frozen lymph node tissue blocks.
Germinal centre pathology is consistent with a dominant Thl
cytokine response
In vitro, IFN-7 has been demonstrated to interfere with B cell
development by inhibiting expression of surface immunoglobulin
after the initiation of proliferation [29-31]. We have previously
shown that T. annulata-infected lymph nodes lose germinal centre
(GC) light zone morphology from 8 days post-infection [18]. Here
we examined GC morphology in more detail. T cells, proliferating
dark zone cells, and VPM30+ light zone B cells were found to be
present within GC in normal and non-draining lymph nodes from
infected animals (Fig. 5). However, although T cells and prolifer¬
ating dark zones were found in infected lymph node GC (Fig. 6),
VPM30 light zone B cell staining was completely lost from all
infected GC by day 8 of infection. The previously reported loss of
germinal centre morphology was therefore due to a failure of B
cells to pass into the light zone rather than physical destruction by
the growing parasite.
DISCUSSION
Theileria annulata-infected macrophages possess augmented anti¬
gen presentation capabilities, as they are capable of activating up to
70% of peripheral T cells from unexposed animals [18], In T.
annulata infection of susceptible animals, there is evidence of
large alterations in immune responses. Infected lymph nodes are
characterized by rapidly proliferating infected cells, T cells are
primarily activated 'non-specifically' by the parasite, and there is a
virtually complete loss of B cell GC. The parasite has therefore
developed a survival strategy which not only allows infected cells
to flourish, but which also disrupts normal immune responses.
Highly successful survival strategies have been developed by intra-
macrophage protozoans such as Leishmania and To. gondii based
on inducing Th2 cytokine responses in their hosts, which counter¬
act the Thl responses which can effectively clear infections [9-
13]. In this study we have examined cytokine responses induced by
T. annulata-medialed activation of T cells both in vitro and in vivo,
and their implications for the induction of effective immune
responses. During infection of naive animals leading to severe
clinical theileriosis, IFN-7 levels in efferent lymph rose sharply,
with approximately 20 times more cytokine produced by naive
animals than by an immune animal. The high IFN-7 levels were
accompanied by a loss of IL-4 mRNA production in naive animals.
Unlike other intra-macrophage parasites such as Leishmania spp.
and To. gondii, the skewing of the host response towards Thl cyto¬
kine production does not confer immunity in T. annulata infection.
Indeed, the peak time of IFN-7 production (4-9 days) coincides
with the time when parasite-associated leuco-proliferation is great¬
est in infected lymph nodes, accompanied by the appearance of
large numbers of macroschizont-infected cells [18]. Theileria
annulata not only survives in the face of greatly increased IFN-7
production, but appears to actively encourage the induction of a
Thl response. IFN-7 is unlikely to be produced directly by T.
aww/attf-infected cells, as mRNA for this cytokine is not usually
found in parasitized macrophages [19]. In vitro activation of T cells
by all T. annulata-infected cell lines induced the production of far
higher levels of IFN-7 mRNA (at least x64 more) than IL-4 mRNA.
Most infected draining lymph node T cell activation is 'non¬
specific' in response to the parasite [18], As production of IFN-7 in
the efferent lymph peaks after large numbers of T. annulata-
activated T cells are established in the node [18], it seems likely
that the parasite is inducing IFN-7 production via non-specific
activation of T cells. Although remaining greatly elevated above
levels seen from an immune animal, efferent lymph IFN-7 levels
do drop partially after 8 or 9 days post-infection. This corresponds
to the times when parasite-activated T cells are seen to leave the
lymph node in the efferent lymph (A. K. Nichani et al., manuscript
in preparation) and further strengthens the link between T
cells 'non-specifically' activated by parasitized cells and IFN-7
production.
The specific induction of an IFN-7-dominated response from T.
annulata-activaied T cells goes some way towards clarifying the
impact of the wide range of cytokine mRNAs produced by
parasite-infected macrophages upon immune responses to the
parasite. Parasitized cells express mRNA for IL-lo;, IL-1/3, IL-6,
IL-10, tumour necrosis factor-alpha (TNF-a) [19] and the p35 and
p40 subunits of IL-12 (J. D. M. Campbell and D. J. Brown,
unpublished observations). Although a role for IL-lo: and IL-6
has been proposed in the induction of T cell proliferation by the
infected cells [19], the biological outcomes of the simultaneous
production of antagonistic cytokines such as IL-10 and IL-12
[32-35] from the same cell were unknown. The results of this
study clearly show that the net influence of T. annulata-infected
cells on their environment is induction of a Thl response, both in
vitro and in vivo.
The induction of a Thl response by T.annulata-infected cells
via T cells is not likely to be purely driven by the antigen
responsible- for the T cell activation. When T cells were simply
'turned on' using Con A, the numbers of PCR cycles required to
detect IL-4 or IFN-7 were similar, agreeing with other studies
which showed that mitogen activation of T cells without the
addition of cytokines to skew responses has the potential to
induce either Thl or Th2 responses [36]. This also holds true for
'genuine' antigens—identical Leishmania infections in the same
inbred strain of mice can lead to either a Thl or Th2 response,
depending on the cytokines used to influence the response [37].
Also, staphylococcal superantigens induce a non-skewed cytokine
response in reacting T cells in the absence of other stimuli [38]. It
seems most likely that the induction of a dominant Thl response in
T cells responding to activation by T. annulata is due to the
influence of infected cell-derived cytokines after the initial 'hit'
of activation by the parasite. In an immune animal, IFN-7 produc¬
tion appeared to be tightly controlled, as only two small bursts of
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cytokine were seen in the efferent lymph. As this control mechan¬
ism is evidently absent from naive infected animals, this would
again suggest that the T. annulata-infected cells are producing
factors which strongly promote IFN-y production and are antagon¬
istic to normal control mechanisms. One obvious candidate for
the induction of IFN-y from responding T cells in naive animals is
IL-12 production by infected cells [39], and although mRNA for
this cytokine is made by infected cells, further work will be
required to determine its significance.
Protection afforded by IFN-y against pathogens which para¬
sitize macrophages is mediated through activation of the host cell
to reject the parasite [9], This is obviously not a protective
mechanism in T. annulata, although the NO intermediates asso¬
ciated with killing of intra-macrophage organisms can be detected
from infected cells [16]. As T. annulata does not parasitize the
endocytic system of the macrophage, but exists in discrete
membrane-bound vacuoles in the cytoplasm [4], it is likely that
it can avoid lysosome-mediated damage. Indeed, it is perhaps
unsurprising that T. annulata does not appear to be killed by
responses designed to activate macrophages, as infection with
the parasite induces an activated surface phenotype in the host
macrophage [3].
IFN-y has been demonstrated in vitro to interfere with B cell
development, after B cells have been induced to proliferate [29]. In
this study we demonstrate a similar phenomenon in vivo. Once
high levels of IFN-y were produced in infected lymph nodes
accompanied by an apparent loss of IL-4 production, germinal
centres were found to be 'arrested' at the proliferating dark zone
stage, with no B cells entering the light zone. Entering the light
zone is dependent upon the expression of antigen-specific immu¬
noglobulin [40]. B cells are particularly sensitive to IFN-y after
initial proliferation, before immunoglobulin is expressed [29], and
a lack of IL-4 also inhibits immunoglobulin production [30,31], It
is likely that the failure of B cells to progress to light zones in the
infection studied here is due to the action of IFN-y inhibiting
immunoglobulin-dependent selection.
In this study we have shown that, contrary to recognized
mechanisms for rejection or survival of similar organisms, the
intra-macrophage protozoan T. annulata specifically induces
the production of greatly elevated levels of IFN-y. The critical
step in the induction of IFN-y is the 'non-specific' activation of T
cells by T. annulata-infected macrophages. These findings provide
the first evidence of a mechanism for T. annulata to avoid
destruction by the immune system. Identification of both the
antigenic element and infected cell cytokines which induce the
non-protective Thl response in parasite-activated T cells is now
essential.
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